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ABSTRACT	  
Role	  of	  Microtubule	  Motor	  Proteins	  in	  Adenoviral	  Infections	  Julian	  Scherer	  	  Viruses	   have	   been	   described	   as	   a	   piece	   of	   nucleic	   acid	   surrounded	   by	   bad	   news.	  	  These	  bad	  news	  determine	  host	  specificity,	  pathogenicity,	  and	  virulence.	  	  In	  the	  case	  of	  adenovirus,	  a	  non-­‐enveloped	  double-­‐stranded	  DNA	  virus	  that	  causes	  self-­‐limiting	  disease	   in	   healthy	   individuals	   but	   can	   cause	   severe	   and	   even	   fatal	   infection	   in	  immunocompromised	   patients,	   the	   bad	   news	   can	   be	   reduced	   to	   the	   viral	   capsid.	  	  The	  adenoviral	  capsid	  mainly	  consists	  of	  three	  proteins	  (fiber,	  penton	  base,	  hexon),	  which	  form	  a	  rigid	  shell	  to	  protect	  the	  viral	  genome	  outside	  of	  host	  cells.	  	  However,	  they	  are	  able	  to	  orchestrate	  a	  precise	  disassembly	  program	  initiated	  once	  the	  next	  susceptible	   cell	   is	   reached,	   leading	   to	   step-­‐wise	   virus	   entry,	   controlled	   capsid	  disintegration,	   efficient	   DNA	   delivery,	   and	   production	   of	   progeny	   virus.	  	  Understanding	   adenovirus	   entry	   is	   not	   only	   beneficial	   for	   pathogenic	   but	   also	  therapeutic	   reasons	   since	   adenoviruses	   have	   become	   an	   increasingly	   popular	  vaccine	   and	   gene	   transfer	   vector	   due	   to	   their	   ability	   to	   infect	   a	   large	   array	   of	  dividing	   and	   post-­‐mitotic	   cells,	   their	   large	   DNA	   capacity,	   and	   easy	   amplification.	  	  Attachment	   to	   cell	   surface	   receptors	   leads	   to	   cellular	   signaling	   events,	   some	   of	  which	   regulate	   receptor-­‐mediated	   uptake	   into	   clathrin-­‐coated	   pits.	   	   Conditions	  inside	   the	   endosome	   trigger	   escape	   of	   the	   virions	   from	   the	   organelle	   through	  membrane	  disruption	  5-­‐15	  min	  post-­‐infection	  and	  most	  capsids	  gain	  access	   to	   the	  nucleus	   about	   30-­‐45	   min	   thereafter.	   	   Interestingly,	   adenovirus	   relies	   on	   the	  
microtubule	   (MT)	   network,	   MT-­‐dependent	   motor	   proteins,	   and	   virus-­‐stimulated	  cAMP-­‐activated	   kinase	   (protein	   kinase	   A,	   PKA)	   activity	   to	   traverse	   the	   cytoplasm	  during	   the	   critical	   intracellular	   transport	   phase	   between	   endosomal	   escape	   and	  nuclear	  pore	  complex	  attachment.	  	  The	  main	  virus	  transporter	  is	  the	  MT	  minus-­‐end	  directed	  motor	   protein	   complex	   cytoplasmic	   dynein,	  which	   functions	   in	   organelle	  positioning,	  cell	  migration,	  cell	  division,	  and	  cell	  differentiation	   in	  uninfected	  cells.	  Cytoplasmic	  dynein	   subunits	  known	   to	   interact	  with	  physiological	   cargo	  also	  bind	  directly	   to	   the	   adenovirus	   capsid	   protein	   hexon,	   which	   remains	   with	   the	   viral	  genome	  until	   its	  delivery	   through	  the	  nuclear	  pore	  complex.	   	  Strikingly,	   for	  strong	  binding	   to	   cytoplasmic	   dynein,	   hexon	   requires	   an	   acidification	   step,	   indicating	   an	  additional	  functional	  role	  of	  the	  passage	  through	  the	  acidic	  endosomal	  lumen	  during	  entry,	  priming	  of	  hexon	  for	  cytoplasmic	  dynein	  binding.	  	  	  Here,	  we	  continue	  previous	  research	  of	  the	  hexon	  –	  dynein	  interaction	  and	  describe	  the	  determinants	  of	  dynein-­‐mediated	  capsid	   transport	   in	   further	  detail.	   	  We	  show	  that	  the	  requirement	  for	  stimulated	  PKA	  activity	  on	  MT	  minus-­‐end	  directed	  motility	  involves	  a	  PKA	  phosphorylation	  site	  in	  the	  dynein	  light	  intermediate	  chain	  1	  (LIC1).	  	  PKA	  phosphorylation	  or	  a	  phosphomimetic	  mutation	  increase	  hexon	  binding	  of	  LIC1	  in	  vitro	  and	  RNAi	  rescue	  experiments	  confirm	  a	  clear	  role	  of	  PKA	  phosphorylation	  in	  adenovirus	   redistribution	   to	   the	   nucleus.	   	   To	   our	   surprise,	   the	   same	  phosphorylation	  site	  also	  plays	  a	   role	   in	  positioning	  of	   lysosomes/late	  endosomes	  (lyso/LE)	   a	   class	   of	   organelles	   shown	   to	   be	   under	   PKA	   control	   in	   other	   systems.	  	  However,	   in	  contrast	  to	  dynein-­‐mediated	  viral	  cargo	  transport	  which	  is	  stimulated	  upon	   phosphorylation,	   dynein-­‐mediated	   lyso/LE	   motility	   is	   strongly	   reduced	  
leading	  to	  lyso/LE	  dispersal	  into	  the	  periphery.	  	  Hence,	  during	  adenoviral	  infections,	  stimulation	  of	  PKA	  activity	  mediates	   two	  distinct	   functions,	   lyso/LE	  dispersal	   and	  efficient	  capsid	  transport.	  Remarkably,	   adenovirus	   transport	   is	   not	   only	   mediated	   by	   cytoplasmic	   dynein	  towards	   the	   cell	   center	   but	   also	   by	   opposite	   polarity	   motors	   towards	   the	   cell	  periphery	  leading	  to	  bidirectional	  capsid	  motility	  along	  MTs,	  similar	  to	  endogenous	  cargo.	   	   The	   motility	   pattern	   implies	   the	   involvement	   of	   members	   of	   the	   kinesin	  family,	  which	  are	  MT	  plus	  end	  directed	  motor	  proteins	  regulating	  MT	  dynamics,	  cell	  division,	   and	   organelle	   transport	   in	   uninfected	   cells.	   	   We	   provide	   evidence	   for	   a	  direct	  capsid	  interaction	  with	  kinesin-­‐1,	  which	  shows	  striking	  differences	  from	  the	  interaction	  between	  the	  capsid	  and	  cytoplasmic	  dynein.	  	  Kinesin	  binding	  appears	  to	  occur	  independent	  of	  low	  pH	  treatment	  of	  the	  virion	  and	  independent	  of	  hexon,	  but	  is	  very	  likely	  mediated	  through	  the	  capsid	  protein	  penton	  base.	  In	   addition,	   we	   also	   explored	   the	   pH	   dependent	   change	   in	   hexon	   affinity	   for	  cytoplasmic	   dynein	   by	   testing	   the	   viral	   capsid	   protein	   for	   structural	   changes	   at	  acidic	   pH	   conditions.	   	   In	   its	   native	   form	   inside	   the	   capsid	   or	   as	   soluble	   antigen,	  hexon	   is	   present	   as	   a	   tightly	   associated	   trimer,	   which	   is	   resistant	   to	   elevated	  temperature,	   high	   ionic	   strength,	   detergent	   treatment,	   and	   low	  pH.	   	   However,	  we	  now	  show	  that	   low	  pH	   treatment	  strongly	   increases	   the	  sensitivity	  of	   the	   trimeric	  structure	   to	   SDS,	   leading	   to	   hexon	  monomerization.	   	   These	   data	   indicate	   a	   subtle	  structural	   change	   in	   the	   hexon	   polypeptide	   upon	   low	   pH	   treatment,	   increasing	  dynein	  affinity	  and	  SDS-­‐sensitivity.	  	  
Taken	   together,	   the	   here	   presented	   work	   contributes	   to	   our	   understanding	   of	  adenovirus	   entry,	   especially	   during	   the	   cytoplasmic	   transport	   phase,	   and	   reveals	  mechanisms	   of	   finely	   orchestrated	   host-­‐pathogen	   interactions	   at	   the	   evolutionary	  interface	  of	  viral	  attack	  and	  cellular	  host	  defense.	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Chapter	  1:	   Introduction	  to	  Microtubule	  Motor	  Proteins	  
and	  Adenovirus	  Entry	  and	  Transport	  
	  
1.1.	  MT	  Motors	  All	   transport	   processes	   inside	   eukaryotic	   cells	   are	   mediated	   by	   molecular	   motor	  proteins	  of	  the	  myosin,	  kinesin,	  and	  dynein	  families.	   	  Whereas	  myosins	  translocate	  along	   actin	   filaments,	   kinesins	   and	   dyneins	   use	   microtubules	   (MT)	   for	   transport	  towards	  MT	  plus	  or	  minus	  ends,	   respectively.	   	  The	  MT	  network	   is	   centered	  at	   the	  MT	  organizing	  center	  (MTOC),	  which	  in	  most	  cells	  is	  located	  close	  to	  the	  nucleus	  and	  bundles	   the	   slow	  growing	  minus	   ends	  of	   the	  MT.	   	  The	   fast-­‐growing	  MT	  plus	   ends	  radiate	  into	  the	  cell	  periphery	  and	  hence	  set	  a	  polarity	  for	  MT	  based	  transport	  with	  cytoplasmic	  dynein	  moving	  towards	  the	  cell	  center	  (in	  the	  retrograde	  direction)	  and	  kinesins	  towards	  the	  plasma	  membrane	  (anterograde).	  	  As	  the	  founding	  member	  of	  the	  kinesin	  class	  of	  motor	  proteins,	  kinesin-­‐1	  was	  first	  described	  about	  30	  years	  ago	  (Allen	   et	   al.,	   1982;	   Brady	   et	   al.,	   1982;	   Vale	   et	   al.,	   1985)	   and	   shares	   structural	  homology	  with	  myosin,	  especially	  in	  their	  motor	  domains.	  	  Subsequently,	  more	  than	  50	   different	   kinesins	   have	   been	   characterized,	   grouped	   in	   15	   families	   based	   on	  sequence,	   structure	   and	   their	   function	   in	   MT	   minus	   or	   plus	   end	   directed	  translocation	   and	   MT	   depolymerization	   (Hirokawa	   et	   al.,	   2009;	   Lawrence	   et	   al.,	  2004).	  	  Cytoplasmic	  dynein	  1	  was	  identified	  as	  a	  high-­‐molecular	  weight	  (HMW)	  MT	  associated	   protein,	   previously	   named	   MAP1C	   (Paschal	   et	   al.,	   1987;	   Paschal	   and	  Vallee,	   1987).	   Besides	   cytoplasmic	   dynein	   1	   (described	   below),	   there	   also	   exist	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cytoplasmic	  dynein	  2	  and	  axonemal	  dyneins.	  	  Cytoplasmic	  dynein	  2	  is,	  together	  with	  kinesin-­‐2,	   responsible	   for	   intraflagellar	   transport	   and	   the	   concerted	   activity	   of	  axonemal	  dyneins	  provide	  the	  mechanical	  force	  to	  generate	  the	  flagellar	  waveform	  (Gibbons	  and	  Rowe,	  1965).	  	  1.1.1.	  Cytoplasmic	  Dynein	  1	  1.1.1.1.	  Structure	  and	  Force	  Production	  Cytoplasmic	   dynein	   1	   (herein	   referred	   to	   as	   “dynein”	   unless	   noted	   otherwise)	  represents	   a	   1.5MDa	   protein	   complex	   that	   consists	   of	   dimers	   of	   the	   heavy	   chain	  (DHC),	   one	   of	   two	   different	   intermediate	   chains	   (IC1	   and	   IC2),	   light	   intermediate	  chains	   (LIC1	   and	   LIC2),	   and	   up	   to	   three	   classes	   of	   light	   chains	   (LC8,	   TcTex,	   and	  LC7/Roadbock)	   (Paschal	   and	   Vallee,	   1987;	   Pfister	   et	   al.,	   2005)	   and	   can	   be	  structurally	   divided	   in	   a	  motor	   and	   tail	   domain	   (Figure	   1-­‐1).	   	   The	  motor	   domain	  consists	  of	  the	  C-­‐terminal	  part	  of	  the	  DHC	  organized	  in	  a	  ring	  shaped	  arrangement	  of	  six	  ATPase	  Associated	  with	   several	   cellular	  Activities	   (AAA)	   domains,	  which	   have	  structural,	  regulatory,	  and	  force	  generating	   function.	   	  AAA+	  proteins	  are	  known	  to	  contain	  P-­‐loop	   sequences	   required	   for	  ATP	  hydrolysis	   and	   function	  by	   connecting	  ATP-­‐mediated	   conformational	   changes	   to	   chemo-­‐mechanical	   motions	   that	   are	  propagated	   to	   a	   target	  macromolecule	   (Erzberger	   and	   Berger,	   2006).	   	   Nucleotide	  binding	   and	   hydrolysis	   defines	   at	   least	   two	   distinct	   conformational	   states	   and	  therefore	   these	  proteins	  act	  as	  molecular	  switches.	   	  The	  ability	   to	  switch	  between	  conformations	   in	   a	   coordinated	   and	   tunable	   fashion	   results	   in	   efficient	   and	  processive	  molecular	  motors	  like	  dynein.	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  Figure	  1-­‐1:	  Dynein	  Structure.	  (A)	  Model	  diagram	  of	  cytoplasmic	  dynein	  complex	  translocating	  along	  a	  microtubule	  (MT).	   	  The	  motor	   complex	   can	  be	  divided	   into	   a	   tail	   domain	  and	   force	  generating	  motor	  domain.	   	  The	  N-­‐terminal	  tail	  of	  the	  dynein	  heavy	  chain	  (blue)	  interacts	  with	  light	   intermediate	   (pink)	  and	   intermediate	  chains	   (yellow),	  which	   in	   turn	  binds	   to	  the	   dynein	   light	   chains	   LC7	   (orange),	   LC8	   (green),	   and	   TcTex	   (light	   blue).	   	   Cargo	  interactions	   are	   usually	  mediated	   through	   the	   accessory	   subunits	   	   (adapted	   from	  (Scherer	  and	  Vallee,	  2011)).	  (B)	  Motor	  domain	  of	  cytoplasmic	  dynein	  at	  atomic	  detail	  (X-­‐ray	  structure	  from	  (Kon	  et	  al.,	  2012))	  illustrates	  the	  required	  length	  of	  signal	  propagation	  from	  AAA1	  to	  the	  MT-­‐binding	  domain.	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In	  dynein,	  only	  AAA1-­‐4	  are	  known	  to	  bind	  ATP,	  and	  only	  AAA1	  shows	  hydrolysis	  at	  a	  reasonable	  rate	  (Gibbons	  et	  al.,	  1987;	  Mocz	  and	  Gibbons,	  2001).	  	  Binding	  of	  ATP	  to	  AAA2-­‐4	  may	  have	   regulatory	   function	  and	  AAA5-­‐6	  are	   thought	   to	  be	  of	   structural	  importance	  since	  they	  lack	  P-­‐loops	  sequences.	  	  From	  the	  AAA	  ring,	  within	  AAA4,	  the	  stalk	   emerges,	   a	   15nm	   coiled-­‐coil	   loop	   structure	   with	   the	   MT	   binding	   domain	  (MTBD)	   at	   its	   tip.	   	   High-­‐resolution	   x-­‐ray	   crystallographic	   data	   (Kon	   et	   al.,	   2012;	  Schmidt	  et	  al.,	  2012)	  reviewed	  in	  (Hook	  and	  Vallee,	  2012)	  is	  beginning	  to	  illustrate	  the	  structural	  changes	  occurring	  during	  the	  cross-­‐bridge	  cycle	  of	  the	  dynein	  motor	  and	  how	  the	  effect	  of	  ATP	  hydrolysis	  is	  propagated	  through	  the	  AAA	  ring	  and	  stalk	  to	  the	  MTBD	  (Burgess	  et	  al.,	  2003).	  	  Dynein	  motility	  is	  powered	  by	  the	  cross-­‐bridge	  cycle	  of	   the	  motor	  domains	   (Figure	  1-­‐2).	   	  Dynein	  binds	   tightly	   to	  MTs	   in	   the	  apo-­‐state	  when	  no	  nucleotide	  is	  bound	  to	  AAA1.	  	  ATP	  binding	  and	  hydrolysis	  induces	  the	  power	  stroke,	  which	  leads	  to	  release	  of	  the	  MT,	  stepping	  of	  the	  motor	  molecule	  and	  rebinding	  to	  the	  MT.	  MT	  rebinding	  promotes	  a	  concerted	  conformational	  change	  in	  the	  AAA	  ring,	  thereby	  activating	  release	  of	  ADP	  and	  phosphate	  from	  AAA1	  (Burgess	  et	   al.,	   2003)	   and	  preparing	   the	  motor	   for	   the	   subsequent	   cycle.	   Elegant	   structural	  work	  on	   the	  stalk	  has	  elucidated	   that	  during	   the	  cross-­‐bridge	  cycle	   the	  register	  of	  the	  coiled-­‐coil	  changes	  slightly	  resulting	  in	  a	  half-­‐heptad	  shift	  in	  coiled-­‐coil	  registry	  (Carter	   et	   al.,	   2008).	   	   The	   shift	   is	   further	   propagated	   into	   the	  MTBD	   affecting	  MT	  affinity,	   but	   obviously	  MT	  binding	   at	   the	  MTBD	   is	   also	   communicated	  back	   to	   the	  AAA	  ring	  in	  a	  reverse	  fashion	  affecting	  ATP	  turnover	  (Carter	  et	  al.,	  2008).	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  Figure	  1-­‐2:	  Dynein	  Cross-­‐Bridge	  Cycle.	  (A)	  Model	  illustration	  of	  possible	  movements	  of	  dynein	  heavy	  chain	  linker	  sequence	  and	  stalk	   relative	   to	   the	  AAA	  ring	   to	  generate	  movement	  along	   the	  MT	  during	   the	  cross-­‐bridge	  cycle.	   	   (i)	  Post-­‐power	  stroke	  dynein	  binds	   tightly	   to	   the	  MT.	   	   (ii)	  ATP	  binding	   induces	   MT	   release	   and	   primes	   the	   motor	   domain	   for	   the	   power	   stroke.	  	  Rebinding	   to	   the	   next	   tubulin	   dimer	   leads	   to	   ADP	   and	   phosphate	   release	   and	   the	  actual	   power	   stroke	   causing	   linker	   displacement.	   	   (iii)	   Dynein	   reaches	   the	   post-­‐power	   stroke	   state	   indicated	  by	  high	  MT	  affinity	   (illustration	   from	   (Roberts	   et	   al.,	  2009)).	  	  (B)	  Representation	  of	  the	  dynein	  motor	  domain	  in	  non-­‐ATP	  and	  ATP-­‐bound	  states.	   	   ATP	   binding	   alone	   induces	   structural	   rearrangements	   leading	   to	   linker	  (white)	   and	   stalk	   (yellow)	  movements,	   which	   affect	   orientation	   of	   the	   two	   heads	  relative	   to	   each	   other	   and	   MT	   affinity	   in	   the	   MT	   binding	   domain	   (MTBD),	  respectively	  (illustration	  from	  (Carter	  et	  al.,	  2011)).	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Furthermore,	   ATP	   hydrolysis	   in	   AAA1	   is	   not	   only	   propagated	   through	   a	   flexible	  movement	  of	  ring	  to	  the	  stalk	  but	  also	  to	  the	  linker,	  another	  flexible	  part	  of	  the	  DHC	  between	  motor	  domain	  and	  N-­‐terminus	  (Burgess	  et	  al.,	  2003;	  Roberts	  et	  al.,	  2012;	  Schmidt	  et	  al.,	  2012).	  The	  linker	  swing	  together	  with	  tight	  DHC-­‐DHC	  binding	  in	  the	  homo-­‐dimerization	  domain	  (Tynan	  et	  al.,	  2000a)	   	  allows	   for	  movement	  of	   the	   two	  motor	  heads	  relative	   to	  one	  another,	  exerting	  a	  maximal	  stall	   force	  of	  up	  to	  1.1pN	  (Mallik	   et	   al.,	   2004).	   	   Advances	   in	   microscopy	   are	   allowing	   for	   more	   detailed	  descriptions	  of	  the	  dynein	  stepping	  behavior.	  The	  step-­‐size	  of	  dynein	  does	  not	  seem	  to	  be	  restricted	  to	  the	  tubulin	  dimer	  length	  of	  8nm.	  	  It	  has	  been	  shown	  that	  dynein	  steps-­‐sizes	  vary	  as	  multiples	  of	  8nm	  up	   to	  32nm,	  depending	  on	   the	  opposing	   load	  (Mallik	   et	   al.,	   2004),	   indicating	   flexibility	   and	   force-­‐sensing	   within	   the	   motor	  complex.	   	  Furthermore,	  dynein	  has	  been	  shown	   to	   side-­‐step	  off	   the	  MT	  main	  axis,	  using	  multiple	  MT	   filaments	  during	  one	  run	  (Ori-­‐McKenney	  et	  al.,	  2010;	  Qiu	  et	  al.,	  2012).	   	  For	  processive	  movement	  along	  the	  MT	  lattice,	  the	  two	  motor	  domains	  are	  taking	   repetitive	   steps	   in	   a	   stochastic	   and	   coordinated	   fashion,	  which	   leads	   to	   an	  inchworm-­‐like	  motility	  pattern	  (DeWitt	  et	  al.,	  2012;	  Qiu	  et	  al.,	  2012).	  	  Besides	   the	   dimerization	   domain,	   the	   N-­‐terminus	   of	   the	   DHC	   also	   contains	   the	  binding	  regions	   for	  LICs	  and	   ICs	   (Tynan	  et	  al.,	  2000a).	   	  Based	  on	   treatment	  of	   the	  dynein	   complex	   with	   the	   chaotropic	   salt	   potassium	   iodide,	   LICs	   seem	   to	   be	  associated	  more	  tightly	  with	  the	  DHC	  than	  the	  ICs	  which	  in	  turn	  form	  a	  subcomplex	  with	   the	   dynein	   LCs	   (King	   et	   al.,	   2002;	   Kini	   and	   Collins,	   2001).	   	   Further	   evidence	  from	   knock-­‐out	   experiments	   in	   the	   filamentous	   fungus	   A.	   nidulans	   indicates	   that	  LICs	  might	   be	   crucial	   for	   the	   core	   assembly	   of	   the	   dynein	   complex	   (Zhang	   et	   al.,	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2009).	   All	   three	   classes	   of	   accessory	   subunits	   have	   been	   implicated	   in	   cargo	  recruitment	   (Table	   1-­‐1).	   Interestingly,	   the	   dynein	   ICs	   also	   bind	   to	   the	   dynein	  regulators	  dynactin	  and	  NudE/EL	  (Karki	  and	  Holzbaur,	  1995;	  Stehman	  et	  al.,	  2007;	  Vaughan	   and	   Vallee,	   1995)	   and	  might	   represent	   the	  major	   interaction	   hub	   of	   the	  motor	  complex	  (see	  below).	   In	  addition,	  dynactin-­‐p150Glued	  and	  NudE	   	  bind	  to	  and	  compete	  for	  the	  same	  N-­‐terminal	  region	  of	  the	  IC	  (McKenney	  et	  al.,	  2011)	  which	  is	  facing	   towards	   the	  dynein	  motor	  domain	   (Watanabe	  et	   al.,	   2011)	  and	  presumably	  can	   bring	   the	   regulators	   in	   close	   proximity	   to	   the	   motor	   domain,	   in	   addition	   to	  mediating	  possible	  allosteric	  effects.	  	  	  	  Table	  1-­‐1:	  Dynein	  Subunits	  and	  Interacting	  Proteins.	  Non-­‐dynein	  Binding	  Partners	  of	  Dynein	  Subunits.	  Y2H,	  yeast	   two	  hybrid;	   coIP,	   co-­‐immunoprecipitation;	   (1)	   binding	   partners	   that	   show	   an	   interaction	   only	   in	   the	  absence	  of	  IC	  are	  omitted;	  (2)	  for	  a	  complete	  list,	  please	  refer	  to	  (Rapali	  et	  al.,	  2011).	  	  
Subunit binding 
partner 
Assay binding region Reference 
DHC Lis1 Y2H,  
coIP 
pull-down, 
cofractionation 
x-ray strucure 
AAA1,  
649-907, AAA1 
n/a 
 
AAA4 
(Sasaki et al., 2000) 
(Tai et al., 2002) 
(McKenney et al., 
2010) 
 
(Huang et al., 2012) 
 NudE/EL Y2H  (Sasaki et al., 2000) 
IC NudE/EL pull-down, NMR 1-70 (McKenney et al., 
2011; Nyarko et al., 
2012; Stehman et al., 
2007) 
 dynactin 
p150Glued 
coIP, cofractionation, 
pull-down, NMR 
1-70 (Karki and Holzbaur, 
1995; McKenney et 
al., 2011; Morgan et 
al., 2011; Vaughan 
and Vallee, 1995) 
 snapin coIP, pull-down 108-268 (Cai et al., 2010) 
 paxillin coIP reg by S84 PKC 
site 
(Rosse et al., 2012) 
 ZW10 coIP reg by T89 
PLK1 site 
(Whyte et al., 2008) 
IC huntingtin Y2H, pull-down 1-283 (Caviston et al., 2007) 
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 kinesin light 
chains 
Y2H, coIP, pull-down, 
cofractionation 
1-283 (Ligon et al., 2004) 
 Herpes Virus 
UL34 
pull-down 1-228 (Ye et al., 2000) 
 beta-catenin coIP, pull-down  (Ligon et al., 2001) 
 hexon coIP, pull-down 150-250 (Bremner et al., 2009); 
this work 
LIC Zyg12 Y2H C-terminus (Malone et al., 2003) 
 JIP3/unc-16 Y2H, coIP  (Arimoto et al., 2011) 
LIC1 pericentrin coIP, pull-down 140-236 (Purohit et al., 1999; 
Tynan et al., 2000b) 
 Rab4a Y2H 181-302 (Bielli et al., 2001) 
 Mad2 coIP (indirect by 
dynein complex in 
LIC1 RNAi cells) 
 (Sivaram et al., 2009) 
 Kinesin light 
chain 2 
coIP  (Arimoto et al., 2011) 
 hexon coIP, competition 
with dynein complex 
174-348 (Bremner et al., 2009); 
this work 
LIC2 Par3 coIP  (Schmoranzer et al., 
2009) 
 Rab11-Fib3 Blot Overlay  (Horgan et al., 2010a; 
Horgan et al., 2010b)  
LC8  
(1) (2) 
Bassoon Y2H, coIP, pull-down, 
Biosensor 
 (Fejtova et al., 2009) 
 swallow Y2H, pull-down  (Schnorrer et al., 
2000) 
 NOS1 Y2H, coIP  (Jaffrey and Snyder, 
1996) 
 IκBα Y2H, pull-down, coIP  (Crepieux et al., 1997) 
 Ebola VP35 Y2H  (Kubota et al., 2009) 
 Human Foamy 
Virus gag 
coIP  (Petit et al., 2003) 
 Rabies Virus  
Phospho-
Protein 
Y2H, coIP  (Jacob et al., 2000; 
Raux et al., 2000) 
 African Swine 
Fever Virus 
p54 
Y2H, coIP  (Alonso et al., 2001) 
TcTex-1 
(1) 
Lfc Y2H, coIP  (Conde et al., 2010) 
 VDAC1 Y2H, coIP  (Fang et al., 2011; 
Schwarzer et al., 
2002) 
 OX1R Y2H, coIP  (Duguay et al., 2011) 
 Rab3D Y2H, coIP  (Pavlos et al., 2011),  
 rhodopsin pull-down, MT 
pelleting with dynein 
 (Tai et al., 1999; Yeh 
et al., 2006) 
 PTHR Y2H, pull-down  (Sugai et al., 2003),  
 Doc2 Y2H, pull-down, coIP  (Nagano et al., 1998) 
 Trk 
neurotrophin 
receptor 
coIP  (Yano et al., 2001) 
TcTex-1 
(1) 
FIP-1 Y2H  (Lukashok et al., 
2000) 
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 p59 fyn kinase Y2H, pull-down  (Campbell et al., 1998; 
Mou et al., 1998) 
 Human 
Papilloma 
Virus 16 L2 
Y2H, coIP, pull-down  (Schneider et al., 
2011) 
 Polio receptor 
CD155 
Y2H, pull-down, co-IP  (Mueller et al., 2002), 
(Ohka et al., 2004) 
 Herpes Virus 
VP26 
Y2H, pull-down  (Douglas et al., 2004) 
 Mason-Pfizer 
monkey virus 
Gag protein 
coIP, pull-down  (Vlach et al., 2008),  
RP3  
(1) 
OX1R Y2H, coIP  (Duguay et al., 2011) 
 Herpes Virus 
VP26 
Y2H, pull-down  (Douglas et al., 2004) 
 Human 
Papilloma 
Virus 16 L2 
Y2H, coIP, pull-down  (Schneider et al., 
2011) 
LC7/Road
block  
(1) 
Rab6 Y2H, coIP, pull-down  (Wanschers et al., 
2008) 	  	  1.1.1.2.	  Cellular	  Functions	  and	  Regulation	  In	   contrast	   to	   the	   kinesin	   family,	   which	   has	   diversified	   to	   cover	   a	   wide	   range	   of	  cellular	  functions,	  there	  is	  only	  one	  dynein	  gene	  product	  that	  solely	  regulates	  a	  large	  number	   of	   cellular	   processes,	   including	   organelle	   transport,	   mitotic	   spindle	  organization	   and	   orientation,	   chromosome	   movement,	   cell	   migration,	   neuronal	  outgrowth,	  and	  nuclear	  movement	  (Vallee	  et	  al.,	  2012).	  	  Diversity	  of	  dynein	  subunits	  might	  contribute	  to	  some	  specificity,	  but	  it	  is	  widely	  accepted	  that	  additional	  dynein	  regulators	   and	   recruitment	   factors	   are	   the	   main	   reason	   how	   individual	   dynein	  motor	  protein	  complexes	  can	  perform	  different	  functions.	  	  	  	  Two	  well-­‐studied	  dynein	  associated	  regulatory	  complexes	  are	  dynactin	  and	  Lis1,	  the	  latter	   in	   association	   with	   NudE	   and	   NudEL	   (Efimov	   and	   Morris,	   2000;	   Gill	   et	   al.,	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1991;	  Holzbaur	   et	   al.,	   1991;	  Minke	   et	   al.,	   1999).	   	   In	   a	   physiological	   context,	   these	  complexes	   can	   have	  multiple	   functions	   ensuring	   proper	  motor	   attachment	   to	   the	  cargo	   (Burkhardt	   et	   al.,	   1997;	   Stehman	   et	   al.,	   2007)	   and	   affecting	   the	   biophysical	  properties	  of	  cytoplasmic	  dynein	  (King	  and	  Schroer,	  2000;	  McKenney	  et	  al.,	  2010).	  	  	  Dynactin	   is	   a	   1.5MDa	   regulatory	   complex	   of	   dynein,	   but	   its	   role	   in	   dynein	   force	  production	  and	  processivity	  remains	  controversial.	  	  Dynactin	  interacts	  with	  the	  first	  70	   residues	   of	   the	   dynein	   IC	   through	   the	   N-­‐terminal	   coiled-­‐coil	   domain	   (CC1)	   of	  p150Glued	   (Karki	   and	  Holzbaur,	   1995;	  McKenney	   et	   al.,	   2011;	  Morgan	   et	   al.,	   2011;	  Vaughan	  and	  Vallee,	  1995).	  	  The	  additional	  role	  of	  p150Glued	  MT	  binding	  is	  still	  being	  investigated	  (Culver-­‐Hanlon	  et	  al.,	  2006;	  Kardon	  et	  al.,	  2009;	  Kim	  et	  al.,	  2007;	  King	  and	   Schroer,	   2000).	   	   Evidence	   exist	   that	   both	   dynactin	   and	   NudE-­‐LIS1	   modulate	  dynein	   processivity	   and	   force	   production	   via	   allosteric	   effects.	   Furthermore,	   the	  mechanism	  with	  which	  the	  binding	  event	  to	  a	  dynein	  tail	  subunit	   is	  propagated	  to	  the	  MD	   remains	  unknown.	   	  However,	   the	  dynein	   regulator	  Lis1	  has	  been	   show	   to	  directly	   interact	   with	   the	   dynein	  MD	   at	   AAA3/4	   (Huang	   et	   al.,	   2012),	   acting	   as	   a	  molecular	  “clutch”,	  possibly	  uncoupling	  ATP	  hydrolysis	   from	  changes	   in	  the	  MTBD	  at	   the	  end	  of	   the	  stalk	   (Huang	  et	  al.,	  2012;	  McKenney	  et	  al.,	  2010).	   	  Lis1	   increases	  dynein	   persistence	   against	   an	   opposing	   force,	   which	   is	   essential	   under	   high-­‐load,	  low-­‐speed	  conditions	  (Faulkner	  et	  al.,	  2000;	  McKenney	  et	  al.,	  2010;	  Tsai	  et	  al.,	  2007;	  Yi	  et	  al.,	  2011).	  	  In	  addition,	  Lis1	  interacts	  with	  NudE/EL,	  which	  by	  itself	  binds	  to	  the	  dynein	   IC,	   has	   inhibitory	   effects	   on	   dynein	   force	   production,	   and,	   given	   its	   long	  coiled-­‐coil	   structure,	   might	   bridge	   the	   distance	   from	   the	   dynein	   tail	   to	   the	   MD	  providing	  Lis1	  transiently	  to	  its	  site	  of	  action	  (McKenney	  et	  al.,	  2010).	  	  Interestingly,	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individual	   dynein	   complexes	   are	   presumably	   controlled	   by	   dynactin	   or	   NudE/EL,	  but	   not	   both,	   in	   view	   of	   mutually	   exclusive	   interaction	   of	   the	   two	   regulatory	  complexes	  to	  the	  dynein	  IC	  binding	  site	  (McKenney	  et	  al.,	  2011;	  Nyarko	  et	  al.,	  2012).	  	  During	   interphase,	   dynein	   is	   involved	   in	   cell	   migration	   (Dujardin	   et	   al.,	   2003),	  centrosome	   positioning	   (Palazzo	   et	   al.,	   2001),	   and	   also	   mediates	   growth	   of	   the	  growth	  cone	  and	  axon	  extension	  in	  neurons	  (Vallee	  et	  al.,	  2009).	  	  Furthermore,	  it	  is	  responsible	   for	   the	   positioning	   of	   membranous	   organelles	   such	   as	   mitochondria	  (Thomas	  Schwarz,	  personal	  communication),	  the	  nucleus	  (Splinter	  et	  al.,	  2010;	  Tsai	  et	   al.,	   2007),	   endosomes,	   lysosomes,	   and	   components	   of	   the	   Golgi	   apparatus	  (Burkhardt	  et	  al.,	  1997).	  Distinct	  classes	  of	  organelles	  seem	  to	  require	  specific	  dynein	  components	  for	  their	  motility,	  an	  issue	  of	  particular	  interest	  for	  the	  endo-­‐lysosomal	  pathway	  (Caviston	  et	  al.,	  2011;	  Deacon	  et	  al.,	  2003;	  Horgan	  et	  al.,	  2010b;	  Palmer	  et	  al.,	  2009;	  Tan	  et	  al.,	  2011).	  	  Dynein	  localizes	  to	  lysosomes	  in	  a	  Ca2+	  and	  serum-­‐dependent	  manner	  (Lin	  and	  Collins,	  1992;	  Lin	  and	  Collins,	  1993).	  	  Starved	  fibroblasts	  or	  fibroblasts	  grown	  in	  Ca2+	   depleted	   medium	   lose	   lysosomal	   dynein	   staining	   while	   kinesin	   staining	  persists	   resulting	   in	   lysosome	  dispersal	   (see	  also	   chapter	  1.1.2.2.).	   	  The	   role	  of	   an	  okadaic	  acid	  sensitive	  DHC	  phosphorylation	  has	  been	  reported	  in	  this	  process	  (Lin	  et	  al.,	  1994).	   	   In	  addition	  to	  possible	   indirect	  recruitment	  pathways	  through	  Rab7,	  RILP	  and	  dynactin	  (Bucci	  et	  al.,	  2000;	  Cantalupo	  et	  al.,	  2001;	   Jordens	  et	  al.,	  2001),	  dynein	  recruitment	  to	  lysosomes	  might	  be	  mediated	  directly	  through	  IC	  binding	  to	  the	   membrane-­‐associated	   scaffolding	   protein	   huntingtin	   (Caviston	   et	   al.,	   2007;	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Caviston	   et	   al.,	   2011)	   or	   through	   LICs	   (Tan	   et	   al.,	   2011).	   	   Using	   RILP	   truncation	  mutants	  impaired	  in	  dynactin	  binding	  leads	  to	  dispersed	  lysosomes	  remaining	  LIC1-­‐positive,	   indicative	   of	   at	   least	   one	   dynactin-­‐independent	   dynein	   recruitment	  pathway.	   	   Interestingly,	   LIC1	  or	   LIC2	  RNAi	   specifically	   affected	   the	  distribution	  of	  lysosomes	  and	   late	  endosomes	   (lyso/LE),	  with	  no	  effects	  on	  early	  endosomes	  and	  the	   Golgi	   apparatus	   (Tan	   et	   al.,	   2011),	   disputing	   results,	   suggesting	   no	   LIC	   RNAi	  effects	  on	  lyso/LEs	  (Palmer	  et	  al.,	  2009).	  	  	  The	  mitotic	   functions	  of	  dynein	   include	  spindle	  positioning,	  aster	   formation,	  MT-­‐kinetochore	   attachment	   and	   movement	   (Bader	   and	   Vaughan,	   2010;	   Kim	   and	   Yu,	  2011).	  	  Of	  note,	  dynein	  localizes	  to	  the	  kinetochore	  and	  mitotic	  spindle	  (Steuer	  et	  al.,	  1990)	  and	  most	  of	  its	  regulators	  and	  recruitment	  factors	  during	  interphase	  are	  also	  detectable	  at	  those	  sites	  (Echeverri	  et	  al.,	  1996;	  Stehman	  et	  al.,	  2007;	  Whyte	  et	  al.,	  2008).	  	  Hence,	  additional	  cues	  must	  regulate	  mitotic	  priming	  of	  the	  dynein	  complex.	  	  Interestingly,	  LIC	  show	  a	  cell-­‐cycle	  specific	  phosphorylation	  pattern	  (Pascale	  Monzo,	  personal	   communication;	   (Niclas	   et	   al.,	   1996)	   and	   four	   Cdk1	   sites	   have	   been	  described	   in	   LIC1	   (Addinall	   et	   al.,	   2001;	   Dell	   et	   al.,	   2000).	   	   In	   vitro	   Cdk1	  phosphorylation	   work	   with	   recombinant	   LIC1	   and	   purified	   dynein	   showed	   that	  Cdk1	  phosphorylation	  inhibits	  dynein	  interaction	  with	  membranes	  (Addinall	  et	  al.,	  2001).	   	   This	   result	   is	   in	   accordance	   with	   drastically	   decreased	   organelle	   motility	  during	  mitosis.	  Another	  phosphorylation-­‐dependent	  switch	  between	  mitotic	  and	  interphase	  dynein	  involves	   T89	   of	   the	   dynein	   IC,	  which	   can	   be	   phosphorylated	   by	   Polo-­‐like	   kinase1	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increasing	  dynein	  localization	  to	  kinetochores	  via	  a	  direct	  ZW10	  interaction	  (Bader	  et	   al.,	   2011).	   	   T89	   dephosphorylation	   by	   PP1-­‐γ	   decreases	   ZW10	   but	   increases	  dynactin	   affinity	   responsible	   for	   dynein-­‐mediated	   streaming	   of	   kinetochore-­‐associated	   proteins	   towards	   the	   spindle	   poles	   by	   anaphase	   onset	   (Bader	   and	  Vaughan,	  2010).	  	  Besides	   these	  physiological	   functions,	  dynein	  has	  been	   implicated	   in	   the	   transport	  and	  infectious	  cycle	  of	  various	  pathogens,	  especially	  viruses	  (see	  chapter	  1.3.1.	  and	  (Dodding	  and	  Way,	  2011;	  Enquist,	  2012;	  Greber	  and	  Way,	  2006;	  Scherer	  and	  Vallee,	  2011).	  	  	  	  	  1.1.1.	  Kinesin-­‐1	  (KIF5)	  1.1.2.1.	  Structure	  and	  Cross-­‐bridge	  Cycle	  Kinesin-­‐1	   (herein	   referred	   to	  as	   “kinesin”	  unless	  noted	  otherwise)	   is	   the	   founding	  member	  of	  the	  kinesin	  family	  of	  motor	  proteins	  (Brady,	  1985;	  Vale	  et	  al.,	  1985)	  and	  functions	   in	   conventional	   cargo	   transport	   in	  non-­‐neuronal	   cells	  but	   also	   in	   axonal	  and	  dendritic	  transport	  in	  neurons.	  	  With	  three	  gene-­‐duplication	  induced	  subtypes	  -­‐	  KIF5A,	  KIF5B,	  and	  KIF5C	  –	  kinesin	  represents	   the	  dominant	  MT	  plus	  end-­‐directed	  motor	   in	   interphase	   cells	   (Hirokawa	  et	   al.,	   2009).	   	   Interestingly,	  KIF5A	  and	  KIF5C	  are	   expressed	   almost	   exclusively	   in	   neurons,	   while	   KIF5B	   shows	   a	   ubiquitous	  expression	  profile	  (Kanai	  et	  al.,	  2000).	  	  Kinesins	  consists	  of	  two	  heavy	  chains	  (KHCs)	  of	  approximately	  120kDa	  (Pfister	  et	  al.,	  1989)	  with	  an	  N-­‐terminal	  motor	  domain,	  a	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long	   central	   coiled-­‐coil	   dimerization	   domain,	   and	   a	   C-­‐terminal	   tail	   for	   light	   chain	  (KLC)	  and	  cargo	  binding	  (described	  below).	  	  	  The	  kinesin	  motor	  domain	  propelles	  the	  molecule	  along	  the	  MT	  lattice	  spanning	  one	  MT	  dimer	  at	  a	  time	  in	  strictly	  8nm	  steps	  (Svoboda	  et	  al.,	  1993)	  and	  generats	  about	  5-­‐7pN	  of	  force	  (Svoboda	  and	  Block,	  1994).	  	  In	  contrast	  to	  dynein,	  kinesin	  shows	  very	  little	   side-­‐stepping	  off	   the	  MT	  main	  axis,	  higher	  processivity	   (Toprak	  et	  al.,	  2009),	  and	   the	   cross-­‐bridge	   cycle	   of	   the	   two	  MT	  motors	  differs	   as	  well.	   	   For	   kinesin,	  MT	  association	   is	  strengthened	  in	  the	  presence	  of	  ATP.	   	  Hence,	   the	   lagging	  head	  binds	  ATP	   and	  MTs	   simultaneously,	  while	   the	  ADP	  bound	   leading	  head	   is	   connecting	   to	  the	   next	   tubulin	   dimer.	   	   Once	   the	   leading	   heads	   interacts	   with	   the	   MT,	   ATP	  hydrolysis	  and	  phosphate	  release	   in	  the	   lagging	  head	  drives	  forward	  displacement	  via	  a	  shift	  of	   the	  neck	   linker	  from	  a	  rearward-­‐	  to	  a	   forward-­‐pointing	  conformation	  (Rice	  et	  al.,	  1999).	  	  Indeed,	  it	  could	  be	  shown	  that	  length	  of	  the	  neck-­‐linker	  directly	  influences	  kinesin	   stepping	  behavior	   (Yildiz	   et	   al.,	   2008).	   	  During	   that	  motion,	   the	  former	  leading	  head	  exchanges	  ADP	  for	  ATP	  and	  binds	  tightly	  to	  the	  MT,	  locking	  the	  motor	  to	  the	  track	  and	  allowing	  processive	  runs	  along	  the	  MT.	  	  1.1.2.2.	  Cargo	  Recruitment	  The	   kinesin	   tail	   domain	   can	   interact	   with	   cargo	   directly	   or	   through	   one	   of	   four	  ~60kDa	  classes	  of	  kinesin	  light	  chains	  (KLC1-­‐4).	  	  Approximately	  half	  of	  the	  kinesin	  molecules	   in	   brain	   extracts	   are	   present	   as	   heterotetramers	   containing	   KLCs	  (Hirokawa	   et	   al.,	   2009).	   	   KLCs	   bind	   cargo	   through	   their	   tetratricopeptide	   repeat	  (TPR)	  domains	  (D'Andrea	  and	  Regan,	  2003;	  Zhu	  et	  al.,	  2012).	  	  Of	  note,	  a	  tryptophan-­‐
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containing	  motif	  in	  KLC-­‐binding	  proteins	  has	  recently	  been	  described	  (Morgan	  et	  al.,	  2010),	  expanding	  the	  possible	  pool	  of	  kinesin	  cargos	  and	  cargo	  proteins	  (Dodding	  et	  al.,	  2011).	  	  	  For	  a	  number	  of	  organelles,	  the	  kinesin	  recruitment	  mechanism	  has	  been	  explored	  in	  greater	  detail.	  
Mitochondria	  react	  to	  local	  energy	  deficiencies	  by	  repositioning	  along	  MTs,	  which	  can	   be	   illustrated	   in	   differentiated	   neuronal	   cells	   where	   mitochondria	   are	  dynamically	   distributed	   along	   the	   axon.	   	   About	   30-­‐40%	   of	   mitochondria	   move	  bidirectionally	   along	   the	   axon,	   according	   to	   the	   need	   for	   ATP.	   	   Besides	   kinesin	  recruitment	  through	  the	  adaptor	  proteins	  syntabulin,	  syntaphilin,	  and	  Ran-­‐binding	  protein	  2	  (RanBP2)	  (Cai	  et	  al.,	  2005;	  Chen	  et	  al.,	  2009;	  Cho	  et	  al.,	  2007),	  a	  different	  mechanisms	   of	   motor	   attachment	   and	   transport	   regulation	   has	   been	   identified.	  	  Mitochondria	   have	   been	   reported	   to	   recruit	   kinesin	   through	   their	   associated	  proteins	  milton	  and	  miro.	  	  The	  miro/milton	  complex	  binds	  O-­‐glucose-­‐transferase	  in	  the	   mitochondria	   membrane	   and	   can	   also	   sense	   Ca2+-­‐concentration	   through	   EF	  hand	  domains	   in	  miro.	   	  Milton/miro	   complex	   is	   constitutively	   associated	  with	   the	  KHC	  tail	  and	  miro	  can	  additionally	  compete	  with	  the	  MT	  for	  the	  KHC	  motor	  domain	  in	  response	  to	  Ca2+	   levels.	   	  Low	  ATP	  concentration	   is	   indicated	  by	  high	  Ca2+	   levels	  which	  leads	  to	  a	  high	  affinity	  confirmation	  of	  miro	  for	  the	  kinesin	  motor	  domain	  and	  therefore	  reduced	  kinesin	  motility	  along	  the	  MT	  (Wang	  and	  Schwarz,	  2009)	  (Figure	  1-­‐3).	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  Figure	  1-­‐3:	  Kinesin	  Recruitment	  Mechanisms.	  (A)	  Kinesin	  is	  recruited	  to	  mitochondria	  by	  the	  miro/milton	  protein	  complex.	  	  Miro	  is	   associated	   with	   the	   mitochondrial	   membrane,	   and	   milton	   acts	   as	   direct	   motor	  recruitment	   factor.	   	   Calcium-­‐binding	   to	   miro	   increases	   its	   affinity	   for	   the	   kinesin	  motor	   domain,	   which	   detaches	   from	   the	   MT	   and	   inhibits	   MT	   plus-­‐end	   directed	  mitochondria	  motility	  (illustration	  from	  (Hirokawa	  et	  al.,	  2009).	  	  (B)	  Recruitment	  of	  kinesin	  to	  lysosomes	  involves	  the	  adaptor	  protein	  SKIP	  and	  the	  lysosome-­‐associated	  GTPase	  Arl8	  (illustration	  from	  (Rosa-­‐Ferreira	  and	  Munro,	  2011)).	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Furthermore,	  p150Glued-­‐CC2	  has	  been	  shown	   to	   interact	  with	  milton/miro	  and	   this	  interaction	   likely	   recruits	   the	   dynein/dynactin	   complex	   to	   mitochondria	   as	   well	  (Cox	  and	  Spradling,	  2009).	  	  	  
Lysosomes	  in	  steady-­‐state	  move	  bidirectionally	  along	  MT	  in	  fibroblasts	  with	  net	  MT	  minus-­‐end	   directed	   motility	   leading	   to	   a	   perinuclear	   localization	   but	   disperse	  towards	   the	   cell	   periphery	   in	   response	   to	   cytoplasmic	   acidification,	   trypanosome	  infection	  (see	  also	  chapter	  1.1.3.),	  starvation,	  or	  dynein	  inhibition	  (Heuser,	  1989;	  Lin	  and	   Collins,	   1993;	   Burkhardt	   et	   al.,	   1997;	   Tardieux	   et	   al.,	   1992;	   Yi	   et	   al.,	   2011).	  	  Lysosome	  dispersal	  upon	  direct	  dynein	  inhibition	  is	  even	  better	  visible	  in	  axons	  of	  hippocampal	   neurons	   (Yi	   et	   al.,	   2011).	   	   Acidity-­‐induced	   lysosome	   dispersal	   is	  inhibited	  in	  KIF5B	  knock-­‐out	  and	  knock-­‐down	  cells	  (Cardoso	  et	  al.,	  2009;	  Tanaka	  et	  al.,	   1998),	   and	   microinjection	   of	   a	   function-­‐blocking	   kinesin	   antibody	   abolishes	  trypanosome-­‐induced	   dispersal	   (Rodriguez	   et	   al.,	   1996),	   indicating	   the	   direct	  involvement	   of	   KIF5B	   in	   centrifugal	   lysosome	   motility.	   	   One	   of	   the	   recruitment	  mechanisms	  connecting	  KIF5B	  to	  lysosomes	  involves	  Arl8-­‐SKIP	  (Rosa-­‐Ferreira	  and	  Munro,	  2011).	  	  Arl8	  is	  a	  lysosome-­‐associated	  GTPase	  that	  also	  binds	  to	  a	  member	  of	  the	   HOPS	   complex,	   which	   is	   involved	   in	   endo-­‐lysosomal	   fusion	   (Bagshaw	   et	   al.,	  2006;	   Garg	   et	   al.,	   2011;	   Hofmann	   and	  Munro,	   2006).	   	   SKIP	   has	   been	   reported	   to	  interact	  with	  Arl8	  and	  KLC	  and	  therefore	  acts	  as	  a	  recruitment	  factor	  of	  the	  kinesin	  motor	   to	  Arl8-­‐positive	   lysosomes	   (Dumont	   et	   al.,	   2010;	  Rosa-­‐Ferreira	   and	  Munro,	  2011)	   (Figure	  1-­‐3).	   	  Another	  possible	  kinesin	  recruitment	  mechanism	  via	  kinectin	  (Ong	  et	  al.,	  2000)	  has	  been	  disputed,	   in	  view	  of	  observatins	   that	  kinectin-­‐deficient	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mice	   show	   no	   abnormalities	   in	   the	   trafficking	   of	   lysosomes,	   phagosomes,	   and	  mitochondria	  (Plitz	  and	  Pfeffer,	  2001).	  If	   KLC	   binding	   to	   axonal	   vesicles	   positive	   for	   amyloid	   precursor	   protein	   (APP	  vesicle)	   (Kamal	   et	   al.,	   2001;	   Kamal	   et	   al.,	   2000)	   represents	   a	   physiological	  interaction	   is	   under	   debate	   now,	   since	   the	   interaction	   seems	   to	   be	   unspecific	   and	  motility	   of	   postulated	   APP	   vesicle	   cargos	   remained	   motile	   in	   APP-­‐deficient	   mice	  (Lazarov	  et	  al.,	  2005).	  	  1.1.3.	  PKA	  Regulation	  of	  Motility	  The	  canonical	  pathway	  leading	  to	  PKA	  (protein	  kinase	  A,	  cAMP	  dependent	  kinase)	  activation	  involves	  ligand	  binding	  to	  G-­‐protein	  coupled	  receptors.	  	  The	  liberated	  G-­‐alpha	  subunit	  activates	  adenylate	  cyclase,	  catalyzing	  the	  reaction	  from	  ATP	  to	  cAMP	  (Tang	  and	  Gilman,	  1992).	   	  PKA	  is	  a	  heterotetramer	  of	   two	  catalytic	  subunits	  along	  with	   two	   regulatory	   subunits,	   of	   which	   several	   isoforms	   have	   been	   identified.	  	  Binding	  of	   cAMP	   to	   the	   regulatory	   subunits	   dissociates	   the	   tetramer,	   and	   the	   free	  catalytic	  subunits	  phosphorylate	  protein	  substrates	  containing	  the	  RRXS/T,	  KRXS/T	  or	   RXXS/T	   consensus	   motifs	   (Dell'Acqua	   and	   Scott,	   1997).	   	   An	   additional	   PKA	  activating	  pathway	   through	  cell	   surface	   integrins	  and	  TRPM7	  has	  been	  postulated	  (Howe,	   2011).	   	   Phosphodiesterases	   down-­‐regulates	   intracellular	   cAMP	   levels,	  allowing	   an	   excess	   of	   regulatory	   subunits	   to	   rebind	   and	   inactivate	   free	   catalytic	  subunits	  (Amieux	  et	  al.,	  1997).	  	  In	  addition,	  the	  ubiquitous	  inhibitor,	  PKI,	  may	  serve	  as	  a	  fail-­‐safe	  device,	  which	  sequesters	  free	  catalytic	  subunit	  and	  mediates	  export	  of	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the	   kinase	   from	   the	   nucleus,	   which	   is	   devoid	   of	   regulatory	   subunits	   (Wen	   et	   al.,	  1995).	  The	  PKA	  pathway	  is	  susceptible	  to	  a	  large	  array	  of	  pharmacological	  stimulators	  and	  inhibitors.	   	   Forskolin	   activates	   cAMP	  production	  by	   stimulating	   adenylate	   cyclase;	  caffeine,	   bucladesine	   (dibutyryl	   cAMP)	   and	   3-­‐isobutyl-­‐1-­‐methylxanthine	   (IBMX)	  inhibit	   phosphodiesterase;	   whereas	   H-­‐89	   and	   exogenous	   PKI	   inhibit	   PKA	   directly	  and	  MDL-­‐12,330A	  indirectly	  through	  irreversible	  inhibition	  of	  adenylate	  cyclase.	  	  Some	  MT-­‐dependent	  transport	  processes	  are	  regulated	  by	  PKA.	  	  	  
Lysosomes	   show	   PKA-­‐	   and	   Ca2+-­‐dependent	   anterograde	   movement	   in	   rat	  fibroblasts	   (Rodriguez	   et	   al.,	   1997)	   in	   response	   to	   Trypanosoma	   cruzi	   infection	  (Chagas	   disease;	   Chagas,	   1909).	   	   Host	   cells	   exhibit	   increased	   cAMP	   levels,	   and	  peripheralization	   of	   lysosomes,	   which	   fuse	  with	   the	   parasitophorous	   vacuole	   and	  enable	  T.	  cruzi	  to	  escape	  from	  the	  vacuole	  and	  establish	  infection	  (Andrews,	  1995).	  	  Levels	   of	   intracellular	   cAMP	   levels	   determine	   the	   ability	   of	   T.	   cruzi	   to	   establish	  successful	   infections	  and	   lysosome	  exocytosis.	   	  MDL-­‐12,330A	   treatment	  decreases	  lysosome	  exocytosis	  about	  two-­‐fold,	  whereas	  IBMX	  and	  forskolin	  can	  increase	  levels	  up	  to	  two-­‐fold	  (Rodriguez	  et	  al.,	  1999).	  	  	  
Melanosomes,	   the	  melanin-­‐containing	   granules	   share	   several	   characteristics	  with	  conventional	  lysosomes,	  in	  spite	  of	  the	  existence	  of	  unique	  biogenetic	  steps	  (Marks	  and	  Seabra,	  2001;	  Raposo	  et	  al.,	  2001;	  Schiaffino,	  2010).	   	  Studies	  using	  amphibian	  melanin-­‐pigmented	   cells	   have	   shown	   that	   melanosomes	   respond	   reliably	   and	  quickly	  to	  environmental	  cues	  (Reilein	  et	  al.,	  1998;	  Tuma	  and	  Gelfand,	  1999).	   	  The	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canonical	  pathway	  for	  melanosome	  aggregation	  towards	  the	  MTOC	  involves	  binding	  of	   noradrenaline,	   melatonin,	   or	   melatonin-­‐concentrating	   hormone	   to	   cell	   surface	  receptors,	  which	   leads	   to	   inhibition	  of	   adenylate	   cyclase,	   lower	  cAMP	   levels	  and	  a	  reduction	  of	   PKA	  activity.	   	  Dynein	   activity	   is	   responsible	   for	   this	   process	   (Nilsson	  and	  Wallin,	  1997).	  	  Melanosome	  dispersal	  is	  stimulated	  by	  high	  cAMP	  concentration,	  leading	   to	   kinesin	   2-­‐driven	   plus-­‐end	   motility	   and	   myosin	   and	   actin-­‐dependent	  scattering	   (Gross	   et	   al.,	   2002).	   	   The	   specific	   effect	   of	   PKA	   on	   kinesins	   and	   dynein	  during	  aggregation	  and	  dispersal	  are	  unknown	  (Figure	  1-­‐4).	  
	   	  Figure	  1-­‐4:	  PKA-­‐regulated	  Organelle	  Movement	  in	  Melanosomes.	  Melanosome	  movement	   in	   fish	   pigment	   cells	   can	   be	   regulated	   by	   changing	   cAMP	  levels	  and	  PKA	  activity.	   	  Stimulation	  of	  PKA	   for	  5min	   leads	   to	  aggregated	  pigment	  vesicles,	   whereas	   PKA	   inhibition	   disperses	   them	   within	   15	   min.	   (picture	   from	  (Rodionov	  et	  al.,	  1998)).	  
	   21	  
Kinesin	  binding	  to	  synaptic	  vesicles	  has	  been	  reported	  to	  be	  	  decreased	  after	  PKA-­‐phosphorylation	  in	  vitro,	  in	  neuronal	  cells	  (Hirokawa	  et	  al.,	  1991;	  Sato-­‐Yoshitake	  et	  al.,	   1992).	   	   Whether	   kinesin	   phosphorylation	   contributes	   to	   the	   observed	  phenotypes	  remains	  to	  be	  elucidated	  (Nakata	  and	  Hirokawa,	  1995;	  Rodriguez	  et	  al.,	  1996).	  	  	  	  	  Finally,	  adenovirus	  infection	  has	  been	  reported	  to	  stimulate	  PKA	  activity	  and	  affect	  MT	  minus	  end-­‐directed	  transport	  of	  the	  capsid	  (Suomalainen	  et	  al.,	  2001).	  	  	  	  	  
1.2.	  Adenovirus	  1.2.1.	  Structure	  Adenoviruses	   represent	   one	   of	   the	   best-­‐characterized	   families	   of	   non-­‐enveloped	  double-­‐stranded	  DNA	  viruses.	   	   They	   cause	  mild,	   self-­‐limiting	   infections	   in	   healthy	  individuals	   but	   can	   be	   fatal	   in	   immunocompromised	   patients.	   Since	   their	   first	  isolation	   from	  adenoid	   tissue	   in	  1953	  (Rowe	  et	  al.,	  1953)	  more	   than	  55	  serotypes	  have	   been	   identified,	   which	   can	   be	   divided	   into	   seven	   subgroups	   (A-­‐G).	   The	  serotypes	   share	   a	   common	   structure	   (Figure	   1-­‐5),	  which	   has	   been	   solved	   at	   near	  atomic	   resolution	   for	   the	   prototypical	   subgroup	   C	   adenovirus	   5	   (Ad5)	   by	   cryo-­‐electronmicroscopy	  (cryo-­‐EM)	  and	  by	  x-­‐ray	  crystallography	  for	  an	  Ad5/35	  chimera	  (Liu	  et	  al.,	  2010;	  Reddy	  et	  al.,	  2010).	  	  These	  studies	  reveal	  an	  apparent	  evolutionary	  relationship	   to	   the	   bacteriophage	   PRD1	   (Benson	   et	   al.,	   1999).	   	   	   The	   adenovirus	  capsid	  has	   a	   diameter	   of	   about	   90nm	  and	   consists	   of	   three	  major	   and	   four	  minor	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capsid	  proteins	   (Stewart	  et	  al.,	  1993).	  The	  major	  capsid	  proteins	   fiber	  and	  penton	  base	   form	   the	   penton	   complex,	   which	   is	   located	   at	   each	   of	   the	   vertices	   of	   the	  icosahedral.	  	  	  
	  	  Figure	  1-­‐5:	  Adenovirus	  Structure.	  Three	   major	   (pII	   (hexon),	   pIII	   (penton	   base),	   pIV	   (fiber)	   and	   four	   minor	   capsid	  proteins	   (pIIIa,	   pVI,	   pVIII,	   pIX)	   form	   the	   icosahedra	   protecting	   the	   viral	   genome	  from	   the	   environment	   and	   mediating	   cell	   attachment	   and	   entry.	   	   Inner	   capsid	  proteins	   (pV,	   pVII,	   pµ,	   pTP)	   are	   responsible	   for	   DNA	   stability.	   The	   viral	   protease	  functions	   during	   capsid	   maturation	   and	   cell	   entry	   (illustration	   from	   Lind	   et	   al.,	  Virology,	  2012).	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The	   spike-­‐like	   timeric	   fiber	   proteins	   protrude	   away	   from	   the	   capsid	   and	  bind	   the	  coxsackie-­‐and-­‐adenovirus	   receptor	   (CAR).	   	   Pentameric	   penton	   base	   also	   plays	   a	  direct	  role	  in	  cell	  surface	  binding,	  interacting	  directly	  with	  integrins	  (Wickham	  et	  al.,	  1993).	  The	   third	  major	   capsid	  protein,	   hexon,	   is	   the	  most	   abundant	  one	  with	  240	  hexon	   trimers	   in	   each	   virus,	   twelve	   of	   which	   form	   one	   facet	   of	   the	   virion.	   The	  extreme	   resistance	   of	   adenovirus	   to	   environmental	   influences	   such	   as	   pH,	  temperature,	   and	   ionic	   strength	   (Rexroad	   et	   al.,	   2003)	   is	   likely	   due	   to	   the	   tight	  quarternary	   structure	   of	   hexon	   (Rux	   et	   al.,	   2003)	   and	   the	   contributionsn	   of	  additional	  minor	  capsid	  components	  pIIIa,	  pVI,	  pVIII,	  and	  pIX,	  which	  act	  as	  “cement	  proteins”,	   bridging	   gaps	   between	   the	  major	   components	   (Figure	   1-­‐6).	   Protein	   IIIa	  links	  penton	  base	  and	  peripentonal	  hexons,	  while	  hexon	  trimers	  are	  connected	  by	  protein	  VIII	  at	  their	  base	  and	  protein	  IX	  on	  the	  surface	  of	  the	  capsid.	  	  Because	  of	  its	  prominent	  location	  on	  the	  outer	  surface	  of	  the	  virus,	  protein	  IX	  has	  been	  used	  as	  a	  platform	   to	   artificially	   introduce	   tags	   and	   fluorescent	   proteins	   into	   the	   capsid	  without	   significant	   loss	   of	   infectivity	   (Dmitriev	   et	   al.,	   2002;	   Meulenbroek	   et	   al.,	  2004).	   	   Another	   minor	   capsid	   subunit,	   protein	   VI,	   resides	   on	   the	   inside	   surface,	  binding	   to	   a	   cavity	   on	   the	   underside	   of	   the	   hexons	   (for	   more	   detailed	   review	  (Vellinga	  et	  al.,	  2005)).	   	   Its	  role	  at	   this	  site	   is	   incompletely	  understood.	   	  Protein	  V,	  which	   interacrts	  with	   penton	   base	   and	   proteins	   IIIa	   and	   VI,	   is	   associates	   directly	  with	   the	  viral	  DNA,	   therefore	  connecting	   the	  protein	  shell	  with	   the	  viral	   core.	  The	  core	   contains	   the	   viral	   protease	   adenain,	   the	   36kb	   virus	   genome,	   and	   the	   DNA-­‐associated	  proteins	  V,	  VII,	  µ,	  and	  terminal	  protein.	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  Figure	  1-­‐6:	  Minor	  Capsid	  Proteins	  in	  Facets	  of	  Adenovirus.	  Atomic	  structure	  of	  one	  capsid	  facet	  viewed	  from	  the	  outside	  (outer	  surface,	  upper	  panel)	  and	  the	  inside	  (inner	  surface,	  lower	  panel).	  	  Four	  hexon	  localizations	  can	  be	  distinguished	   filling	   the	   face	   of	   the	   facet,	  while	   the	  penton	   complexes	   are	  present	  only	  at	  the	  vertices.	  	  Localization	  of	  minor	  capsid	  proteins	  pIIIa	  (red),	  pVI	  (yellow),	  and	   pVIII	   (blue)	   on	   the	   inside,	   whereas	   pIX	   (pink)	   is	   visible	   in	   the	   outside	   view	  (illustration	  from	  (Liu	  et	  al.,	  2010)).	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1.2.2.	  Infectious	  Cycle	  1.2.2.1.	  Cell	  Entry	  The	   distinct	   shape	   of	   the	   viral	   capsid	   and	   abundance	   of	   anti-­‐viral	   antibodies	  facilitated	   early	   negative	   stain	   EM	   and	   immunocytochemical	   studies	   of	   the	   entry	  pathway	  of	  adenoviruses.	  To	  gain	  access	   to	   the	  nucleus	  where	   the	  viral	  genome	   is	  replicated	   and	   transcribed,	   the	   virus	   has	   to	   overcome	   two	   cellular	   hurdles:	   The	  plasma	   membrane,	   which	   is	   impermeable	   to	   macromolecules	   and	   the	   cytoplasm	  which	  restricts	   the	  150MDa	  adenovirus	  capsid	  to	  sub-­‐diffusional	  behavior	  (Seksek	  et	  al.,	  1997).	  Hence,	  virus	  entry	   into	  host	  cells	   is	  a	  step-­‐wise	  process	  that	  requires	  the	  concerted	   interaction	  of	  virus	   ligands	  with	   their	  host	  cell	   receptors	   (Greber	  et	  al.,	  1993)	  (Figure	  1-­‐7).	  	  For	  most	  adenovirus	  serotypes,	  uptake	  into	  the	  cell	   is	  initiated	  by	  the	  fiber	  knob	  –	  CAR	  binding	  (Bergelson	  et	  al.,	  1997)	  and	  strengthened	  by	  the	  interaction	  of	  the	  RGD	  motif	   in	  penton	  base	  with	  α5	   integrins	   (Wickham	  et	   al.,	   1993).	   	   Fiber	   and	  penton	  base	  proteins	  undergo	  a	  structural	  rearrangement	  during	  receptor	  binding	  (Lindert	  et	  al.,	  2009),	  which	  may	  facilitate	  endocytosis	  of	  the	  capsid	  into	  clathrin	  coated	  pits	  (Chardonnet	   and	   Dales,	   1970;	   Patterson	   and	   Russell,	   1983).	   Integrin	   binding	  stimulates	  activity	  of	  various	  cellular	  kinases.	  The	  lipid	  kinase,	  phosphatidylinositol-­‐3-­‐OH	  kinase	  (PI3K)	  has	  been	  implied	  in	  endosomal	  uptake	  of	  viral	  capsids	  through	  the	  local	  activation	  of	  its	  p85	  subunit	  and	  seems	  to	  be	  crucial	  for	  infection	  (Li	  et	  al.,	  1998b).	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  Figure	  1-­‐7:	  Adenovirus	  Entry.	  Entry	   Pathway	   of	   Adenovirus	   into	  Host	   Cells.	   After	   binding	   to	   the	   cell	  membrane	  through	  the	  Coxsackie	  and	  Adenovirus	  receptor,	  adenovirus	  is	  taken	  up	  by	  the	  cell	  into	   endosomes.	   .	   Further	   loss	   of	   capsid	   proteins	   in	   the	   acidic	   endosomal	   lumen	  facilitates	  rupture	  of	  the	  membrane	  and	  endosomal	  escape	  of	  the	  virus.	   	  Following	  endosomalysis,	   adenovirus	   moves	   bidirectionally	   along	   MTs,	   using	   dynein	   for	  transport	   towards	  MT	  minus	   ends,	  which	   are	   typically	   focused	   at	   the	   centrosome	  and	   the	   vicinity	   of	   the	   nucleus.	   Finally,	   adenovirus	   binds	   to	   the	   nuclear	   pore	  complex	  through	  which	  it	  injects	  its	  genome	  for	  viral	  reproduction	  (illustration	  from	  (Scherer	  and	  Vallee,	  2011)).	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Besides	   PI3K	   effects	   on	   cell	   cycle	   progression,	   it	   could	   be	   demonstrated	   that	   the	  PI3K	   linked	   signaling	   cascade	   through	   the	   Rho	   family	   GTPases,	   Rac1,	   CDC42,	   and	  RhoA	  promote	  reorganization	  of	  the	  actin	  cytoskeleton	  for	  capsid	  endocytosis	  (Li	  et	  al.,	   1998a).	   Hence,	   actin	   depolymerization	  with	   cytochalasin	  D	   inhibits	   Ad	   uptake	  into	   cells,	   but	   a	   role	   of	   the	   actin	   cytoskeleton	   in	   viral	   endocytosis	   remains	   to	   be	  determined	  in	  greater	  detail	  (Nemerow	  and	  Stewart,	  1999).	  Inside	   the	   endosome,	   the	   acidification	   is	   thought	   to	   change	   the	   hydrophobicity	   of	  the	   major	   capsid	   proteins	   (Seth	   et	   al.,	   1985),	   leading	   to	   the	   shedding	   of	   fiber	  proteins	  from	  the	  capsid	  (Nakano	  et	  al.,	  2000)	  and	  the	  release	  of	  protein	  VI	  into	  the	  endosomal	  lumen	  (Wiethoff	  et	  al.,	  2005).	  	  The	  amino-­‐terminal	  end	  of	  protein	  VI	  has	  an	  amphipathic	  helix	   that	  ruptures	  the	  endosomal	  membrane	  by	   inducing	  positive	  curvature	  (Maier	  et	  al.,	  2010),	  thus	  allowing	  the	  capsid	  to	  escape	  into	  the	  cytoplasm.	  About	  15min	  post-­‐infection	  (p.i.),	  adenovirus	  subgroups	  A,	  C,	  D,	  E,	  and	  G	  escape	  the	  early	  endosome	  (Gastaldelli	  et	  al.,	  2008),	  while	  subgroup	  B	  and	  F	  adenoviruses	  stay	  in	  the	  endosomal/lysosomal	  pathway	  for	  up	  to	  8	  hours	  (Albinsson	  and	  Kidd,	  1999;	  Miyazawa	   et	   al.,	   2001).	   Interestingly,	   endosomal	   acidification	   seems	   to	   be	  accelerated	  in	  adenovirus	  infected	  cells	  with	  pH	  values	  measured	  in	  the	  range	  of	  pH	  4.6-­‐6.0	   (Martin-­‐Fernandez	   et	   al.,	   2004)	   at	   15min	   p.i.,	   somewhat	   lower	   than	   the	  range	   reported	   for	   early	   endosomes	  of	   uninfected	   cells,	   at	   pH5.0	   to	   pH6.2,	   (Saftig	  and	  Klumperman,	  2009).	  After	  endosomal	  escape,	  the	  virus	  capsid	  is	  transported	  towards	  the	  nucleus	  within	  30-­‐45min	  in	  a	  microtubule	  (MT)	  dependent	  fashion	  (Mabit	  et	  al.,	  2002)	  (see	  chapter	  1.3.2.),	   where	   hexon	   interacts	   tightly	   with	   the	   nuclear	   pore	   complex	   (NPC)	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component	   Nup214/CAN	   (Trotman	   et	   al.,	   2001).	   	   Furthermore,	   histone	   H1	   is	  postulated	  to	  interact	  with	  the	  hypervariable	  region	  1	  of	  adenovirus	  hexon	  and	  H1	  import	   factors	   are	   responsible,	   in	   a	   Ca2+-­‐dependent	   fashion,	   to	   shuttle	  H1,	   hexon,	  and	  the	  viral	  DNA	  into	  the	  nucleus	  (Trotman	  et	  al.,	  2001).	  In	  addition	  to	  the	  histone	  import	   machinery,	   kinesin-­‐1C	   has	   also	   been	   reported	   to	   contribute	   to	   capsid	  disassembly	   at	   the	   NPC	   (Figure	   1-­‐8).	   	   Besides	   the	   hexon–Nup214	   interaction,	  adenovirus	  pIX	  has	  been	  reported	  to	  bind	  to	  kinesin	  light	  chains	  of	  kinesin-­‐1C	  which	  in	  turn	  interacts	  with	  the	  NPC	  component	  RanBP2	  (Nup358)	  and	  exerts	  a	  force	  on	  capsid	   and	   NPC,	   possibly	   enhancing	   viral	   DNA	   injection	   from	   a	   disrupted	   capsid	  through	  a	  structurally	  compromised	  NPC	  into	  the	  nucleus	  (Strunze	  et	  al.,	  2011).	  
	  Figure	  1-­‐8:	  Adenovirus	  Genome	  Delivery	  at	  the	  NPC.	  Adenovirus	   capsid	   (red)	   gains	   access	   to	   the	   nuclear	   pore	   complex	   (NPC)	   after	  dynein-­‐mediated	  transport	  via	  a	  hexon-­‐Nup214	  (yellow)	  interaction.	  	  Furthermore,	  pIX	   bind	   KLC.	   	   KHC	   binding	   to	   Nup358	   (green)	   and	   force	   generation	   along	  microtubules	  leads	  to	  capsid	  and	  NPC	  disruption	  and	  facilitated	  DNA	  entry	  into	  the	  nucleus	  (illustration	  from	  (Strunze	  et	  al.,	  2011)).	  	  
	   29	  
1.2.2.2.	  Gene	  Expression,	  DNA	  Replication	  and	  Protein	  Translation	  Once	   the	  viral	  genome	  with	  associated	  core	  proteins	   (DNA	  binding	  protein	   (DBP),	  terminal	  protein	  (TP),	  mu)	  has	  entered	  the	  nucleus,	  a	   finely	  tuned	  string	  of	  events	  leads	   to	   viral	   gene	   expression	   and	   protein	   translation	   relying	   on	   the	   host	  transcription	  and	  translation	  machinery	  (Ginsberg	  and	  Young,	  1976).	   	  The	  genome	  architecture	   of	   different	   adenovirus	   serotypes	   is	   very	   similar	   and	   can	   be	   divided	  into	  early	  class	  I	  and	  class	  II	  genes,	  involved	  in	  regulation	  of	  viral	  gene	  expression,	  DNA	  replication,	  and	  repression	  of	  host	  responses,	  and	   late	  genes	  encoding	  capsid	  components	   (Figure	   1-­‐9).	   Of	   particular	   importance	   to	   virus	   replication	   is	   the	  expression	   of	   the	   early	   E1A	   gene.	   	   It	   encodes	   the	   first	   viral	   polypeptides	   to	   be	  transcribed	  and	  can	  be	  seen	  as	  the	  master	  regulator	  of	  adenoviral	  infection	  (Pelka	  et	  al.,	   2008).	   	   EA1	  proteins	   optimize	   the	   host	   cell	   environment	   for	   virus	   production.	  	  They	   are	   trans-­‐acting	   regulators	   of	   transcription	   activating	   early	   genes	   without	  binding	  DNA.	  	  E1A	  can	  also	  immortalize	  primary	  cells	  in	  vitro,	  an	  effect	  potentiated	  by	  the	  expression	  of	  E1B	  (Endter	  and	  Dobner,	  2004).	   	  Further	  early	  gene	  clusters,	  especially	   E3,	   have	   additional	   immune-­‐modulating	   functions,	   which	   are	   not	  required	   for	   replication	   in	   cultured	   cells	   (Fessler	   et	   al.,	   2004;	   Lichtenstein	   et	   al.,	  2004;	  Windheim	  et	  al.,	  2004).	  	  	  Replication	   of	   viral	   DNA	   requires	   the	   virus-­‐encoded	   proteins	   TP,	   DBP,	   and	   the	  140kDa	   DNA-­‐dependent	   polymerase	   and	   host	   proteins	   including	   nuclear	   factor	   I	  and	   II	   (NFI	   and	   NFII),	   and	   topoisomerase	   I.	   For	   efficient	   levels	   of	   replication,	   all	  these	   proteins	   are	   required	   to	   bind	   to	   the	   origin	   of	   DNA	   replication	   (ori),	   the	  terminal	  18bp	  of	  each	  linear	  viral	  DNA	  strand	  to	  form	  the	  pre-­‐initiation	  complex	  (de	  
	   30	  
Jong	   and	   van	   der	   Vliet,	   1999).	   	   Interestingly,	   the	   expression	   machinery	   for	   host	  genes	   is	  strongly	   inhibited	  during	   infection	  and	  12hr	  p.i.	  virtually	  exclusively	  viral	  gene	  products	  are	  being	  synthesized	  (Bello	  and	  Ginsberg,	  1967).	  	  	  	  
	  	  Figure	  1-­‐9:	  Adenovirus	  Transcription	  Map.	  Schematic	  representation	  of	  the	  linear	  adenoviral	  dsDNA	  (purple,	  center)	  reflecting	  the	  connection	  between	  gene	  localization	  within	  the	  genome	  and	  its	  transcription	  in	  the	  course	  of	  infection.	  	  Early	  genes	  are	  present	  in	  6	  clusters	  (E1A-­‐B,	  E2A-­‐B,	  E3,	  E4,	  red)	  and	  expressed	  as	  early	  as	  1h	  post-­‐infection.	   	  Coping	  sequences	   in	  a	   late	  gene	  cluster	   (L1-­‐L5,	   green)	   are	   under	   the	   control	   of	   a	   specific	   promoter	   and	   encode	  mostly	   capsid	   proteins	   required	   for	   the	   generation	   of	   viral	   progeny	   (illustration	  from	  (Broker,	  1984)).	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At	  the	  onset	  of	  DNA	  replication,	  the	  pattern	  of	  transcription	  changes	  radically	  from	  the	   early	   to	   the	   late	   genes	   and	   only	   newly	   replicated	   DNA	   is	   used	   for	   late	   gene	  transcription,	  driven	  primarily	  by	  the	  major	  late	  promoter.	  	  This	  promoter	  regulates	  expression	   of	   five	   gene	   clusters	   (L1-­‐L5),	   predominantly	   encoding	   virion	   proteins.	  	  Similar	   to	   host	   proteins,	   translation	   of	   viral	   mRNA	   occurs	   in	   the	   cytoplasm.	  	  However,	   especially	   the	   major	   capsid	   proteins	   feature	   uncommon	   tertiary	   and	  quaternary	  structures	  which	  require	  the	  aid	  of	  the	  viral	  chaperone	  protein	  100K	  for	  correct	  folding	  and	  oligomerization	  (Hong	  et	  al.,	  2005).	  	  Temperature-­‐sensitive	  Ad5	  mutant	  with	  compromised	  100K	  function	  fails	  to	  produce	  hexon	  trimers	  at	  the	  non-­‐permissive	   temperature,	   but	   the	   effect	   can	  be	   rescued	  by	   shifting	   infected	   cells	   to	  the	  permissive	  temperature	  (Oosterom-­‐Dragon	  and	  Ginsberg,	  1981).	  	  	  1.2.2.3.	  Virus	  Assembly	  and	  Cell	  Lysis	  Synthesis	   of	   viral	   polypeptides	   peaks	   at	   15h	   p.i.	   allowing	   rapid	   capsid	   assembly.	  	  Assembly	   occurs	   in	   the	   nucleus,	   but	   begins	   in	   the	   cytoplasm	   when	   individual	  monomers	  form	  into	  hexon	  and	  penton	  capsomers.	  	  For	  nuclear	  localization,	  hexon	  trimers	   have	   to	   rely	   on	   the	  minor	   capsid	   protein	  VI,	  which	   provides	   the	   required	  nuclear	   localization	   signals	   (NLS)	   absent	   in	   the	   hexon	   sequence	   (Wodrich	   et	   al.,	  2003).	   	   Both	  members	   of	   the	   penton	   complex,	   penton	   base	   and	   fiber,	   in	   contrast,	  contain	   NLS.	   	   Inside	   the	   nucleus,	   the	   pre-­‐formed	   capsid	   building	   blocks	   are	  assembled	   into	   capsids	   and	   filled	   with	   viral	   DNA	   with	   the	   help	   of	   minor	   capsid	  proteins	  and	   the	  virally	  encoded	  protease	  adenain	   (Weber,	  1995).	   	   In	  a	  DNA-­‐	  and	  pVI-­‐dependent	  manner,	  adenain	  cleaves	  the	  capsid	  proteins	  IIIa,	  VI,	  and	  VIII,	  and	  the	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core	   proteins	   VII,	   mu,	   and	   TP	   (Mangel	   et	   al.,	   1993)	   for	   correct	   capsid	   assembly.	  	  Temperature-­‐sensitive	   adenovirus	   mutants,	   which	   lack	   functional	   adenain	   when	  grown	  at	   the	  non-­‐permissive	   temperature	  are	  not	   infectious,	  more	  rigid,	  and	  their	  cryoEM	  data	   reveal	   extra-­‐densities	   on	   the	   capsid	   inside	   (Perez-­‐Berna	   et	   al.,	   2009;	  Silvestry	  et	  al.,	  2009).	  Thus,	  it	  has	  been	  hypothesized	  that	  viral	  DNA	  is	  packed	  into	  an	  empty	  immature	  virion,	  subsequently,	  adenain	  cleaves	  precursor	  capsid	  proteins	  resulting	   in	   a	   packed	   mature	   adenovirus	   (Ostapchuk	   and	   Hearing,	   2005).	  	  Interestingly,	  the	  icosahedral	  capsid	  seems	  to	  reveal	  some	  asymmetry	  since	  protein	  IVa2	  has	  been	  found	  on	  one	  vertex	  only	  and	  seems	  to	  act	  as	  the	  ATPase	  responsible	  for	  pulling	  the	  viral	  DNA	  into	  the	  immature	  capsid	  (Zhang	  and	  Arcos,	  2005;	  Zhang	  and	  Imperiale,	  2003).	  	  Although	  host	  cell	  metabolism	  ceases	  earlier	  in	  the	  infection,	  infected	   cells	   remain	   largely	   intact,	   round	   up,	   but	  many	   do	   not	   lyse.	   Unlike	   other	  viruses,	  adenovirus	  seems	  to	  rely	  on	  rather	  unspecific	  pathways	  for	  progeny	  virus	  release.	  Although,	  prolonged	  infection	  will	  eventually	  lead	  to	  cell	  lysis,	  which	  may	  be	  facilitated	  by	  the	  adenovirus	  “death	  protein”	  (ADP,	  initially	  E3-­‐11.6K)	  (Tollefson	  et	  al.,	  1996),	  secreted	  penton	  base	  (Trotman	  et	  al.,	  2003),	  or	  fiber	  protein	  (Walters	  et	  al.,	  2002).	   	  Virus	  particles	   tend	  to	  accumulate	   in	   the	  nucleus	  and	  are	  visible	   in	   the	  microscope	  as	  eosinophilic	  crystals	  (Franqueville	  et	  al.,	  2008).	  	  These	  are	  thought	  to	  be	  the	  basis	  of	  occult	  infections	  in	  unlysed,	  infected	  cells	  and	  reactivation	  is	  caused	  by	  accidental	  lysis	  of	  infected	  cells,	  releasing	  stored	  virus	  particles.	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1.3.	  Adenovirus	  Transport	  1.3.1.	  Dynein	  Binding	  Capsid	  Protein	  Live-­‐cell	   analysis	   of	   fluorescently	   labeled	   adenovirus	   capsids	   between	   endosomal	  escape	   and	   docking	   to	   the	   NPC	   with	   high	   temporal	   resolution	   illustrates	   a	  bidirectional	  motility	   pattern	   of	   adenovirus	   along	  MT	   (Suomalainen	   et	   al.,	   1999).	  	  This	  indicates	  the	  engagement	  of	  active	  MT	  minus	  and	  plus	  end	  directed	  molecular	  motors,	   but	   the	   net	   movement	   of	   incoming	   adenovirus,	   however,	   is	   towards	   the	  MTOC.	  	  Weihing	  and	  coworkers	  identified	  the	  ability	  of	  adenovirus	  to	  interact	  with	  MTs	   in	   vitro	   (Luftig	   and	  Weihing,	   1975);	   an	   interaction	   that	   is	   dependent	   on	   the	  presence	   of	   HMW	  MT	   associated	   proteins	   (MAPs)	   (Weatherbee	   et	   al.,	   1977).	   	  MT	  binding	   assays	   showed	   that	   the	   interaction	   between	   MTs	   and	   adenovirus	  presumably	   requires	   cytoplasmic	   dynein	   (Kelkar	   et	   al.,	   2004).	   	   These	   results	  suggested	   that	   dynein	   is	   required	   for	   adenovirus	   transport	   in	   early	   phases	   of	  infection,	   but	   despite	   the	   limited	   number	   of	   candidate	   proteins	   in	   the	   adenovirus	  capsid	  (hexon,	  fiber,	  penton	  base,	  proteins	  IIIa,	  VI,	  VIII,	  and	  IX),	  the	  identification	  of	  the	   most	   crucial	   transport	   determinant	   for	   virus	   entry	   is	   surprisingly	   still	   under	  debate.	  	  Knowledge	  of	  the	  stepwise	  dismantling	  of	  the	  virus	  and	  shedding	  of	  capsid	  proteins	   early	   in	   the	   entry	  pathway	   further	   reduces	   the	  pool	   of	   possible	  proteins.	  	  However,	  many	   trafficking	   studies	   have	   been	   plagued	   by	   the	   presence	   of	   nuclear	  localization	  sequences	  (NLS)	  in	  some	  viral	  proteins.	  	  At	  late	  stages	  of	  infection,	  NLS	  ensure	  a	  nuclear	  localization	  of	  the	  viral	  proteins	  for	  proper	  capsid	  assembly	  inside	  the	   nucleus.	   	   Thus,	   they	   allow	   for	   nucleus-­‐directed	   movement	   of	   artificially	  expressed	   or	   incorporated	   versions	   of	   the	   viral	   protein	   in	   the	   cell.	   	   Subsequently,	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several	  lines	  of	  evidence	  connect	  all	  major	  and	  some	  minor	  capsid	  proteins	  directly	  or	   indirectly	   to	   MT-­‐based	   cytoplasmic	   transport	   of	   adenovirus.	   	   However,	   the	  possibility	  of	  each	  capsid	  protein	  to	  interact	  directly	  with	  dynein	  and	  represent	  the	  viral	  receptor	  are	  rarely	  discussed:	  (1)	   A	   dodecahedron	   consisting	   of	   recombinant	   penton	   base	   with	   or	   without	  attached	   fiber	   molecules	   not	   only	   enters	   HeLa	   cells	   by	   itself	   and	   shows	   nuclear	  localization	   10-­‐20min	   thereafter,	   it	   can	   also	   be	   loaded	   with	   plasmid	   DNA	   and	  facilitates	  gene	  expression	  (Fender	  et	  al.,	  1997).	   	  The	  entry	  pathway	  of	  the	  penton	  base	  dodecahedron	  resembles	   that	  of	   the	  virion	  closely	  and	  requires	  an	   intact	  MT	  network	   for	   nuclear	   delivery	   after	   endosomal	   escape	   (Fender	   et	   al.,	   2005;	  Rentsendorj	   et	   al.,	   2006).	   	   If	   penton	   base	   dodecahedra	   properly	   represent	   the	  situation	  during	  an	  ongoing	  adenovirus	   infection	   is	  questionable,	   since	   the	  notion,	  that	  the	  pH-­‐dependent	  change	  in	  hydrophobicity	  of	  penton	  base	  indicates	  its	  ability	  to	   disrupt	   the	   endosomal	   membrane	   (Seth	   et	   al.,	   1984),	   contradicts	   more	   recent	  work	   which	   demonstrates	   that	   the	   minor	   capsid	   protein	   VI	   alone	   facilitates	   this	  function	  (Wiethoff	  et	  al.,	  2005).	   	  This	  would	   leave	  the	  dodecahedra	  trapped	   inside	  the	   endosomal	   pathway	   without	   a	   direct	   engagement	   to	   the	   dynein	   motor	  machinery.	  (2)	  Protein	  VI	  appears	  to	  be	  a	  versatile	  mediator	  of	  many	  viral	  functions	  during	  the	  intracellular	   life	   cycle.	   	   It	   has	   membrane-­‐disrupting	   abilities	   if	   released	   from	   the	  inside	   of	   the	   capsid	   into	   the	   endosomal	   lumen	   during	   entry.	   	   Protein	   VI	   is	   also	  contributes	   to	   capsid	   assembly	   processes	   at	   later	   stages	   of	   infection.	   	   Protein	   VI	  binds	   closely	   to	   hexon	   (Matthews	   and	   Russell,	   1994)	   and	   shuttles	   newly	   formed	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hexon	   trimers	   from	   the	   cytoplasm	   into	   the	   nucleus	   via	   an	   importin	   alpha/beta-­‐dependent	  mechanism	   (Wodrich	   et	   al.,	   2003).	   	   Furthermore,	   protein	   VI	  was	   very	  recently	   linked	  to	  cytoplasmic	  transport	  of	  adenovirus	  by	  describing	  a	  decrease	   in	  plaque	   formation	   and	   viral	   infectivity	   after	   generating	   an	   Ad5	   mutant	   with	   an	  altered	  ubiquitinylation	  sequence	   in	  protein	  VI,	  Ad5-­‐VI-­‐M1	   (Wodrich	  et	  al.,	   2010).	  	  However,	   the	   decrease	   in	   infectivity	   is	   presumably	   due	   to	   an	   indirect	   effect	   on	  capsid	   transport	   since	   protein	   VI	   stays	   associated	   with	   only	   about	   5-­‐10%	   of	  incoming	  wild-­‐type	  virions	  after	  endosomal	  escape	  and	  would	  therefore	  represent	  an	   inefficient	   viral	   receptor	   for	  motor	   proteins.	   	   Additionally,	   the	   ubiquitinylation	  site	   is	  only	  exposed	  and	  accessible	   to	  ubiquitin	   ligases	  after	  protein	  VI	  dissociates	  from	  the	  capsid.	  	  Thus,	  the	  observed	  differences	  between	  wild-­‐type	  Ad5	  and	  Ad5-­‐VI-­‐M1	   are	   more	   likely	   due	   to	   a	   delayed	   dissociation	   of	   protein	   VI	   from	   the	   mutant	  capsid	  and	  delayed	  endosomalysis	  (Wodrich	  et	  al.,	  2010)	  but	  not	  related	  to	  dynein-­‐mediated	  transport	  of	  the	  virus.	  	  (3)	   The	   minor	   capsid	   protein	   IX	   is	   accessible	   on	   the	   outside	   of	   the	   adenovirus	  capsid	  for	  host	  cell	   interactions	  and	  resides	  in	  the	  outside	  grove	  of	  adjacent	  hexon	  trimers	  (Akalu	  et	  al.,	  1999;	  Liu	  et	  al.,	  2010;	  Reddy	  et	  al.,	  2010).	  	  In	  addition,	  infection	  of	  cells	  with	  adenovirus	  mutants	  containing	  GFP-­‐tagged	  protein	  IX	  results	  in	  green	  fluorescence	  at	   the	  nucleus	  40min	  after	   infection,	   indicating	  a	   close	  association	  of	  protein	  IX	  with	  the	  virus	  genome	  until	  its	  delivery	  into	  the	  nucleus	  (Meulenbroek	  et	  al.,	   2004).	   	   Furthermore,	   adenovirus	   mutants	   without	   protein	   IX	   (Ad-­‐ΔIX)	   show	  reduced	   infectivity	   in	   cultured	   293	   cells	   (Sargent	   et	   al.,	   2004).	   	   Hence,	   it	   is	  conceivable	   that	   protein	   IX	   represents	   the	   viral	   receptor	   for	   motor	   protein(s).	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However,	   the	  reason	  why	  Ad-­‐ΔIX	  shows	  a	   lower	   infectivity	   lies	  presumably	  within	  decreased	  capsid	  stability	  and	  effects	  on	  viral	  gene	  transcription	  (Parks,	  2005)	  but	  not	  within	   defective	  motor	   attachment	   since	  Ad-­‐ΔIX	   shows	   the	   same	   intracellular	  motility	  characteristics	  as	  the	  wild-­‐type	  virus	  (Gazzola	  et	  al.,	  2009).	  (4)	  Besides	  protein	  IX,	  hexon	  is	  the	  only	  capsid	  protein	  that	  has	  been	  clearly	  shown	  to	   remain	   associated	   with	   the	   viral	   DNA	   until	   virus	   attachment	   to	   the	   nuclear	  envelope	  (Greber	  et	  al.,	  1993;	  Saphire	  et	  al.,	  2000;	  Trotman	  et	  al.,	  2001).	   	  Hexon	  is	  present	   in	   high	   copy	   numbers	   per	   virion	   and	   is	   recognized	   by	   most	   neutralizing	  anti-­‐adenovirus	  antibodies	  which	  act	  predominantly	  by	  aggregating	  virus	  particles	  (Wohlfart,	   1988).	   	   At	   least	   one	   neutralizing	   anti-­‐hexon	   antibody,	   however,	   shows	  post-­‐entry	   effects	   after	   endosomal	   escape	   but	   before	   binding	   to	   the	   nuclear	   pore	  complex,	   presumably	   by	   affecting	   the	   capsid	   association	   with	   MT	   and	   MT	  motor	  proteins	  (Smith	  et	  al.,	  2008).	  	  These	  findings	  argue	  for	  an	  important	  role	  of	  hexon	  in	  motor	   recruitment.	   	   But	   microinjected	   purified	   hexon	   or	   hexon	   expressed	   in	  cultured	  cells	  remains	  spread	  in	  the	  cytoplasm	  and	  shows	  an	  accumulation	  neither	  at	  the	  MTOC	  nor	  the	  nuclear	  envelope	  (Bremner	  et	  al.,	  2009;	  Wodrich	  et	  al.,	  2003).	  This	   indicates	   that	   hexon	   itself	   is	   not	   actively	   transported	   in	   the	   MT	   minus	   end	  direction	   and	   cannot	   obtain	   nuclear	   localization.	   	   These	   results	   are	   supported	   by	  biochemical	   evidence	   that	   hexon	   and	   cytoplasmic	   dynein	   do	   not	   interact	   at	  physiological	  pH.	  	  However,	  short-­‐term	  exposure	  of	  immunopurified	  hexon	  to	  acidic	  pH	   before	   neutralization	   and	   subsequent	   incubation	   with	   purified	   cytoplasmic	  dynein	   strongly	   increases	   its	   ability	   to	   bind	   the	   motor	   protein	   (Bremner	   et	   al.,	  2009).	  	  In	  a	  simplified	  model	  of	  the	  passage	  through	  the	  acidic	  endosomal	  lumen,	  it	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could	   be	   shown	   that	   an	   exposure	   of	   hexon	   to	   pH≤5.4	   buffer,	   allows	   detectable	  interaction	   between	   the	   capsid	   protein	   and	   dynein	   in	   coimmunprecipitation	  experiments	   (Bremner	   et	   al.,	   2009).	   	   This	   result	   argues	   for	   the	   necessity	   of	  adenovirus	  exposure	  to	  low	  pH	  in	  the	  endosome	  for	  efficient	  infection	  (Smith	  et	  al.,	  2010b).	   	   A	   pH-­‐dependent	   affinity	   of	   hexon	   for	   dynein	   would	   also	   explain	   a	  differential	   behavior	   of	   acid-­‐exposed	   hexon	   after	   endosomalysis	   and	   newly	  expressed	   hexon	   trimers	   later	   in	   infection,	   which	   show	   no	   directed	   motility	   by	  themselves	  but	  require	  protein	  VI	  for	  nuclear	  localization.	  	  Taken	  together,	  this	  summary	  strongly	  suggests	  that	  the	  major	  capsid	  protein	  hexon	  constitutes	   the	   link	   between	   the	   incoming	   viral	   capsid	   and	   the	   dynein	   motor	  protein.	  	  1.3.2.	  Capsid	  Binding	  Dynein	  Subunits	  Acidified	  adenovirus	  capsid	  or	  hexon	  alone	  interact	  with	  rat	  brain	  purified	  dynein.	  To	   identify	   the	  dynein	   subunit	   that	   interacts	  with	   the	   virion,	   lysate	   from	   cultured	  293A	   cells	   overexpressing	   individual	   dynein	   subunits	   were	   screened	   for	   hexon	  interaction.	   	   These	   studies	   reveal	   that	   the	   dynein	   ICs	   and	   LIC1,	   but	   not	   LIC2	   or	  TcTex-­‐1,	  RP3	  or	  LC8	  are	  able	  to	  bind	  to	  acidified	  immunopurified	  hexon	  (Bremner	  et	  al.,	  2009).	   	  These	  findings	  are	  insofar	  novel	  as	  it	   is	  the	  first	  description	  that	  two	  dynein	   subunits	   are	   able	   to	   interact	   with	   one	   individual	   protein.	   Both	   subunits	  reside	   in	   the	   tail	   region	  of	   the	  dynein	  motor	  complex	  and	  have	  been	   implicated	   in	  binding	  to	  physiological	  cargo	  (Table	  1-­‐1)	  and	  it	  is	  conceivable	  that	  the	  interaction	  with	  the	  viral	  capsid	  interferes	  with	  regular	  cellular	  transport	  processes.	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Besides	  the	  possible	  analysis	  of	  a	  competition	  between	  pathologic	  and	  physiological	  cargo	   of	   dynein,	   a	   more	   detailed	   determination	   of	   the	   exact	   binding	   sites	   on	   the	  dynein	   subunits	   might	   open	   avenues	   for	   the	   development	   of	   adenovirus-­‐specific	  therapeutic	   peptides.	   	   Similar	   to	   the	   mode	   of	   neutralization	   of	   α-­‐defensins	   that	  prevent	   endosomal	   uncoating	   by	   low	   affinity	   binding	   in	   high	   copy	   number	   at	  sensitive	  sites	  in	  the	  peripentonal	  region	  (Smith	  et	  al.,	  2010a),	  bona	  fide	  fragments	  of	  dynein	  subunits	  might	  be	  able	  to	  block	  the	  interaction	  with	  the	  dynein	  motor	  and	  therefore	  neutralize	  the	  virus	  at	  a	  post-­‐entry	  step.	  	  However,	  more	  work	  needs	  to	  be	  completed	   to	   determine	   the	   molecular	   mechanism	   of	   hexon	   binding	   to	   dynein	  before	  additional	  steps	  in	  regards	  to	  blockage	  of	  virus	  infectivity	  can	  be	  undertaken.	  	  1.3.3.	  Cytoplasmic	  Adenovirus	  Transport	  After	   receptor-­‐mediated	   uptake	   into	   the	   endosome,	   adenovirus	   progression	  towards	   the	   nucleus	   depends	   on	   cytoplasmic	   dynein.	   	   Besides	   dynein-­‐mediated	  transport	  of	  the	  virus-­‐containing	  endosome	  (Burkhardt	  et	  al.,	  1997;	  Gastaldelli	  et	  al.,	  2008),	   virus	   particles	   show	   a	   MT-­‐	   and	   dynein-­‐dependent	   motion	   pattern	   after	  endosomalysis,	   revealed	   by	   nocodazole	   treatment	   or	   dynein	   function-­‐blocking	  antibody	  microinjections	  (Bremner	  et	  al.,	  2009;	  Leopold	  et	  al.,	  2000;	  Suomalainen	  et	  al.,	  1999).	  	  Interestingly,	  Ad5	  progression	  towards	  the	  nucleus	  along	  the	  MT	  appears	  to	   be	   dependent	   on	   PKA	   activity	   (Suomalainen	   et	   al.,	   2001).	   	   Furthermore,	   virus	  attachment	  to	  cell	  surface	  integrins	  has	  been	  reported	  to	  stimulate	  host	  PKA	  activity	  required	  for	  efficient	  dynein-­‐mediated	  capsid	  transport	  (Suomalainen	  et	  al.,	  2001).	  	  In	   addition,	   it	   could	   be	   shown	   by	   immunocytochemistry	   that	   several	   dynein	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subunits	   still	   colocalize	   to	   high	   levels	  with	   incoming	   adenovirus	   in	   the	   cytoplasm	  after	   endosomal	   escape	   (Bremner	   et	   al.,	   2009).	   	   Furthermore,	   two	  of	   the	   growing	  number	   of	   known	   cargo	   adaptors	   and	   regulators	   of	   cytoplasmic	   dynein,	   dynactin	  and	  NudE/EL,	  also	  colocalize	  with	  incoming	  virus	  particles	  in	  the	  cytoplasm.	  	  After	  microinjection	  of	   function-­‐blocking	  NudE/EL	  or	  Lis1	  antibodies	  or	  overexpression	  of	   dominant-­‐negative	   constructs	   that	   disrupt	   the	   NudE/EL	   and	   Lis1	   regulation	   of	  cytoplasmic	   dynein	   (Stehman	   et	   al.,	   2007),	   no	   change	   in	   adenovirus	   progression	  towards	   the	  MTOC	  was	   seen	   in	   infected	  cells.	   	   In	   stark	   contrast,	   interference	  with	  dynactin-­‐mediated	   dynein	   regulation	   by	   overexpression	   of	   headless	   dynactin	  p150Glued	   and	   p150Glued-­‐CC1	   constructs,	   strongly	   affected	   virus	   redistribution	  (Bremner	   et	   al.,	   2009;	   Engelke	   et	   al.,	   2011).	   	   Thus,	   dynein	   is	   presumably	   under	  dynactin	   control	  when	   transporting	   incoming	   adenovirus,	  which	  would	   indicate	   a	  low-­‐load,	  high-­‐speed	  transport	  of	  the	  capsid.	  	  Indeed,	  the	  speed	  of	  the	  capsid	  along	  MT	  can	  exceed	  600nm/s	  (Bremner	  et	  al.,	  2009),	  which	  is	  close	  to	  the	  maximal	  speed	  measured	  for	  mammalian	  dynein	  (800nm/s).	  In	  strong	  contrast	  to	  most	  physiological	  cargos,	  biochemical	  evidence	  indicates	  that	  adenovirus	   recruits	   dynein	   directly	   and	   only	   the	   regulatory	   function	   of	   dynactin	  seems	  to	  be	  required	  for	  adenovirus	  transport.	  	  Work	  on	  herpes	  simplex	  virus	  (HSV)	  supports	   the	   finding	  of	   a	  predominantly	   regulatory	   function	  of	   dynactin	   in	   a	  non-­‐physiological	  context.	  	  HSV	  protein(s)	  of	  the	  inner	  tegument	  have	  the	  ability	  to	  bind	  dynein	   directly,	   but	   dynactin	   is	   required	   for	   virus	   transport	   (Döhner	   et	   al.,	   2002;	  Radtke	  et	  al.,	  2010).	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ZW10,	  an	  additional	  dynein	  recruitment	  factor	  (Starr	  et	  al.,	  1998),	  showed	  minimal	  colocalization	   with	   incoming	   adenovirus	   and	   ZW10	   RNAi	   had	   no	   effect	   on	   virus	  progression	   towards	   the	  nucleus	   (Bremner	  et	   al.,	   2009).	   	  Recently,	   further	  dynein	  regulators	   and	   cargo	   adaptors	   such	   as	   BicD2,	   spindly,	   bassoon,	   and	   snapin	   have	  been	  identified	  (Cai	  et	  al.,	  2010;	  Fejtova	  et	  al.,	  2009;	  Griffis	  et	  al.,	  2007;	  Hoogenraad	  et	   al.,	   2001)	   and	   it	   is	   of	   interest	   to	   elucidate	   their	   possible	   contribution	   to	  adenovirus	  motility.	  	  With	  the	  first	  movies	  of	  adenovirus	  motility	  inside	  an	  infected	  cell	  at	  high	  temporal	  and	   spatial	   resolution,	   it	   has	   become	   obvious	   that	   the	   capsid	   does	   not	   follow	   a	  unidirectional	   trajectory	   towards	   the	  MTOC	   (Bremner	   et	   al.,	   2009;	   Leopold	   et	   al.,	  2000;	  Suomalainen	  et	  al.,	  1999).	  	  Instead,	  adenovirus	  follows	  a	  bidirectional	  motion	  pattern	  with	   short	   runs	   in	   the	  MT	  minus	   and	  plus	   end	  direction.	   Importantly,	   the	  overall	   net	   motility	   is	   MT	  minus	   end	   directed	   and	   allows	   the	   virus	   to	   reach	   and	  tightly	  bind	  the	  nuclear	  pore	  complex	  before	  it	  delivers	  its	  genome	  into	  the	  nucleus.	  	  Interestingly,	  enucleated	  cells	  or	  cells	  treated	  with	  leptomycin	  B,	  which	  inhibits	  the	  nuclear	   export	   factor	   CRM1,	   do	   not	   show	   capsid	   accumulation	   at	   the	   nucleus	   but	  instead	  at	  the	  MTOC	  (Bailey	  et	  al.,	  2003;	  Strunze	  et	  al.,	  2005).	  	  This	  indicates	  that	  the	  MTOC	  is	  the	  primary	  target	  of	   incoming	  virions	  and	  the	  nucleus	  acts	  as	  a	  “sink”	  to	  which	   capsids	   bind	   with	   high	   affinity.	   	   The	   bidirectional	   motion	   reveals	   that	   the	  capsid	  is	  not	  only	  transported	  by	  cytoplasmic	  dynein	  towards	  the	  MTOC	  but	  also	  by	  kinesin(s)	   in	   the	   opposite	   direction.	   	   However,	   microinjections	   of	   anti-­‐kinesin-­‐1	  monoclonal	   antibodies,	   which	   were	   shown	   previously	   to	   interfere	   with	   kinesin	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function,	  have	  no	  effect	  on	  virus	  redistribution	  1h	  p.i.	   (Leopold	  et	  al.,	  2000).	   	  This	  result	  argues	  that	  either	  the	  efficiency	  of	  adenovirus	  motility	  towards	  the	  nucleus	  is	  independent	   of	   kinesin,	   the	   adenovirus	   associated	  MT	   plus	   end	   directed	  motor	   is	  not	  kinesin-­‐1,	  the	  correct	  isoform	  of	  kinesin-­‐1	  is	  only	  inadequately	  targeted	  by	  the	  function	  blocking	  antibodies,	  or	  more	   than	  one	  class	  of	  kinesins	   is	   responsible	   for	  the	  bidirectional	  motion	  of	  the	  capsid	  and	  they	  can	  substitute	  for	  each	  other.	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Chapter	  2:	   Control	  of	  Adenovirus-­Host	   Interactions	  by	  
a	  Single	  Motor	  Protein	  Phosphorylation	  
	  	  
2.1.	  Introduction	  2.1.1.	  Introduction	  Infection	  of	   cells	  by	   all	  DNA	  viruses	   and	  most	   retroviruses	   requires	   their	   efficient	  transport	   from	   the	   cell	   membrane	   to	   the	   nucleus	   to	   overcome	   premature	  inactivation	  (Marsh	  and	  Helenius,	  2006;	  Radtke	  et	  al.,	  2006).	   	  A	  number	  of	  viruses	  have	  been	   found	   to	  accomplish	   this	   transition	  using	  microtubules	   (MTs)	  and	   their	  associated	  motors	  (Dodding	  and	  Way,	  2011;	  Enquist,	  2012;	  Greber	  and	  Way,	  2006;	  Scherer	  and	  Vallee,	  2011).	  	  In	  uninfected	  cells	  this	  machinery	  is	  responsible	  for	  the	  redistribution	   of	   cell	   organelles	   and	   macromolecular	   complexes.	   	   At	   least	   some	  viruses	  have	  evolved	  mechanisms	  allowing	   them	   to	  masquerade	  as	  motor	  protein	  cargo	  (Bremner	  et	  al.,	  2009;	  Radtke	  et	  al.,	  2010).	  	  Transport	  of	  these	  viruses	  to	  the	  nucleus	   involves	   the	   microtubule	   minus	   end-­‐directed	   motor	   protein	   cytoplasmic	  dynein,	   a	   complex	   of	   1.5MDa	   (Paschal	   et	   al.,	   1987)	   and	   possibly	   its	   regulators,	  including	  dynactin,	  LIS1,	  NudE,	  and	  NudEL	  (Vallee	  et	  al.,	  2012).	  Adenovirus	  is	  a	  small	  non-­‐enveloped	  dsDNA	  virus	  with	  a	  simple	  capsids	  consisting	  of	   three	   major	   (fiber,	   hexon,	   penton	   base)	   and	   five	   minor	   proteins.	   	   Adenovirus	  enters	  the	  cell	  by	  endocytosis	  (Dales,	  1962;	  Fitzgerald	  et	  al.,	  1983)	  and	  the	  acidic	  pH	  of	   the	   endosomes	   triggers	   structural	   rearrangements	   of	   the	   viral	   capsid	   allowing	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endosomalysis	   and	   additionally	   primes	   hexon	   for	   dynein	   binding	   (Bremner	   et	   al.,	  2009;	   Nakano	   et	   al.,	   2000).	   	   After	   endosomalysis,	   the	   capsid	   recruits	   cytoplasmic	  dynein	  directly	  through	  its	  IC	  and	  LIC1	  subunits	  (Bremner	  et	  al.,	  2009),	  and	  uses	  the	  motor	  protein	  to	  travel	  to	  the	  centrosome	  and	  nuclear	  envelope	  regions	  (Bremner	  et	   al.,	   2009;	   Leopold	   et	   al.,	   2000;	   Suomalainen	   et	   al.,	   1999).	   	   Dynactin,	  NudE,	   and	  NudEL	   localize	  to	  the	  virus	  particles,	  but,	  unlike	  many	  physiological	  cargo,	  are	  not	  required	  for	  dynein	  recruitment	  (Bremner	  et	  al.,	  2009).	  	  	  	  Within	  minutes	  of	  adenovirus	  infection	  PKA	  and	  p38/MAPK	  activity	  rise.	  	  Inhibition	  of	   these	   pathways	   each	   resulted	   in	   a	   2.5-­‐fold	   decrease	   in	   the	   efficiency	   of	   virus	  transport	   toward	   the	   nucleus	   (Suomalainen	   et	   al.,	   2001),	   affecting	   parameters	   of	  motor	   protein-­‐driven	   virus	   motility,	   but	   the	   kinase	   substrates	   remain	   unknown	  (Suomalainen	  et	  al.,	  2001).	  	  PKA	  signaling	  has	  been	  shown	  to	  modulate	  bidirectional	  movement	  of	  melanosome	  pigment	  granules	  in	  fish	  and	  amphibian	  chromatophore	  cells	  (Reilein	  et	  al.,	  1998).	  	  	  Although	  the	  molecular	  basis	  for	  the	  PKA	  effects	  is	  also	  incompletely	  understood	   in	   these	  systems,	   it	   is	  possible	   that	  virus	   transport	   takes	  advantage	  of	  existing	  physiological	  mechanisms.	  	  Here	   we	   describe	   a	   novel	   PKA	   phosphorylation	   site	   in	   the	   dynein	   subunit	   LIC1,	  which	  we	   find	   to	   represent	   a	   crucial	  determinant	   for	   activating	  virus	   transport	   to	  the	  cell	  center.	   	  We	  have	  also	  identified	  a	  dramatic	  virus-­‐activated,	  PKA-­‐dependent	  lysosomes/late	  endosome	  dispersal,	  which	  could	  represent	  a	  novel	  host	  response	  to	  virus	  infection.	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2.1.2.	  Materials	  and	  Methods	  
Cells,	  Viruses,	  and	  Antibodies	  	  A549,	   Cos7,	   and	   293A	   cells	   were	   grown	   in	   DMEM	   supplemented	   with	   10%	   FBS.	  Replication-­‐deficient	   Ad5	   engineered	   to	   express	   GFP	   (Ad5-­‐GFP,	   plaque-­‐purified;	  obtained	   from	  H.	  Young,	  Columbia	  University)	  or	  wild-­‐type	  Ad3	  (VR-­‐3,	  ATCC)	  and	  Ad41	   (VR-­‐930,	   ATCC)	  were	   propagated	   in	   293A	   cells	   and	   purified	   by	   banding	   on	  two	  linear	  CsCl	  gradients	  (Lawrence	  and	  Ginsberg,	  1967)	  and	  dialyzed	  against	  10%	  glycerol	  in	  PBS	  before	  cryo-­‐storage.	  Viral	  titer	  was	  obtained	  using	  fluorescent	  focus	  assays	   for	   Ad5-­‐GFP	   (Thiel	   and	   Smith,	   1967).	   	   Alexa546-­‐labelling	   was	   described	  earlier	   (Bremner	  et	  al.,	  2009).	   	  A549	  cell	   infections	   for	   fixed	  cell	  microscopy	  (MOI	  20)	  were	  all	  performed	  in	  a	  low	  volume	  of	  DMEM	  without	  FBS	  at	  4°C	  for	  30	  min	  to	  allow	  virus	  attachment.	  The	  cells	  were	  washed	  twice	  in	  warm	  PBS	  and	  incubated	  in	  fresh	   DMEM/10%	   FBS	   for	   60	   min	   at	   37°C,	   unless	   stated	   otherwise,	   to	   allow	  internalization	  and	  intracellular	  transport.	  	  For	  live	  cell	  imaging,	  cells	  were	  infected	  at	  100MOI	  with	  virus	  attachment	  at	  37°C	  for	  5	  min.	  	  Antibodies	   used	   included	   mouse	   monoclonal	   anti-­‐hexon	   (Novocastra),	   anti-­‐HA	  (clone	  16B12,	   Covance),	   anti-­‐FLAG	   (M2,	   Sigma),	   anti-­‐myc	   (9E10,	   SantaCruz),	   anti-­‐tubulin	  (Sigma),	  anti-­‐p150Glued	  (BD	  Bioscience)	  and	  anti-­‐dynein	  IC	  (74.1,	  Chemicon),	  rabbit	   antibodies	   anti-­‐LIC,	   and	   anti-­‐LIC2	   (Tynan	   et	   al.,	   2000b),	   anti-­‐adenovirus5	  (Abcam),	   anti-­‐Arp1	   (Sigma),	   anti-­‐DHC	   (Mikami	   et	   al.,	   1993),	   anti-­‐Lamp1	   (abcam),	  anti-­‐GFP	  (Invitrogen),	  anti-­‐FLAG	  (Abcam),	  anti-­‐HA	  (Sigma),	  antibodies	  recognizing	  phosphorylated	   PKA	   sites	   (RRXp[S/T],	   or	   RXXp[S/T],	   CellSignaling),	   and	   chicken	  anti-­‐LIC1	  (Tan	  et	  al.,	  2011),	  and	  anti-­‐GFP	  (Milipore).	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LysoTracker	  Green	  and	  Mitotracker	  Green	  (Invitrogen)	  was	  used	  to	  label	  lysosomes	  and	  mitochondria,	  respectively.	  	  
Plasmids,	  RNAi,	  and	  Molecular	  Methods	  Mammalian	   expression	   constructs	   used	   in	   this	   work	   included	   LIC1	   truncations	  (Tynan	  et	  al.,	  2000b),	  GFP-­‐CD63,	  -­‐Rab7	  (Tan	  et	  al.,	  2011),	  -­‐NPC1,	  and	  -­‐NAGT	  (Yi	  et	  al.,	  2011).	  Rat	  LIC1	  was	  subcloned	  into	  the	  pEGFP-­‐C1	  vector	  (Clontech,	  Mountain	  View,	  CA)	  by	  introducing	  5’	   	  XhoI	  and	  3’	  KpnI	   restriction	  sites	  by	  PCR.	  Resistance	   to	  LIC1	  RNAi	  was	  archived	  as	  described	  (Tan	  et	  al.,	  2011).	  LIC1	  point-­‐mutants	  were	  generated	  by	  site-­‐directed	   mutagenesis	   (QuikChange	   II,	   Agilent	   Stratagene,	   Cedar	   Creek,	   TX)	  using	   primer	   sequences	   CCCCTCAGCGAAGAGCCGCGGCTGCACAGG	   and	  CCCCTCAGCGAAGAGCCGATGCTGCACAGG	   for	   T213A	   and	   T213D,	   respectively	  (mutations	  in	  bold	  letters).	  For	   RNAi,	   shRNA	   constructs	   based	   on	   the	   pRetro-­‐U6G	   vector	   (Cellogenetics,	   MD)	  were	   used,	   the	   sequence	   for	   pRETRO-­‐LIC1	   is	   GTTGATTAGAGACTTCCAATT,	   for	  pRETRO-­‐LIC2	   is	   GCCAGAAGATGCATATGAA,	   and	   for	   the	   scrambled	   control	   is	  CTTCATTAGAGAGTTCCAA.	   The	   RNA	   sequence	   used	   for	   LIC1	   siRNA	   was	  GUUGAUUAGAGACUUCCAATT,	  for	  LIC2	  siRNA	  it	  was	  GGAUAGAAUGACUCGAAAAUU	  (Tan	  et	  al.,	  2011).	  Transient	   transfections	   were	   performed	   using	   either	   Lipofectamine	   2000	  (Invitrogen)	   or	   Effectene	   (QIAGEN).	   siRNA	   oligos	  were	   transfected	  with	  HiPerfect	  (QIAGEN).	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Cloning	   of	   bacterial	   expression	   constructs	   of	   his-­‐tagged	   LIC1	   and	   LIC2	   constructs	  was	  described	  previously	   (Tynan	  et	  al.,	  2000b)	  and	  subjected	   to	  above	  mentioned	  mutagenesis.	   	   GST-­‐tagged	   IC2C	   truncations	   and	   LC8	   were	   described	   previously	  (McKenney	   et	   al.,	   2011),	   full-­‐length	   rat	   IC1A	   and	   IC2C	  were	   cloned	   in	   frame	  with	  GST	  into	  the	  pGEX-­‐6p	  vector	  (GE	  Bioscience)	  using	  BamHI/XhoI	  and	  BamHI/EcoRI	  sites,	  respectively.	  An	  additional	  C-­‐terminal	  his-­‐tag	  was	  introduced	  by	  PCR.	  	  
Immunofluorescence	  Microscopy,	  Live	  Cell	  Imaging,	  and	  Drugs	  Cells	  were	   grown	  on	   glass	   coverslips	   and	   fixed	   in	  methanol	   at	   -­‐20°C	   for	   5	  min	  or	  with	   4%PFA/PBS	   at	   RT	   for	   15min.	   Coverslips	  were	   blocked	   for	   >60	  min	   in	   0.5%	  donkey	   serum/PBS;	   incubated	   in	   primary	   antibody	   at	   37°C	   for	   1	   hr;	  washed	   and	  incubated	  for	  1	  hr	  at	  37°C	  in	  Cy2-­‐,	  Cy3-­‐,	  or	  Cy5-­‐conjugated	  secondary	  antibody;	  then	  mounted	  using	  ProLong	  Gold	  antifade	  mounting	  media	  containing	  DAPI	  (Invitrogen)	  and	   imaged	   using	   a	   confocal	   microscope	   (IX-­‐81,	   Olympus,	   Center	   Valley,	   PA)	  equipped	  with	  a	  63x	  oil	   immersion	  objective.	   	  Live	  cell	   imaging	  experiments	  were	  described	   earlier	   (Bremner	   et	   al.,	   2009).	   	   Briefly,	   cells	   were	   grown	   in	   glass-­‐bottomed	  dishes	   (MatTek	  Corp,	  Ashland,	  MA),	   infected	  with	  Alexa546-­‐Ad,	  covered	  with	  CO2-­‐independent	  medium	  and	  then	  processed	  for	  imaging	  in	  a	  37°C	  chamber.	  	  Movies	   were	   acquired	   for	   90	  min	   p.i.	   at	   2frames/min	   using	   a	   63x	   oil	   immersion	  objective	  and	  a	  CCD	  camera	  (model	  C9100-­‐12;	  Hamamatsu)	  attached	  to	  an	  inverted	  microscope	  (Leica)	  operated	  by	  Metamorph	  Imaging	  software	  (Molecular	  Devices).	  For	  image	  and	  movie	  analysis	  and	  particle	  counting	  ImageJ	  was	  used.	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Drugs	   targeting	   PKA	   activity	   included	   H-­‐89	   and	   forskolin	   (FSK)	   purchased	   from	  Sigma-­‐Aldrich	   (Saint	   Louis,	   MO),	   cRGD	   and	   PKI-­‐myr	   from	   Enzo	   LifeSciences	  (Farmingdale,	  NY),	  and	  3-­‐isobutyl-­‐1-­‐methylxanthine	  (IBMX)	  from	  Santa	  Cruz	  (Santa	  Cruz,	  CA).	  	  
Proteins	  and	  Biochemical	  Analysis	  Rat	  brain	   lysate	  and	  purified	  rat	   cytoplasmic	  dynein	  were	  prepared	   in	  phosphate-­‐glutamate	  buffer	  (pH	  7.0)	  as	  previously	  described	  (Paschal	  et	  al.,	  1987).	  Adenovirus	  hexon	   was	   either	   recovered	   from	   virus-­‐depleted	   supernatant	   of	   the	   first	   CsCl	  gradient	   by	   immunoprecipitation	   as	   described	   (Bremner	   et	   al.,	   2009)	   or	   by	   anion	  exchange	   chromatography	   (Waris	   and	  Halonen,	   1987).	   	   Vectors	   for	   GST-­‐	   and	   his-­‐tagged	  dynein	  subunits	  were	  transformed	  into	  BL21-­‐Gold(DE3)pLysS	  E.coli	  (Agilent	  Stratagene,	  Cedar	  Creek,	  TX)	  and	  expressed	  for	  3-­‐5h	  at	  20°C	  after	  15min	  ice-­‐shock	  of	   LB	   cultures	   at	   OD600=0.6	   and	   induction	   with	   0.5mM	   IPTG.	   	   Purification	   was	  performed	   following	   standard	   procedures	   with	   Ni+	   (Sigma-­‐Aldrich)	   in	   buffer	   A	  (30mM	   TrisHCl,	   150mM	   NaCl,	   5mM	   imidazole,	   5mM	   β-­‐Mercaptoethanol,	   pH7.4)	  supplemented	  with	  protease	  inhibitor	  cocktail	  (Sigma-­‐Aldrich),	  eluted	  with	  450mM	  NaCl	   and	   200mM	   imidazole,	   followed	   by	   buffer	   exchange	   into	   buffer	   A	   or	  Glutathione	   (USB)	   beads	   in	   buffer	   B	   (10mM	   TrisHC,	   150mM	   NaCl,	   1mM	   EDTA,	  0.5mM	  DTT,	   pH7.4),	   and	   eluted	  with	   10mM	   reduced	   glutathione	   or	   digested	  with	  R3C	   protease	   to	   cleave	   off	   GST.	   	   Proper	   protein	   folding	   was	   checked	   by	   size	  exclusion	  chromatography	  and	  by	  binding	  to	  known	  interaction	  partners.	   	  Purified	  proteins	  were	  flash	  frozen	  in	  liquid	  nitrogen	  and	  stored	  at	  -­‐80°C.	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For	   phosphatase	   treatment,	   purified	   dynein	   was	   incubated	   with	   λ-­‐phosphatase	  (NEB)	  2:1	  (w/v)	  for	  1	  hr	  at	  30°C	  in	  phosphatase	  buffer	  supplemented	  with	  MnCl2.	  The	  reaction	  was	  stopped	  using	  a	  phosphatase	  inhibitor	  cocktail	  (50mM	  NaF,	  5mM	  tetra-­‐sodium	   pyrophosphate,	   1mM	   sodium	   ortho-­‐vanadate,	   10mM	   β-­‐glyceropyrophosphate).	   	  For	   in	  vitro	  PKA	  phosphorylation,	   the	  catalytic	  subunit	  of	  PKA	  (Sigma)	  was	   incubated	  with	  purified	  dynein	  or	  dynein	  subunits	  at	  about	  50:1	  (unit/nmole)	  for	  30	  min	  at	  30°C	  before	  the	  reaction	  was	  stopped	  with	  67	  μM	  H-­‐89	  (Sigma).	  Mammalian	   cultured	   cell	   lysates	   were	   prepared	   in	   RIPA	   buffer	   (50mM	   Trisma-­‐maleate,	  100	  mM	  NaCl,	  1	  mM	  EGTA,	  [pH	  7.4])	  containing	  protease	  inhibitor	  cocktail	  (Sigma)	  and	  1%	  NP40,	  and	  the	  membrane	  fraction	  was	  removed	  by	  centrifugation.	  	  Hexon	   binding	   assays	   were	   described	   previously	   (Bremner	   et	   al.,	   2009).	   	   Briefly,	  hexon	  was	   immunoprecipitated	   from	  virus-­‐depleted	   infected	  293A	  cell	   lysate	  with	  anti-­‐hexon	   antibodies	   and	   protein	   A	   sepharose	   beads	   (GE	   Bioscience).	   The	   hexon	  beads	   were	   washed	   and	   incubated	   for	   30	   min	   in	   Tris-­‐maleate	   buffer	   (50	   mM	  Trizma-­‐maleate,	  10	  mM	  NaCl,	  1	  mM	  EDTA,	  and	  0.1%	  Tween	  20,	  pH	  4.4),	  washed	  in	  the	  same	  buffer	  at	  pH	  7.4,	  and	  then	  incubated	  with	  purified	  cytoplasmic	  dynein	  or	  bacterially	  expressed	  polypeptides	  at	  4°C	   for	  1.5	  hr.	  Following	  washing,	   the	  beads	  were	  analyzed	  for	  the	  presence	  of	  dynein	  or	  dynein	  subunits	  by	  immunoblotting.	  	  
Statistical	  Analysis	  For	   analysis,	   two-­‐sample	   comparisons	   were	   performed	   via	   Student’s	   t	   test.	  	  	  Statistical	   significance	   was	   inferred	   for	   p	   values	   less	   than	   0.05.	   Analysis	   and	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statistical	   tests	  were	  performed	  using	  Excel	   (Microsoft,	  Redmond,	  WA)	   and	  Prism	  (GraphPad,	  La	  Jolla,	  CA).	  	  
2.2.	  Results	  2.2.1.	  LIC1	  phosphorylation	  	  While	   screening	   conditions	   to	   optimize	   dynein	   binding	   to	   acidified	   hexon	   during	  earlier	  work	  (Bremner	  et	  al.,	  2009),	  we	  found	  that	  dynein	  treatment	  with	  a	  general	  phosphatase	  significantly	  reduces	  the	  hexon	  affinity	  of	  the	  motor	  complex	  (Figure	  2-­‐1).	   	  Regarding	   stimulated	  PKA	  activity	  upon	  adenoviral	   infection	   (data	  not	   shown	  and	  (Suomalainen	  et	  al.,	  2001))	  and	  the	  reported	  involvement	  of	  PKA	  in	  MT	  minus-­‐end	  directed	  motility	  of	  adenovirus	  (Suomalainen	  et	  al.,	  2001),	  we	  sought	  to	  rescue	  the	   dephosphorylation	   effect	   by	   subsequent	   in	   vitro	   PKA	   phosphorylation.	   	   PKA	  phosphorylation	  alone	  or	  after	  phosphatase	  treatment	   increases	  the	  hexon	  affinity	  compared	  with	  untreated	  dynein	   to	  158%	  (±39%)	  or	  168%	  (±65%),	   respectively,	  indicating	  a	  clear	  role	  of	  PKA	  phosphorylation	  in	  dynein	  binding	  to	  hexon	  (Figure	  2-­‐1A).	   	   In	   a	   separate	   experiment,	   we	   used	   a	   monospecific	   antibody	   against	   the	  phosphorylated	   PKA	   motif	   (RRXpS/T)	   for	   immunoblotting	   of	   rat	   brain	   purified	  dynein	  before	  and	  after	  PKA	  treatment.	  	  The	  antibody	  reacted	  with	  only	  two	  dynein	  subunits,	  strongly	  with	  the	  IC	  and	  to	  a	  lesser	  extent	  with	  LIC1	  (Figure	  2-­‐1B).	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Figure	  2-­‐1:	  PKA	  Phosphorylation	  of	  Dynein	  LIC1	  Affects	  Hexon	  Binding.	  (A)	   Purified	   rat	   brain	   cytoplasmic	   dynein	   was	   exposed	   to	   λ-­‐phosphatase	   (PPase)	  and/or	   protein	   kinase	   A	   (PKA)	   catalytic	   subunit	   and	   evaluated	   for	   co-­‐immunoprecipitation	  with	  hexon	  by	   immunoblotting	  of	   the	  pellets	  with	  antibodies	  against	  hexon,	  and	  dynein	  heavy,	  intermediate,	  and	  light	  intermediate	  chain	  (HC,	  IC,	  LIC)	  subunits.	  	  Lower	  panel,	  quantification	  of	  immunoblotting	  results:	  n	  =	  3,	  mean	  ±	  SD,	  mock	  treated	  =	  100%.	  	  Dynein	  dephosphorylation	  decreased,	  and	  PKA	  treatment	  enhanced	   binding	   to	   hexon.	   	   (B)	   Purified	   dynein	   was	   exposed	   to	   PKA	   catalytic	  subunit,	   and	   phosphorylation	   was	   evaluated	   by	   immunoblotting	   with	   antibodies	  against	   the	   dynein	   ICs,	   LIC1,	   and	   the	   phosphorylated	   PKA	   consensus	   sequence	  RRXp(S/T).	  	  Clear	  phosphorylation	  of	  the	  IC	  and	  LIC1	  subunits	  is	  observed.	  	  Higher	  molecular	  weight	   band	   is	   contaminant	   in	   PKA	  preparation	   (data	   not	   shown).	   	   (C)	  Bacterially	  expressed	  full-­‐length	  dynein	  subunits	  IC1,	  IC2,	  LIC1,	  LIC2,	  LC8,	  LC7,	  and	  TcTex	  were	   exposed	   to	   PKA	   catalytic	   subunit	   and	   tested	   for	   phosphorylation	   and	  hexon	   co-­‐immunoprecipitation	   by	   immunoblotting	   with	   the	   anti-­‐RRXp(S/T)	  antibody.	   	   	  LIC1	  and	  IC1	  were	  clearly	  phosphorylated,	  which	  specifically	   increased	  LIC1	  binding	  to	  hexon	  	  	  Of	  note,	  IC	  and	  LIC1	  are	  the	  same	  dynein	  subunits	  that	  we	  previously	  identified	  to	  interact	  with	  hexon	  after	  expression	  in	  mammalian	  cells	  (Bremner	  et	  al.,	  2009).	  	  To	  elucidate	   which	   subunit	   is	   responsible	   for	   the	   increased	   affinity	   to	   hexon	   of	   the	  entire	  dynein	  complex,	  we	  purified	  recombinant	  full-­‐length	  rat	  dynein	  IC1,	  IC2,	  LIC1,	  LIC2,	   LC8,	   LC7	   and	   TcTex	   from	   bacterial	   lysate,	   mock	   or	   PKA	   treated	   the	  polypeptides,	   and	   performed	   coimmunoprecipitation	   experiments	   with	   acidified	  hexon.	   	   Using	   the	   RRXpS/T	   antibody,	   we	   identified	   only	   IC1	   and	   LIC1	   to	   be	  substrates	  of	  PKA,	  in	  contrast	  to	  IC2,	  LIC2,	  LC8,	  LC7	  and	  TcTex	  (Figure	  2-­‐1C).	   	  The	  same	  results	  were	  seen	  using	  a	  less	  stringent	  RXXpS/T	  antibody	  (data	  not	  shown).	  	  Furthermore,	   IC1	   and	   IC2	   were	   coimmunoprecipitated	   with	   acidified	   hexon	   to	   a	  similar	  extent	  independent	  of	  their	  phosphorylation	  state,	  while	  LIC2	  and	  LC8	  were	  absent	   in	   the	   coimmunoprecipitates	   for	   both	   conditions	   (Figure	   2-­‐1C).	   	   Mock	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treated,	   bacterially	   expressed	   LIC1	   did	   not	   interact	   with	   hexon	   in	   contrast	   to	  mammalian	  expressed	  LIC1	  (Bremner	  et	  al.,	  2009)	  indicating	  that	  post-­‐translational	  modifications	  regulate	  the	  hexon	  affinity	  of	  this	  dynein	  subunit.	  	  In	  agreement	  with	  this,	   LIC1	   is	   the	   only	   subunit	   that	   showed	   an	   enhanced	   signal	   in	   the	  coimmunoprecipitate	  after	  PKA	  treatment	  (Figure	  2-­‐1C).	  	  Together,	   these	   results	   show	   that	   PKA	   phosphorylation	   of	   the	   dynein	   complex	  increases	   its	   hexon	   affinity	   and	   that	   one	   or	   multiple	   PKA	   sites	   in	   LIC1	   are	  responsible	  for	  this	  effect.	  For	   the	   identification	   of	   possible	   PKA	   sites,	   we	   aligned	   the	   protein	   sequences	   of	  human,	  rat,	  mouse,	  chicken,	  xenopus,	  and	  zebrafish	  LIC1	  and	  screened	  them	  for	  the	  RRXS/T	   motif.	   	   Only	   one	   evolutionary	   conserved	   site	   could	   be	   identified	   at	  threonine	   213	   (rat,	   mouse,	   human	   sequence)	   (Figure	   2-­‐2A).	   	   Interestingly,	   LIC2	  contains	  a	  non-­‐phosphorylatable	  proline	  at	  that	  site.	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Figure	  2-­‐2:	  LIC1-­‐T213	  Represents	  PKA	  Site	  that	  Regulates	  Hexon	  Binding.	  (A)	   LIC1	   sequences	   of	  H.sapiens	   (human),	  R.norvegicus	   (rat),	  M.musculus	   (mouse),	  
G.gallus	  (chicken),	  X.laevis	  (frog),	  D.rerio	  (zebrafish),	  and	  human	  and	  rat	  LIC2	  were	  aligned	   to	   identify	   conserved	   PKA	   phosphorylation	   sites	   in	   LIC1,	   which	   are	   not	  present	   in	  LIC2.	   	  Only	  parts	  of	   the	  sequences	  surrounding	  T213	  are	  shown	  (upper	  panel).	   	  LIC1	  domain	  structure	  with	  P-­‐loop	  sequence,	  ras-­‐like	  GTPase	  domain,	  and	  location	  of	  T213	   in	   the	  polypeptide	  are	  shown	  (middle	  panel).	   	  Bold	   line	   indicates	  sequence	   covered	   in	   upper	   panel.	   Delineated	   truncation	   constructs	   of	   LIC1	   for	  mammalian	  expression	  were	  used	  to	  identify	  hexon	  binding	  site	  (lower	  panel).	  (B)	  LIC1	  truncation	  constructs	  were	  expressed	  in	  293A	  cells	  and	  were	  tested	  in	  hexon	  co-­‐immunoprecipitation.	   	   Only	   fragments	   including	   the	   middle	   third	   of	   the	   LIC1	  polypeptide	   show	  hexon	  binding.	   	   (C)	  Bacterially	   expressed	  LIC1	  wild-­‐type	  or	   the	  LIC1-­‐T213A	  and	  -­‐T213D	  mutants	  were	   tested	   for	  PKA	  phosphorylation	  and	  hexon	  co-­‐immunoprecipitation.	   	   The	   phosphomimetic	   LIC1-­‐T213D	   mutant	   alone	  interacted	   with	   hexon.	   	   No	   PKA	   phosphorylation	   was	   detected	   in	   the	   mutant	  polypeptides,	   identifying	  T213	   as	   the	  major	  PKA	   site.	   	   (D)	  Monospecific	   antibody,	  which	  recognizes	  phosphorylated	  LIC1-­‐T213	  was	  tested	  for	  competition	  with	  hexon	  for	  LIC1	  binding.	   	  Adding	  the	  antibody	  to	  the	  PKA-­‐phosphorylated	  LIC1	  pull-­‐down	  reaction	  drastically	  reduces	  the	  amount	  of	  hexon	  in	  the	  pellets.	   	  Unphosphorylated	  LIC1	  was	  used	  as	  negative	  control.	  	  	  Additionally,	  two	  conserved	  RXXS/T	  sites	  can	  be	  found	  specifically	  in	  LIC1,	  serine	  9	  and	  414,	  respectively.	  	  However,	  they	  appear	  to	  be	  outside	  the	  hexon-­‐binding	  region	  of	   LIC1,	   which	   is	   in	   the	   vicinity	   of	   T213	   (Figure	   2-­‐2B).	   	   Myc-­‐tagged	   truncation	  constructs	   of	   LIC1	  were	   expressed	   in	  mammalian	   cells	   (Tynan	   et	   al.,	   2000b)	   and	  used	   for	   anti-­‐hexon	   coimmunoprecipitation	   studies.	   Like	   the	   full-­‐length	   protein	  (Bremner	   et	   al.,	   2009),	   we	   found	   the	   C-­‐terminal	   N174	   and	   N-­‐terminal	   C348	  constructs,	   which	   both	   contain	   T213,	   to	   interact	   with	   hexon	   (Figure	   2-­‐2B).	   In	  contrast,	   the	   two	  N349	  and	  C173	   constructs,	  which	   lack	   the	  middle	   third	  of	   LIC1,	  show	  no	  interaction	  with	  hexon	  (Figure	  2-­‐2B).	  	  These	  results	  further	  argue	  for	  T213	  as	  the	  PKA	  site	  regulating	  hexon	  binding.	  	  We	  mutated	  this	  residue	  either	  to	  aspartic	  acid	   (T213D,	   phospho-­‐mimetic)	   or	   alanine	   (T213A,	   dephospho-­‐mutant)	   in	   our	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bacterial	   expression	   constructs.	   	   Even	  without	   PKA	   phosphorylation,	   LIC1-­‐T213D	  was	   able	   to	   interact	   with	   acidified	   hexon,	   indicating	   that	   the	   aspartic	   acid	  successfully	   mimics	   the	   phosphorylated	   threonine	   at	   that	   side	   (Figure	   2-­‐2C).	   In	  contrast,	  LIC1-­‐T213A	  could	  not	  be	  phosphorylated	  by	  PKA	  as	  indicated	  by	  an	  absent	  RXXpS/T	  signal	  and	  did	  not	   interact	  with	  acidified	  hexon	  above	  background	  levels	  (Figure	   2-­‐2C).	   	   Furthermore,	   the	   interaction	   between	   hexon	   and	   PKA	  phosphorylated	  wild-­‐type	  LIC1	  could	  be	   inhibited	  by	  adding	  RRXpS/T	  antibody	   to	  the	  reaction	  (Figure	  2-­‐2D).	  These	   results	   illustrate	   that	   within	   dynein,	   PKA	   phosphorylation	   of	   LIC1-­‐T213	  represents	   a	   necessary	   and	   sufficient	   event	   to	   prime	   the	  motor	  protein	   for	   hexon	  binding.	  	  	  We	   also	   tested	   the	   dynein	   LIC1	   T213D	   and	   IC2C	   1-­‐250	   (see	   chapter	   4.2.3.)	   for	  competition	   for	   hexon	   binding	   and	   found	   that	   both	   accessory	   subunits	   can	   bind	  hexon	   to	   the	   same	   extent	   either	   by	   themselves	   or	   in	   combination	   under	   limiting	  hexon	   conditions,	   arguing	   against	   a	   common	  binding	   site	   on	  hexon	   (Figure	  2-­‐3A).	  However,	  the	  two	  subunits	  behaved	  differently	  in	  competition	  experiments	  with	  the	  dynein	   complex.	   	   Addition	   of	   LIC1	   T213D	   to	   the	   binding	   reaction	   reduces	   the	  amount	   of	   dynein	   in	   the	   anti-­‐hexon	   coimmunoprecipitates	   in	   comparison	   to	   the	  reaction	  with	   dynein	   alone	   but	   shows	   clear	   LIC1	   binding	   to	   hexon	   (Figure	   2-­‐3B).	  	  Adding	  IC	  1-­‐250	  to	  the	  reaction	  does	  not	  reduce	  the	  dynein	  signal	  in	  the	  pellet	  but	  in	  addition	  shows	  interacting	  IC	  fragment	  (Figure	  2-­‐3B).	  	  These	  findings	  establish	  LIC1	  as	  the	  most	  critical	  subunit	  of	  the	  dynein	  complex	  for	  hexon	  binding.	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  Figure	  2-­‐3:	  LIC1-­‐T213D,	  but	  not	  IC1-­‐250	  Competes	  with	  Dynein.	  (A)	   Bacterially	   expressed	   full-­‐length	   LIC1-­‐T213D	   and	   IC2C	   1-­‐250	   fragment	   were	  tested	  individually	  and	  in	  combination	  for	  hexon	  binding.	   	  Both	  polypeptides	  show	  similar	   concentrations	   in	   the	   hexon	   co-­‐immunoprecipitate	   independent	   of	   the	  presence	  of	  the	  other	  dynein	  subunit	  indicating	  a	  non-­‐competitive	  interaction.	   	  (B)	  Purified	   rat	   brain	   cytoplasmic	   dynein	  was	   tested	   for	   pull-­‐down	  with	  hexon	   in	   the	  presence	  of	  bacterially	  expressed	  LIC1-­‐T213D	  or	  IC2C	  1-­‐250	  by	  immunoblotting	  of	  the	   inputs	  (I),	  supernatants	  (S),	  and	  pellets	  (P)	  with	  antibodies	  against	  hexon,	  and	  dynein	   IC	   and	   LIC1	   subunits.	   	   LIC1-­‐T213D	   strongly	   reduced	   sedimentable	   dynein	  (red	   box),	   as	   indicated	   by	   a	   loss	   of	   IC	   signal,	   whereas	   LIC1-­‐T213D	   can	   now	   be	  detected.	   	   Addition	   of	   the	   IC	   fragment	   has	   no	   effect	   on	   dynein	   co-­‐immunoprecipitation	   (red	   box)	   and	   combined	   binding	   of	   IC	   fragment	   and	   dynein	  complex	  to	  hexon	  was	  detected.	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To	  elucidate	  if	  dynein	  LIC1	  also	  has	  a	  functional	  relevance	  for	  virus	  transport	  in	  vivo,	  we	  used	  vector	  based	  RNAi	  constructs	  against	  LIC1	  and	  LIC2	  and	  tested	  transfected	  A549	   cells	   for	   nuclear	   targeting	   of	   adenovirus	   at	   60min	  post-­‐infection	   (p.i.)	  when	  most	   capsids	   localize	   at	   the	   nucleus	   in	   control	   settings	   (Bremner	   et	   al.,	   2009)	  (Greber	   et	   al.,	   1993;	  Leopold	   et	   al.,	   2000;	   Suomalainen	  et	   al.,	   1999).	   	  Two	  days	  of	  RNAi	  shows	  a	  clear,	  specific	  reduction	  of	  the	  LIC1	  and	  LIC2	  protein	  levels	  (Figure	  2-­‐4A)	  and	  for	  LIC1	  RNAi	  also	  a	  striking	  reduction	  of	  capsids	  at	  the	  nucleus	  60min	  p.i.	  (Figure	   2-­‐4B	   and	   C).	   This	   is,	   however,	   in	  marked	   contrast	   to	   the	   control	   or	   LIC2	  RNAi	   transfected	   cells,	   which	   show	   nuclear	   virus	   targeting	   similar	   to	   control	  untransfected	  cells	  (Figure	  2-­‐4B	  and	  C).	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  Figure	  2-­‐4:	  	  LIC1,	  but	  not	  LIC2	  shRNA	  Reduces	  Nuclear	  Redistribution.	  (A)	  Protein	   levels	   in	   lysates	  of	  A549	  cells	   transfected	  with	  control,	  LIC1-­‐,	  or	  LIC2-­‐targeted	  shRNAs	  for	  48h	  evaluated	  by	  immunoblotting	  using	  anti-­‐p150Glued,	  anti-­‐IC,	  anti-­‐LIC1,	  anti-­‐LIC2,	  and	  anti-­‐Arp1	  antibodies,	  with	  anti-­‐tubulin	  as	  a	  loading	  control.	  	  LIC1	   was	   reduced	   by	   88%	   and	   LIC2	   by	   65%.	   (B)	   LIC	   RNAi	   effect	   on	   adenovirus	  redistribution.	  	  LIC1,	  LIC2,	  or	  control	  shRNA-­‐expressing	  A549	  cells	  infected	  at	  48	  hr	  with	  Ad5	  and	  fixed	  at	  60	  min	  p.i.	   	  Cells	  were	  immunostained	  for	  Ad5	  and	  GFP,	  and	  counterstained	  for	  DNA	  (DAPI).	  	  LIC1	  shRNA	  inhibited	  Ad5	  redistribution,	  an	  effect	  not	   detected	   for	   control	   or	   LIC2	   shRNA.	   	   Bar	   =	   20	   µm.	   (C)	  Quantification	   of	   virus	  redistribution	   shown	   in	   panel	   B.	   	   Mean	   percent	   of	   Ad5	   particles	   localizing	   at	   the	  nucleus	  60	  min	  p.i.	  ±	  SD	  from	  three	  independent	  experiments	  with	  >30	  cells	  each.	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Furthermore,	   we	   performed	   rescue	   experiments	   with	   RNAi	   resistant	   GFP-­‐LIC	  constructs,	  which	  we	  transfected	   into	  cells	  24h	  after	  LIC1-­‐targeted	  siRNAs	  (Figure	  2-­‐5A).	  	  At	  24h	  of	  rescue	  construct	  expression,	  we	  infected	  the	  cells	  with	  adenovirus	  and	   fixed	  at	  60min	  p.i.	   to	   analyze	  nuclear	   redistribution	  phenotypes	   for	  wild-­‐type	  LIC1,	  LIC1-­‐T213D,	  LIC1-­‐T213A,	  and	  wild-­‐type	  LIC2	  compared	  to	  GFP	  control	  (Figure	  2-­‐5B	  and	  D).	   	   In	  accordance	  to	  the	  biochemical	  evidence,	  wild	  type	  LIC1	  and	  LIC1-­‐T213D	  are	  able	  to	  rescue	  the	  RNAi	  phenotype,	  while	  LIC1-­‐T213A	  and	  LIC2	  are	  not	  (Figure	   2-­‐5B	   and	   D).	   	   We	   have	   shown	   that	   our	   GFP-­‐LIC1	   construct	   successfully	  incorporates	   into	   the	   dynein	   complex	   (Tan	   et	   al.,	   2011)	   and	   the	   low	   expression	  levels	  during	  rescue	  presumably	  prevent	  possible	  dominant-­‐negative	  effects.	  	  Using	  an	  inhibitor	  of	  PKA	  activity	  in	  the	  LIC1-­‐T213D	  rescue	  condition	  should	  discriminate	  between	  LIC1	  being	  the	  only	  PKA	  substrate	  that	  is	  required	  for	  nuclear	  localization	  of	   adenovirus	   and	   the	   presence	   of	   possible	   other	   PKA	   substrates	   critical	   for	   MT	  based	   adenovirus	   transport	   (Figure	   2-­‐5C	   and	  D).	   	  When	  we	   compared	   LIC1	  RNAi	  cells	   treated	   with	   a	   highly	   specific	   PKA	   inhibitor	   (PKI-­‐myr,	   50uM),	   we	   saw	   an	  incomplete	   rescue	   of	   the	   nuclear	   redistribution	   phenotype	   in	   the	   LIC1-­‐T213D	  expressing	  cells	  (Figure	  2-­‐5C	  and	  D).	  	  Taken	   together,	   these	   results	   indicate	   that	   LIC1-­‐T213	   plays	   an	   important	   role	   in	  intracellular	  adenovirus	  motility	  and	  that	  other	  PKA	  substrates	  besides	  LIC1-­‐T213	  might	  be	  responsible	  for	  efficient	  nuclear	  targeting	  of	  adenoviruses.	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Figure	   2-­‐5:	   	   Phosphorylated	   LIC1	   is	   Required	   for	   Transport	   of	   Adenovirus	   to	   the	  Nucleus.	  	  	  (A)	  Protein	  levels	  in	  lysates	  of	  A549	  cells	  exposed	  to	  siRNAs	  (48h),	  and	  expression	  of	  RNAi	  resistant	  GFP-­‐LIC1	  (24h)	  evaluated	  by	  immunoblotting	  using	  anti-­‐LIC1	  and	  anti-­‐GFP	  antibodies,	  with	  anti-­‐tubulin	  as	  a	  loading	  control.	  	  (B)	  LIC1	  RNAi	  rescue	  of	  adenovirus	  redistribution.	  	  LIC1	  siRNA-­‐treated	  A549	  cells	  transfected	  at	  24	  hr	  with	  GFP-­‐tagged	  LIC1	  and	  LIC2	  cDNAs	  (indicated	  on	  left)	  and	  infected	  at	  48	  hr	  with	  Ad5	  for	  60	  min.	  	  Cells	  were	  stained	  for	  Ad5,	  GFP,	  and	  DNA	  (DAPI).	  Transfected	  cells	  are	  outlined.	   	   Adenovirus	   normally	   redistributes	   to	   the	   nucleus	   (control).	   	   LIC1	   RNAi	  inhibits	   redistribution	   (LIC1	   siRNA,	   GFP),	   an	   effect	   rescued	   by	   GFP-­‐LIC1-­‐wt	   and	  GFP-­‐T213D,	  but	  not	  GFP-­‐T213A	  or	  GFP-­‐LIC2.	  	  Bar	  =	  20	  µm.	  	  (C)	  LIC1	  RNAi	  rescue	  of	  adenovirus	  redistribution	  like	  in	  panel	  B,	  in	  presence	  of	  PKA	  inhibitor	  PKI-­‐myr.	  	  The	  inhibitor	   alone	   (control)	   inhibited	   virus	   accumulation	   at	   the	   nucleus,	   whereas	  partial	   inhibition	   was	   observed	   in	   the	   RNAi	   rescue	   cells.	   	   Bar	   =	   20	   µm.	   	   (D)	  Quantification	  of	  virus	  redistribution	  shown	  in	  panels	  B	  and	  C.	  	  Mean	  percent	  of	  Ad5	  particles	   localizing	   at	   the	   nucleus	   60	  min	   p.i.	   ±	   SD	   from	   at	   least	   two	   independent	  experiments	  with	  >40	  cells	  each.	  	  	  	  	  	  	  2.2.2.	  Lysosome	  dispersal	  Unexpectedly,	  from	  an	  evolutionary	  perspective,	  a	  cellular	  kinase	  activity	  on	  dynein	  seems	   to	   aid	   viral	   infection.	   	   In	   addition,	   the	   physiological	   role	   of	   this	  phosphorylation	   site	   has	   not	   been	   identified.	   	   Hence,	   we	   set	   out	   to	   visualize	   the	  redistribution	  of	  physiological	  dynein	  cargo	  in	  response	  to	  viral	  infection	  (Figure	  2-­‐6,	  Figure	  2-­‐7,	  Table	  2-­‐1).	  	  The	  overall	  cell	  shape	  and	  MT	  array	  remained	  unaffected	  up	   to	   2hr	   p.i.	   	   To	   our	   surprise,	   LysoTracker-­‐positive	   lysosomes/late	   endosomes	  (lyso/LEs)	  and	  Rab7	  positive	  late	  endosomes,	  organelles	  that	  have	  previously	  been	  shown	  to	  be	  under	  direct	  dynein	  and	  LIC1	  control	  (Tan	  et	  al.,	  2011;	  Yi	  et	  al.,	  2011),	  show	   a	   drastic,	   repeatable,	   and	   robust	   dispersal	   upon	   viral	   infection	   (Figure	   2-­‐6,	  Figure	   2-­‐7,	   Table	   2-­‐1).	   	   Vesicles	   positive	   for	   the	   Nieman-­‐Pick	   disease	   associated	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protein	   NPC1,	   the	   Golgi	   apparatus	   (visualized	   with	   GFP-­‐NAGT	   I),	   multivesicular	  bodies	   (GFP-­‐CD63),	   and	   mitochondria	   (MitoTracker)	   maintain	   their	   perinuclear	  localization	   and	   early	   endosomes	   (GFP-­‐Rab5)	   continue	   to	   stream	   from	   the	   cell	  periphery	  towards	  the	  center	  (Figure	  2-­‐7	  and	  not	  shown).	  	  Furthermore,	  inhibition	  of	  PKA	  in	  combination	  with	  viral	  uptake	  reduced	   lyso/LE	  dispersal,	   indicative	  of	  a	  role	  of	  PKA	  in	  lysosome	  motility	  (Figure	  2-­‐6,	  Table	  2-­‐1).	   	  Furthermore,	  stimulating	  PKA	   outside	   of	   an	   adenoviral	   challenge	   with	   forskolin	   (10mM)	   has	   an	   effect	   on	  lyso/LEs	   with	   similar	   kinetics	   as	   adenoviral	   infection	   (Figure	   2-­‐6,	   Table	   2-­‐1).	  	  Therefore,	  PKA	  is	  necessary	  and	  sufficient	  for	  adenovirus	  induced	  lyso/LE	  dispersal.	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  Figure	  2-­‐6:	  	  Ad5	  Infection	  Disperses	  Lyso/LE.	  (A)	   Still	   images	   of	   90	   min	   movies	   of	   LysoTracker-­‐stained	   A549	   cells.	   	   Controls	  showed	  an	  unchanging	  perinuclear	  distribution	  of	   lyso/LEs.	   	  Ad5	   infection	  caused	  dramatic	   lyso/LE	   dispersal,	   especially	   notable	   in	   the	   appearance	   of	   individual	  vesicles	   toward	  the	  cell	  periphery	  (arrow	  heads).	   	  This	  effect	  was	   inhibited	  by	  the	  PKA	   inhibitor	   H-­‐89	   (5µM),	   but	   not	   by	   p38/MAP	   kinase	   inhibitor	   SB203580	   (SB,	  10µM).	   	  Treatment	  of	  uninfected	  cells	  with	  the	  adenylyl	  cyclase	  activator	  forskolin	  (10µM)	   caused	   lyso/LE	   dispersal	   with	   similar	   kinetics	   to	   those	   seen	   upon	   virus	  infection.	  	  Bar	  =	  15	  µm.	  	  (B)	  Series	  of	  enlarged	  images	  of	  boxed	  areas	  in	  panel	  A	  of	  “control”	   and	   “Ad5”	   movies	   spanning	   from	   nuclear	   envelope	   (NE)	   to	   the	   plasma	  membrane	  (PM).	  Frames	  every	  5min.	  	  (C)	  Relative	  changes	  in	  live	  behavior	  of	  Alexa-­‐546	  labeled	  Ad5	  (red)	  and	  LysoTracker-­‐labeled	  lyso/LEs	  (green)	  in	  same	  A549	  cell	  at	  5	  min	  and	  or	  60	  min	  p.i.	  	  Ad5	  progression	  towards	  the	  cell	  center	  is	  visible	  while	  lyso/LEs	  disperse	  through	  the	  cytoplasm.	  	  Bar	  =	  15	  µm.	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  Figure	  2-­‐7:	  Effects	  of	  Ad5	  Infection	  on	  Membranous	  Organelles.	  	  Still	  images	  of	  90	  min	  movies	  of	  A549	  cells	  expressing	  GFP-­‐tagged	  marker	  proteins	  for	  lyso/LE	  (Rab7,	  NPC1),	  multi-­‐vesicular	  bodies	  (CD63),	  Golgi	  elements	  (NAGT)	  or	  treated	  with	  MitoTracker	   to	   specifically	   label	  mitochondria.	   Ad5	   infection	   caused	  dramatic	   lyso/LE	   dispersal,	   whereas	   the	   localization	   of	   other	   membranous	  organelles	  remains	  unaffected.	  	  Bar	  =	  15	  µm	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Table	   2-­‐1:	   	   Effect	   of	   Adenoviruses	   and	   PKA-­‐targeting	   Drugs	   on	   the	   Dispersal	   of	  Membranous	  Organelles.	  	  Dispersal	  was	  scored	  based	  on	  90min	  time-­‐lapse	  movies.	  
organelle 
marker 
virus drug # of cells # of cells 
showing 
organelle 
dispersal 
cells showing 
organelle 
dispersal (%) 
LysoTracker none none 31 5 16.1 
LysoTracker Ad5 none 46 39 84.8 
LysoTracker Ad5 H-89 (5µM) 31 11 35.5 
LysoTracker Ad5 SB203580 (10µM) 20 16 80.0 
LysoTracker Ad5 cRGD (8.5µM) 15 6 40.0 
LysoTracker none FSK (10µM) 32 25 78.1 
LysoTracker Ad3 none 57 41 71.9 
LysoTracker Ad3 H-89 (5µM) 32 5 15.6 
GFP-Rab7 Ad5 none 10 7 70.0 
GFP-NPC1 Ad5 none 6 5 83.3 
GFP-CD63 Ad5 none 7 0 0.0 
GFP-NAGT Ad5 none 13 0 0.0 
MitoTracker Ad5 none 20 1 5.0 
 	  We	   employed	   two	   additional	   adenovirus	   serotypes	   to	   identify	   the	   upstream	  initiation	  of	  the	  PKA	  signaling.	  	  Ad3,	  a	  subgroup	  B	  adenovirus,	  which	  does	  not	  bind	  to	   CAR	   but	   interacts	   with	   alpha5	   integrins	   like	   Ad5.	   	   Subgroup	   B	   adenoviruses	  remain	   in	   the	   endo-­‐lysosomal	   pathway	   much	   longer	   than	   Ad5	   (Miyazawa	   et	   al.,	  2001)	  but	  still	  induces	  lyso/LE	  dispersal;	  indicative	  of	  integrin	  but	  not	  CAR	  binding	  or	   endosomal	   escape	   to	   trigger	   the	   effect	   (Figure	   2-­‐8).	   	   Ad41,	   a	   member	   of	   the	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enteric	  subgroup	  F,	  cannot	  interact	  with	  cell	  surface	  integrins	  since	  its	  penton	  base	  protein	   lacks	   the	   required	  RGD	  motif	   (Albinsson	   and	  Kidd,	   1999).	   It	   still	   binds	   to	  CAR	  but	  fails	  to	  induce	  lyso/LE	  dispersion	  as	  seen	  with	  Ad3	  and	  Ad5	  (Figure	  2-­‐8).	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Figure	  2-­‐8:	  	  Lyso/LE	  Dispersal	  by	  Additional	  Adenovirus	  Serotypes.	  Still	  images	  of	  90	  min	  movies	  of	  LysoTracker-­‐labeled	  A549	  cells	  infected	  with	  Ad3,	  Ad41,	   or	   Ad5	   in	   combination	   with	   8.5	   µM	   cyclic-­‐RGD	   peptide	   (cRGD)	   to	   block	  integrin	   signaling.	   	   Ad3	   infection	   caused	   lyso/LE	   dispersal,	   whereas	   lyso/LE	  maintain	  their	  perinuclear	  cluster	  during	  Ad41	  infection,	  which	  cannot	  interact	  with	  integrins,	  or	  Ad5	  infection	  plus	  integrin	  inhibition.	  	  Bar	  =	  15	  µm	  	  Hence,	  upstream	  integrin	  binding	  by	  capsid	  penton	  base	  seems	  to	  initiate	  a	  host	  cell	  response	   leading	   to	   PKA	   activation	   and	   lyso/LE	   dispersal.	   	   To	   further	   test	   these	  results,	  we	  used	  cyclic	  RGD	  peptide	   (cRGD)	  during	  Ad5	   infection	   to	  block	   integrin	  signaling.	   	  Lyso/LE	  dispersal	  was	  completely	   inhibited	  with	  8.5µM	  cRGD	  added	   to	  the	  medium	  during	  Ad5	  infection	  (Figure	  2-­‐8,	  Table	  2-­‐1).	  	  To	  test	  for	  a	  specific	  role	  of	  LIC1-­‐T213	  phosphorylation	   in	   lyso/LE	  dispersal,	  we	  again	  used	  LIC	  RNAi.	   	  LIC1	  and	   LIC2	   RNAi	   disrupted	   lyso/LE	   organization	   (Tan	   et	   al.,	   2011),	   with	   clear	  dispersal	  observed	   in	   the	  A549	  cells	  used	  here	  (Figure	  2-­‐9A).	   	  Expression	  of	  wild-­‐type	  LIC1	  rescued	   lyso/LE	  dispersal	   (Tan	  et	  al.,	  2011),	  as	  did	  LIC1-­‐T213A,	   though	  LIC1-­‐T213D	   was	   significantly	   less	   effective	   (Figure	   2-­‐9B).	   	   In	   Ad5	   infected	   cells	  LIC1-­‐T213A	   strongly	   inhibited	   both	   lyso/LE	   dispersal	   and	   virus	   transport	   to	   the	  nucleus,	  whereas	  rescue	  with	  LIC1	  wild	  type	  allowed	  organelle	  dispersal	  and	  capsid	  progression	  towards	  the	  cell	  center	  (Figure	  2-­‐9C	  and	  D).	  	  	  
These	  results	  connect	  evidence	  for	  a	  possible	  PKA	  regulation	  of	  Lyso/LE	  to	  dynein	  recruitment	  and	  clearly	  indicate	  a	  role	  of	  LIC1-­‐T213	  in	  the	  motility	  of	  this	  particular	  class	  of	  organelles.	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Figure	  2-­‐9:	  	  Role	  of	  LIC1-­‐T213	  in	  Lysosome	  Dispersal.	  	  	  (A)	  Rescue	  of	  LIC1/LIC2	  RNAi-­‐induced	  lyso/LE	  dispersal	  by	  overexpression	  of	  GFP	  (control),	  GFP-­‐LIC1-­‐wt,	  -­‐T213A	  or	  -­‐T213D	  in	  A549	  cells	  shown	  by	  immunostaining	  for	  GFP	  (green)	  and	  LAMP1	  (red).	   	  Bar	  =	  20	  µm.	   	   	  Rescue	  was	  observed	  with	  GFP-­‐LIC1-­‐wt	   and	   LIC1-­‐T213A,	   but	   not	  with	   LIC1-­‐T213D.	   	   (B)	  Quantification	   of	   data	   in	  panel	  A.	   	  Mean	  of	  at	   least	   two	   independent	  experiments	  with	  >40	  cells	  each,	  error	  bars	   represent	   SD,	   *	   indicates	   p	   <	   0.05.	   	   (C)	   Involvement	   of	   LIC1-­‐T213	   in	   Ad5-­‐induced	  lyso/LE	  dispersal.	  	  Rescue	  of	  LIC1/LIC2	  RNAi-­‐induced	  lyso/LE	  dispersal	  as	  in	  panel	  A,	  but	  in	  Ad5-­‐infected	  cells.	  	  The	  non-­‐phosphorylatable	  LIC1-­‐T213A	  mutant	  still	   rescues	   lyso/LE	  dispersal.	  Bar	  =	  10	  µm.	   	   (D)	  Quantification	  of	  data	   in	  panel	  C.	  Mean	   of	   at	   least	   two	   independent	   experiments	   with	   >40	   cells	   each,	   error	   bars	  represent	  SD.	  	  	  	  
2.3.	  Discussion	  2.3.1.	  Role	  in	  Virus	  Transport	  These	   results	   reveal	   a	   remarkable	   use	   of	   a	   highly	   specific	   phosphorylation	  mechanism,	   involving	   a	   single	  PKA	   site	  within	   a	   specific	   LIC	   isoform,	   for	   opposite	  purposes	  by	  host	  and	  pathogen	  (Figure	  2-­‐10).	  	  Enhanced	  virus	  transport	  toward	  the	  cell	  center	  is	  likely	  caused	  by	  increased	  recruitment	  of	  the	  phosphorylated	  dynein	  to	  adenovirus	   particles.	   	   Enhanced	   Lyso/LE	   transport	   toward	   the	   cell	   periphery	  appears	  to	  be	  due	  to	  inhibition	  of	  dynein	  recruitment	  to	  these	  structures	  or	  dynein	  activity.	  	  These	  organelles	  normally	  undergo	  short	  inward	  and	  outward	  movements	  driven	  by	   the	  opposing	  activities	  of	  dynein	  and	  kinesin,	   respectively	   (Herman	  and	  Albertini,	   1983;	   Soppina	   et	   al.,	   2009).	   	   Dynein	   inhibition	   causes	   kinesin-­‐driven	  outward	  movements	   to	   predominate,	   resulting	   in	   Lyso/LE	   dispersal	   (see	   chapter	  1.1.2.2.	  and	  Julie	  Yi,	  personal	  communication).	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This	  behavior	  may	  increase	  the	  ability	  of	  Lyso/LE	  to	  reach	  incoming	  viruses	  before	  they	   exit	   to	   the	   cytoplasm,	   perhaps	   to	   inhibit	   escape.	   	   Ad3	   and	   Ad41	   are,	   in	   fact,	  known	   to	   remain	   within	   endosomal	   organelles	   for	   prolonged	   periods,	   an	   effect	  correlated	   with	   reduced	   infectivity	   (Albinsson	   and	   Kidd,	   1999;	   Miyazawa	   et	   al.,	  2001).	   	   However,	   similar	   to	   Trypanosoma	   cruzi	   (Tardieux	   et	   al.,	   1992),	   which	  induces	  lysosome	  redistribution	  to	  the	  cell	  periphery	  for	  enhanced	  infection,	  fitness	  of	   some	   adenovirus	   serotypes	  might	   gain	   from	   Lyso/LE	   dispersal	   and	   premature	  endo-­‐lysosomal	   fusion	   through	   faster	   escape	   from	   the	   organelle.	   Nevertheless,	  whether	   adenovirus-­‐induced	   Lyso/LE	   dispersal	   represents	   an	   effective	   defense	  mechanism	  or,	  instead,	  a	  vestigial	  response	  remains	  to	  be	  shown	  (further	  discussed	  in	  chapter	  2.3.3.).	  	  Surprisingly,	  adenovirus	  appears	  to	  have	  evolved	  to	  use	  the	  same	  underlying	   phosphorylation	   mechanism	   to	   reach	   the	   nucleus	   quickly	   after	  endosomalysis,	   avoiding	   intracellular	   innate	   immunity	   responses	   and	   degradation	  (Mallery	   et	   al.,	   2010).	   	   It	   will	   be	   interesting	   to	   test	   a	   broader	   field	   of	   additional	  viruses,	  known	  to	  passage	  through	  the	  endosomal	  compartments	  during	  entry,	   for	  PKA	   activation	   and	   lysosome	  dispersal.	   	   In	   this	   regard,	   Ebola	   virus	   infectivity	   has	  recently	   been	   found	   to	   depend	   on	   the	   endo-­‐lysosomal	   fusion	   complex	   HOPS	   and	  NPC1,	  but	  a	  dependence	  on	  PKA	  activity	  has	  not	  been	  reported	  (Carette	  et	  al.,	  2011;	  Cote	  et	  al.,	  2011).	  	  
	   72	  
	  Figure	   2-­‐10:	   Schematic	   Representation	   of	   Adenovirus-­‐induced	   Effects	   on	   Dynein-­‐mediated	  Lyso/LE	  Distribution.	  	  	  At	   basal	   PKA	   activity	   levels	   in	   uninfected	   cells,	   lyso/LE	   cluster	   around	   the	  centrosome.	  	  At	  the	  onset	  of	  infection,	  adenovirus	  binds	  integrins,	  increasing	  cAMP	  levels	  and	  PKA	  activity.	  	  PKA	  phosphorylation	  of	  the	  dynein	  LIC1	  subunit	  promotes	  virus	  transport	  to	  the	  centrosome	  and	  nucleus,	  while	  dispersing	  lyso/LEs	  in	  a	  novel	  mechanism	  for	  host-­‐virus	  competition.	  	  Furthermore,	  possible	  therapies	  against	  adenoviral	  infections	  might	  be	  developed	  to	  target	   the	   post-­‐entry	   hexon	   –	   LIC1	   interaction.	   	   Expression	   of	   LIC1-­‐T213D,	  which	  results	   in	   attenuated	   nuclear	   targeting	   of	   the	   virions,	   indicates	   a	   significant	  dominant-­‐negative	   effect	   on	   motor	   recruitment.	   Hence,	   it	   becomes	   plausible	   that	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short	   LIC1-­‐T213D	   peptides	   containing	   the	   hexon	   binding	   site	   might	   block	   the	  interaction	   even	   when	   added	   during	   the	   viral	   attachment	   phase.	   	   Following	   co-­‐uptake	   of	   viral	   capsids	   and	   blocking	   peptide	   into	   the	   endosome,	   acidification	  renders	   hexon	   susceptible	   for	   peptide	   binding,	   which	   presumably	   will	   cover	   all	  available	  LIC1	  binding	  sites	  if	  administered	  in	  high	  doses.	  	  After	  endosomal	  escape,	  the	  blocking	  peptides	  compete	  with	  dynein	  for	  capsids	  capsid	  binding	  which	  would	  drastically	  affected	  nuclear	  redistribution	  and	  reduce	  infectivity.	  	  	  	  	  2.3.2.	  Role	  in	  Organelle	  Transport	  Our	   identification	   of	   a	   LIC1-­‐mediated	   dynein	   regulatory	   mechanism	   may	   have	  general	   implications.	   	   PKA	   activates	   dispersal	   of	   pigment	   granules	   in	   vertebrate	  chromatophores	   (Marks	   and	   Seabra,	   2001;	   Reilein	   et	   al.,	   1998;	   Rodriguez	   et	   al.,	  1997)	   and	   although	   the	   target	   of	   PKA	   phosphorylation	   is	   unknown,	   LIC1	   now	  emerges	  as	  a	  likely	  candidate.	  	  We	  also	  note	  that	  the	  site	  of	  PKA	  phosphorylation	  in	  LIC1,	   T213,	   is	   near	   S207	   (S197	   in	   Xenopus	   LIC1),	   a	   Cdk1	   phosphorylation	   site	  correlated	  with	  dynein	  dissociation	  from	  membranes	  during	  mitosis	  (Addinall	  et	  al.,	  2001;	  Dell	  et	  al.,	  2000;	  Niclas	  et	  al.,	  1996).	  	  Hence,	  the	  possibility	  exists,	  that	  the	  part	  of	   the	   LIC1	   structure,	   which	   contains	   S207	   and	   T213	   represents	   a	   functional	  element	   in	   the	   dynein	  motor	   complex	   regulating	  membrane	   recruitment.	   	   At	   this	  point,	   however,	   no	   detailed	   structural	   information	   of	   either	   LIC	   is	   available	   as	   is	  definite	   proof	   of	   the	   direct	   involvement	   of	   these	   phosphorylation	   sites	   in	   dynein	  recruitment	   to	   Lyso/LE.	   	   However,	   S207	   and	   T213	   are	   located	   in	   a	   hydrophilic	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region	  of	  the	  LIC1	  polypeptide	  and	  may	  be	  responsible	  to	  switch	  functional	  states	  of	  LIC1	  and	  the	  dynein	  complex.	  	  2.3.3.	  Evolutionary	  Origins	  Given	  the	  robust	  host	  response	  to	  adenoviral	   infections,	   this	  mechanism	  has	   likely	  been	   fine-­‐tuned	   in	   the	   course	   of	   evolution.	   Lyso/LE	   dispersal	   has	   presumably	  evolved	   as	   a	   protective	  measure	   for	   host	   cells	   and	   it	   has	   been	   reported	   now	   for	  pathogens	   of	   multiple	   kingdoms	   that	   infection	   leads	   to	   Lyso/LE	   dispersal	   or	  exocytosis	   on	   the	   cellular	   level	   (this	   work	   and	   (Andrews,	   1995)).	   	   Hence,	   the	  physiological	   role	   of	   Lyso/LE	   dispersal	   and	   exocytosis,	   providing	   additional	  phospholipids	   for	  cell	  membrane	  repair	  (Reddy	  et	  al.,	  2001;	  Roy	  et	  al.,	  2004),	  was	  expanded	   and	   adapted	   to	   pathogen	  defense.	   	   In	   the	   case	   of	   the	   tested	   adenovirus	  serotypes,	  only	  Ad5	  exits	  the	  endo-­‐lysosomal	  pathway	  within	  15mins,	  whereas	  Ad3	  and	  Ad41	  stay	  within	  vesicular	  structures	  for	  prolonged	  periods	  of	  time	  and	  shows	  low	  rates	  of	  infectivity	  in	  cultured	  cells	  (Albinsson	  and	  Kidd,	  1999;	  Miyazawa	  et	  al.,	  2001).	   	   We	   have	   been	   able	   to	   visualize	   co-­‐translocation	   of	   Alexa546-­‐Ad3	   with	  LysoTracker	   Green	   labeled	   Lyso/LE	   in	   cells	   (not	   shown),	   which	   have	   been	   pre-­‐labeled	  with	  the	  dye.	  	  These	  results	  indicate	  either	  re-­‐uptake	  of	  capsids	  into	  Lyso/LE	  after	   endosomalysis	   or	   fusion	   of	   the	   virus-­‐containing	   organelle	  with	   Lyso/LE	   and	  thus	  an	  active	  protective	  mechanism	  against	  Ad3	  and	  Ad41	  infection.	  	  Ad5,	  however,	  appears	   to	   have	   evolved	   specific	   counter-­‐measures	   avoiding	   re-­‐uptake	   into	   a	  Lyso/LE	   or,	   more	   likely,	   enabling	   rapid	   escape	   from	   the	   acidic	   organelle.	   	   In	  addition,	  Ad5	  has	  evolved	  to	  profit	  from	  this	  vestigial	  host	  defense	  mechanism	  in	  an	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additional	  way.	  	  The	  same	  phosphorylation	  event	  that	  leads	  to	  Lyso/LE	  dispersal	  is	  also	   used	   by	   the	   virus	   for	   transport	   towards	   the	   nucleus.	   	   This	   represents	   a	  remarkable	  manifestation	  of	  pathogen	  adaptation	  to	  host	  responses.	  	  Further	   analysis	   of	   these	   phenomena	   should	   shed	   important	   light	   on	   innate	  responses	   to	  virus	   infection	  and,	  potentially,	   a	  wide	   range	  of	   important	   feature	  of	  intracellular	  transport.	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Chapter	  3:	   Adenovirus	   Penton	   Base	   Interaction	   with	  
Kinesin-­1	  
	  
3.1.	  Introduction	  3.1.1.	  Introduction	  Most	  adenoviruses	  enter	  the	  cell	  via	  receptor-­‐mediated	  endocytosis	  but	  are	  able	  to	  escape	  the	  endosomal	  vesicle	  shortly	  after	  uptake	  (Dales,	  1962;	  Greber	  et	  al.,	  1993;	  Wiethoff	  et	  al.,	  2005).	   	  Subsequently	  the	  virus	  makes	  use	  of	  the	  microtubule	  (MT)-­‐based	  motor	  machinery	  for	  active	  transport	  towards	  the	  cell	  center.	   	   Interestingly,	  adenoviruses	   show	  bidirectional	  motility	   at	   high	   temporal	   resolution	   (Bremner	   et	  al.,	  2009;	  Leopold	  et	  al.,	  2000;	  Suomalainen	  et	  al.,	  1999),	  indicating	  the	  involvement	  of	  MT	  minus-­‐	  and	  plus-­‐end	  directed	  motor	  proteins	  in	  virus	  transport.	  	  MT	  plus	  end-­‐directed	  motility	  at	  rates	  measured	  for	  adenoviruses	  (~600µm/sec;	  Bremner	  et	  al.,	  2009;	  Suomalainen	  et	  al.,	  1999)	  are	  highly	  indicative	  of	  kinesin	  transport,	  which	  can	  be	   unmasked	   by	   treating	   cells	   with	   dynein	   function-­‐blocking	   reagents	   (Yi	   et	   al.,	  2011).	   	   Candidate	   kinesins	   possibly	   involved	   in	   capsid	   transport	   are	   kinesin-­‐1	  (Kif5),	   kinesin-­‐2	   (Kif3,	   Kif17),	   kinesin-­‐3	   (Kif1),	   and	   kinesin-­‐4	   (Kif4),	  which	   all	   are	  regulating	  vesicle	  transport,	  interacting	  with	  physiologic	  cargo	  through	  their	  heavy	  chain	  or	  accessory	  light	  chains	  (Okada	  et	  al.,	  1995;	  Sekine	  et	  al.,	  1994;	  Setou	  et	  al.,	  2000;	  Sheetz	  et	  al.,	  1986;	  Yamazaki	  et	  al.,	  1995).	  	  Some	   of	   these	   kinesins	   have	   also	   been	   reported	   to	   play	   a	   role	   in	   viral	   infections	  (Dodding	  and	  Way,	  2011;	  Greber	  and	  Way,	  2006).	  	  Human	  Immunodeficiency	  Virus	  
	   77	  
(HIV)	   Gag	   protein,	   which	   promotes	   viral	   particle	   production	   at	   the	   plasma	  membrane,	  is	  being	  delivered	  to	  its	  site	  of	  action	  by	  kinesin-­‐4	  (Martinez	  et	  al.,	  2008;	  Tang	  et	  al.,	  1999).	  Expression	  of	  dominant-­‐negative	  tail	  constructs	  of	  kinesin-­‐4,	  but	  not	   kinesin-­‐3,	   severely	   disrupted	   gag	   trafficking	   to	   the	   plasma	   membrane	   and	  kinesin-­‐4	   RNAi	   inhibits	   virus	   production	   (Martinez	   et	   al.,	   2008).	   	   Inner	   tegument	  proteins	  of	  Herpes	   Simplex	  Virus	   (HSV)	  have	  been	   implied	   in	   recruiting	  kinesin-­‐1	  and	   kinesin-­‐2	   to	   the	   non-­‐enveloped	   cytoplasmic	   from	   of	   the	   virus	   (Radtke	   et	   al.,	  2010)(Radke	   et	   al.,	   PLoS	   Pathogen,	   2010).	   	   VP1/2	   (pUL36),	   one	   of	   the	   inner	  tegument	   proteins	   required	   for	   virus	   egress	   (Luxton	   et	   al.,	   2006),	   represents	   a	  strong	  candidate	  for	  virus	  binding,	  especially	  since	  it	  contains	  WD/E	  repeats	  which	  have	   recently	   been	   implicated	   in	   modulating	   kinesin-­‐1	   binding	   (Dodding	   et	   al.,	  2011;	  Morgan	  et	  al.,	  2010).	   	  However,	   it	   is	  unclear	  at	   the	  moment,	   if	   the	  heavy	  or	  light	   chains	   of	   kinesin-­‐1	   and	   kinesin-­‐2	   is	   able	   to	   interact	  with	  HSV	   (Dodding	   and	  Way,	  2011).	  	  Progeny	  of	  vaccinia	  virus	  assembles	  close	  to	  the	  nucleus	  and	  leaves	  the	  infected	  cell	  via	  MT-­‐	  and	  actin-­‐dependent	  processes.	   	  From	  the	  perinuclear	  site	   to	  the	   plasma	  membrane,	   intracellular	   enveloped	   virus	   (IEV)	   relies	   on	   kinesin-­‐1	   for	  efficient	   transport	   during	   egress	   (Moss	   and	   Ward,	   2001).	   	   The	   viral	   membrane	  protein	   A36	   appears	   crucial	   for	   this	  motility	   since	   A36-­‐deficient	   viruses	   show	   no	  MT-­‐based	  transport	  during	  egress	  but	  remain	  clustered	  at	  their	  perinuclear	  site	  of	  assembly	   (Rietdorf	   et	   al.,	   2001).	   	   In	   fact,	   residues	   81–111	   of	   A36	   are	   capable	   of	  interacting	   directly	   with	   the	   cargo	   binding	   TPRs	   of	   KLC	   (Ward	   and	  Moss,	   2004),	  supporting	  an	  important	  role	  of	  A36	  in	  recruiting	  kinesin-­‐1	  to	  IEV.	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The	   role	   of	   kinesins	   during	   adenovirus	   entry	   remains	   controversial.	   	   Agreement	  exists	  that	  bidirectional	  MT-­‐based	  transport	  of	  cytoplasmic	  capsids	  involves	  at	  least	  one	   class	   of	   the	   kinesins	   (Bremner	   et	   al.,	   2009;	   Leopold	   et	   al.,	   2000;	   Scherer	   and	  Vallee,	   2011;	   Suomalainen	   et	   al.,	   1999;	   Yi	   et	   al.,	   2011).	   	   However,	   the	   function	   of	  bidirectional	   MT-­‐based	   transport	   during	   early	   adenoviral	   infections	   remains	  unknown,	  since	  microinjection	  of	  kinesin	  function-­‐blocking	  antibodies	  into	  infected	  cells	  fails	  to	  block	  nuclear	  capsid	  redistribution	  (Leopold	  et	  al.,	  2000).	  	  Similarly,	  the	  identity	   of	   the	   responsible	   kinesin	   remains	   to	   be	   elucidated.	   	   However,	   a	   second,	  transport-­‐independent	   role	   of	   kinesins	   has	   been	   reported	   to	   affect	   adenoviral	  fitness.	   	   Kinesin-­‐1	   (Kif5c)	   seems	   to	   function	   after	   viral	   capsid	   are	   attached	   to	   the	  nuclear	   pore	   complex	   (NPC)	   by	   generating	   force	   to	   disrupt	   the	   virus	   capsid	   and	  facilitate	  injection	  of	  the	  viral	  genome	  into	  the	  nucleus	  (Strunze	  et	  al.,	  2011).	  	  Kif5c	  RNAi	  leads	  to	  slightly	  decreased	  rates	  of	   infectivity	  (Strunze	  et	  al.,	  2011),	  does	  not	  affect	   viral	   redistribution	   to	   the	   nucleus,	   but	   reduces	   the	   accumulation	   of	   empty	  capsid	  shells	  in	  the	  cell	  periphery	  after	  genome	  delivery.	   	  The	  mechanism	  entails	  a	  direct	   KLC	   interaction	   with	   the	   minor	   capsid	   protein	   IX	   and	   Kif5c	   heavy	   chain	  binding	   to	   the	   nuclear	   pore	   protein	   Nup358	   (RanBP2).	   	   Furthermore,	   adenovirus	  hexon	   binds	   to	   Nup214	   (Trotman	   et	   al.,	   2001)	   and	   in	   this	   tightly	   interlocked	  constellation,	   it	   has	   been	   hypothesized,	   Kif5c	   generates	   sufficient	   force	   to	  structurally	   compromise	   viral	   capsid	   and	   NPC	   to	   allow	   efficient	   genome	   transfer	  (Strunze	  et	  al.,	  2011).	  	  	  	  
	   79	  
Here,	   we	   present	   biochemical	   work	   supporting	   a	   role	   of	   kinesin-­‐1	   mediated	  transport	  in	  the	  cytoplasmic	  phase	  of	  Ad5	  entry.	   	  The	  major	  capsid	  protein	  penton	  base,	   which	   largely	   remains	   with	   viral	   DNA	   until	   the	   capsid	   reaches	   the	   nucleus,	  interacts	   directly	   and	   independent	   of	   KLC	   with	   immunopurified	   kinesin-­‐1.	  	  Furthermore,	   additional	   data	   show	   that	   a	   minimal	   motile	   virus-­‐like	   particle,	   the	  penton	   dodecahedron	   (Pt-­‐Dd)	   (Fender	   et	   al.,	   1997;	   Norrby	   and	   Skaaret,	   1967),	  shows	  kinesin	  binding	  and	  motility	  in	  cultured	  hippocampal	  neurons.	  	  3.1.2.	  Materials	  and	  Methods	  
Cells,	  Viruses,	  and	  Antibodies	  	  293A	   cells	   were	   grown	   in	   DMEM	   supplemented	   with	   10%	   FBS.	   	   Embryonic	  hippocampal	   neuron	   cultures	   were	   generated	   from	   E18–E19	   rat	   embryos	   as	  described	   (Grabham	   et	   al.,	   2007).	   Briefly,	   hippocampi	   were	   dissected	   in	   HBSS	  containing	  10	  mM	  HEPES,	  trypsinized,	  and	  triturated	  in	  the	  plating	  medium	  DMEM	  containing	   10%	   FBS,	   0.5	   mM	   L-­‐glutamine,	   and	   1	   mM	   sodium	   pyruvate.	   After	  trituration	   the	   cells	  were	   plated	   in	   50	  mm	  MatTek	   (Ashland,	  MA)	   imaging	   dishes	  that	  were	  pre-­‐coated	  with	  0.5	  mg/ml	  poly-­‐D-­‐	   lysine	   in	  borate.	   	  Once	   the	   cells	  had	  adhered	   to	   the	  substrate,	   the	  medium	  was	  removed	  completely	  and	  replaced	  with	  Neurobasal	  medium	  (Invitrogen)	  containing	  B-­‐27	  supplement	  (Invitrogen)	  and	  0.5	  mM	  L-­‐glutamine.	  	  Cultures	  were	  grown	  for	  5	  DIV	  before	  prepared	  for	  infection	  and	  live	   cell	   imaging.	   	   Replication-­‐deficient	   Ad5	   engineered	   to	   express	   GFP	   (Ad5-­‐GFP,	  plaque-­‐purified;	   obtained	   from	  H.	   Young,	   Columbia	   University)	   and	  modified	   Ad5	  with	   FLAG-­‐tagged	   protein	   IX	   (Ad5pIXflag,	   kind	   gift	   of	   Igor	  Dmitriev,	   University	   of	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Alabama)	  were	  propagated	  in	  293A	  cells	  and	  purified	  by	  banding	  on	  two	  linear	  CsCl	  gradients	  (Lawrence	  and	  Ginsberg,	  1967)	  and	  dialysed	  against	  10%	  glycerol	  in	  PBS	  before	  cryo-­‐storage.	  	  Viral	  titer	  was	  obtained	  using	  fluorescent	  focus	  assays	  for	  Ad5-­‐GFP	   (Thiel	   and	   Smith,	   1967).	   	   Hippocampal	   neuronal	   cell	   incubations	   with	  Alexa546-­‐Pt-­‐Dd	   for	   live	   cell	   imaging	   were	   all	   performed	   in	   a	   low	   volume	   of	  Neurobasal	  medium	  with	  B-­‐27	  at	  37°C	  for	  15	  min	  to	  allow	  particle	  attachment.	  The	  cells	  were	  washed	  twice	  in	  warm	  PBS	  and	  prepared	  for	  live	  cell	  imaging.	  	  Antibodies	   used	   included	   mouse	   monoclonal	   anti-­‐hexon	   (Novocastra),	   anti-­‐HA	  (clone	  16B12,	   Covance),	   anti-­‐FLAG	   (M2,	   Sigma),	   anti-­‐myc	   (9E10,	   SantaCruz),	   anti-­‐tubulin	  (Sigma),	  anti-­‐kinesin-­‐1	  H1	  and	  H2	  (Millipore),	  anti-­‐p150Glued	  (BD	  Bioscience)	  and	   anti-­‐dynein	   IC	   (74.1,	   Chemicon),	   rabbit	   antibodies	   anti-­‐LIC,	   and	   anti-­‐LIC2	  (Tynan	   et	   al.,	   2000b),	   anti-­‐adenovirus5	   (Abcam),	   anti-­‐GFP	   (Invitrogen),	   anti-­‐FLAG	  (Abcam),	  anti-­‐HA	  (Sigma),	  and	  chicken	  anti-­‐LIC1	  (Tan	  et	  al.,	  2011).	  	  
Plasmids,	  and	  Molecular	  Methods	  Mammalian	  cell	  expression	  constructs	  used	  in	  this	  work	  included	  HA-­‐tagged	  penton	  base,	  GFP-­‐100K,	  and	  untagged	  hexon	  described	  in	  (Bremner	  et	  al.,	  2009).	  Protein	  IX	  tagged	  with	   FLAG	   and	  GFP	   (pIX-­‐flag-­‐GFP)	  was	   cloned	   from	  purified	   adenovirus	   5	  DNA.	  Viral	  DNA	  was	  separated	  from	  capsid	  proteins	  by	  boiling	  ~1010	  purified	  virus	  particles	  at	  100°C	  for	  5min	  in	  1%SDS	  and	  subsequent	  MiniPrep	  (Qiagen).	  	  Protein	  IX	  was	  cloned	  into	  the	  pEGFP-­‐N1	  vector	  (Clontech,	  Mountain	  View,	  CA)	  by	  introducing	  5’	  	  EcoRI	  and	  3’	  AgeI	  restriction	  sites	  by	  PCR. 	  The	  additional	  C-­‐terminal	  FLAG-­‐tag	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was	   introduced	  during	  PCR.	   	  Mutations	   in	   the	   sequence	  and	   in-­‐frame	   cloning	  was	  tested	  for	  by	  5’	  and	  3’	  sequencing.	  	  Transient	  transfections	  were	  performed	  using	  Lipofectamine	  2000	  (Invitrogen).	  	  	  
Live	  Cell	  Imaging	  Hippocampal	   neuronal	   cells	   grown	   in	   glass	   bottom	   dishes	   and	   incubated	   with	  Alexa546-­‐Pt-­‐Dd	  were	   covered	  with	  CO2-­‐independent	  medium	  and	   then	  processed	  for	   imaging	   in	   a	   37°C	   chamber.	   	   Movies	   were	   acquired	   between	   15-­‐	   90	   min	  thereafter	  at	  video	  frame	  rate	  (16frames/min)	  for	  1min	  using	  a	  63x	  oil	   immersion	  objective	  and	  a	  CCD	  camera	  (model	  C9100-­‐12;	  Hamamatsu)	  attached	  to	  an	  inverted	  microscope	  (Leica)	  operated	  by	  Metamorph	  Imaging	  software	  (Molecular	  Devices).	  For	  image	  and	  movie	  analysis	  and	  particle	  counting	  ImageJ	  was	  used.	  	  	  
Proteins	  and	  Biochemical	  Analysis	  Rat	  brain	   lysate	  and	  purified	  rat	   cytoplasmic	  dynein	  were	  prepared	   in	  phosphate-­‐glutamate	  buffer	  (pH	  7.0)	  as	  previously	  described	  (Paschal	  et	  al.,	  1987).	  Kinesin	  was	  enriched	   for	   by	   sucrose	   gradient	   density	   centrifugation	   of	   the	   GTP	   release	   of	   the	  dynein	   preparation	   protocol	   on	   5-­‐20%	   linear	   sucrose	   gradients.	   	   Fractions	  containing	   kinesins-­‐1,	   -­‐2,	   and	   -­‐3	   but	   no	   dynein	   were	   chosen	   for	   further	   analysis.	  	  Adenovirus	  hexon	  was	  either	  recovered	  from	  virus-­‐depleted	  supernatant	  of	  the	  first	  CsCl	   gradient	   by	   immunoprecipitation	   as	   described	   (Bremner	   et	   al.,	   2009)	   or	   by	  anion	  exchange	  chromatography	  (Waris	  and	  Halonen,	  1987).	  	  Initial	  steps	  of	  penton	  dodecahedra	   (Pt-­‐Dd)	   purification	   followed	   the	   protocol	   described	   in	   (Waris	   and	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Halonen,	  1987).	  	  Additionally,	  the	  first	  eluding	  peak	  of	  the	  anion	  exchange	  step	  was	  pooled,	  concentrated	  using	  spin	  columns	  (Milipore),	  and	  poured	  over	  a	  Superose	  6	  10/300	  GL	  column	  equilibrated	  with	  PBS.	  	  Pt-­‐Dd	  containing	  fractions	  eluted	  close	  to	  the	   void	   volume	   were	   pooled	   and	   concentrated.	   	   Labeling	   with	   Alexa546	   as	  described	   for	   adenoviral	   capsids	   (Bremner	   et	   al.,	   2009;	   Leopold	   et	   al.,	   2000).	  	  Briefly,	   ~1mg	   purified	   Pt-­‐Dd	   was	   dialysed	   in	   500µl	   dialysis	   cassette	   (10MWCO,	  Thermo	   Scientific)	   against	   8mM	   sodium	   carbonate,	   92mM	   sodium	   bicarbonate,	  pH9.3	   for	  4h	  at	  4°C,	   incubated	  with	  2µg	  Alexa546	   (Invitrogen)	   for	  30min	  at	  25°C,	  and	   separated	   from	   uncoupled	   dye	   by	   sixe	   exclusion	   chromatography.	   	   Purified	  proteins	  were	  flash	  frozen	  in	  liquid	  nitrogen	  and	  stored	  at	  -­‐80°C.	  	  Mammalian	   cultured	   cell	   lysates	   were	   prepared	   in	   RIPA	   buffer	   (50mM	   Trizma-­‐maleate,	  100	  mM	  NaCl,	  1	  mM	  EGTA,	  [pH	  7.4])	  containing	  protease	  inhibitor	  cocktail	  (Sigma)	  and	  1%	  NP40,	  and	  the	  membrane	  fraction	  was	  removed	  by	  centrifugation.	  	  Adenovirus	  capsid	  and	  hexon	  binding	  assays	  were	  described	  previously	   (Bremner	  et	   al.,	   2009).	   	   Briefly,	   virus	   or	   hexon	   was	   immunoprecipitated	   with	   anti-­‐hexon	  antibodies	  and	  protein	  A	  sepharose	  beads	  (GE	  Bioscience)	  from	  purified	  virus	  stock	  or	   virus-­‐depleted	   infected	   293A	   cell	   lysate,	   respectively.	   The	   beads	   were	  washed	  and	   incubated	   for	   30	  min	   in	   Tris-­‐maleate	   buffer	   (50	  mM	  Trizma-­‐maleate,	   10	  mM	  NaCl,	  1	  mM	  EDTA,	  and	  0.1%	  Tween	  20,	  pH	  4.4	  or	  pH	  7.4),	  washed	  in	  the	  same	  buffer	  at	   pH	   7.4,	   and	   then	   incubated	  with	   purified	   kinesins	   at	   4°C	   for	   1.5	   hr.	   Following	  washing,	  the	  beads	  were	  analyzed	  for	  the	  presence	  of	  dynein	  or	  dynein	  subunits	  by	  immunoblotting.	  	  In	  reciprocal	  experiments,	  anti-­‐kinesin	  antibodies	  H1,	  H2,	  or	  Kif5b	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were	   used	   to	   immunopurify	   kinesin-­‐1,	   which	   was	   subsequently	   incubated	   with	  purified	   virus	   stock,	   virus-­‐depleted	   infected	   293A	   cell	   lysate,	   or	   293A	   cell	   lysate	  expressing	  viral	  capsid	  components.	  	  	  	  	  
Microtubule	  Gliding	  Assay	  Unlabeled	  and	  rhodamine-­‐labeled	  tubulins	  (Cytoskeleton)	  were	  mixed	  at	  a	  ratio	  of	  1:1	  (total	  concentration	  of	  5mg/ml)	   in	  BRB80	  buffer	  (80	  mM	  PIPES,	  pH	  6.8,	  1	  mM	  EGTA,	  1	  mM	  MgCl2,	  1	  mM	  GTP,	  3%	  glycerol).	  The	  mixture	  was	  polymerized	  at	  37°C	  for	  15	  min	  and	  then	  stabilized	  by	  adding	  prewarmed	  BRB80/T	  buffer	  (BRB80	  buffer	  plus	  20	  μM	   taxol)and	  microtubules	  were	   stored	  at	   room	   temperature	   in	   the	  dark.	  For	   chamber	   assays,	  microtubules	  were	   diluted	   in	   PMEE	   buffer	   (35	  mM	   PIPES,	   5	  mM	  MgSO4,	   1	  mM	  EGTA,	   0.5	  mM	  EDTA,	   pH	  7.4)	   supplemented	  with	  20	  μM	   taxol.	  	  For	  in	  vitro	  MT	  gliding	  assays,	  flow	  chambers	  were	  assembled	  from	  a	  glass	  slide	  and	  acid-­‐washed	   cover	   slip,	   using	   double-­‐sided	   adhesive	   tape	   (chamber	   volume,	  approximately	  10	  μl).	   	  All	   solutions	  were	   incubated	   for	  10	  min.	  The	   chamber	  was	  first	  incubated	  with	  5	  mg/ml	  BSA	  (bovine	  serum	  albumin),	  washed	  twice	  with	  20	  μl	  PMEE	   buffer,	   incubated	   with	   kinesin-­‐enriched	   fraction,	   washed	   twice,	   then	  incubated	  with	   rhodamin-­‐labelled	  MT	   and	  washed	   twice	   again	   with	   PMEE	   buffer	  containing	   5	   μM	   taxol.	   Motility	   was	   initiated	   with	   the	   addition	   of	   500	   μM	   ATP	  diluted	   in	   PMEE	   buffer,	   and	   imaging	   was	   performed	   in	   a	   inverted	   microscope	  (Leica)	   operated	   by	   Metamorph	   Imaging	   software	   (Molecular	   Devices)	   at	   25°C,	  equipped	  with	  a	  63x	  oil	   immersion	  objective	  and	  a	  CCD	  camera	  (model	  C9100-­‐12;	  Hamamatsu).	  For	  image	  and	  movie	  analysis	  and	  particle	  counting	  ImageJ	  was	  used.	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Statistical	  Analysis	  For	   analysis,	   two-­‐sample	   comparisons	   were	   performed	   via	   Student’s	   t	   test.	  	  	  Statistical	   significance	   was	   inferred	   for	   p	   values	   less	   than	   0.05.	   Analysis	   and	  statistical	   tests	  were	  performed	  using	  Excel	   (Microsoft,	  Redmond,	  WA)	   and	  Prism	  (GraphPad,	  La	  Jolla,	  CA).	  	  	  3.2.	  Results	  3.2.1.	  pH-­‐independent	  binding	  of	  Ad5	  to	  Kinesin-­‐1	  A	   striking	   phenomenon	   of	   adenovirus	   transport	   during	   the	   cytoplasmic	   phase	   of	  entry	   represents	   the	   bidirectional	   motility	   behavior	   (Bremner	   et	   al.,	   2009)	  (Suomalainen	  et	  al.,	  1999).	   	  Thus	  far,	  the	  only	  functional	  interaction	  between	  a	  MT	  plus-­‐end	  directed	  motor	  and	  the	  virion	  has	  been	  reported	  for	  capsid	  disassembly	  at	  the	   NPC.	   	   A	   weak	   interaction	   of	   Kif5c	   light	   chains	   with	   protein	   IX	   was	   reported,	  which,	  apparently,	  had	  	  no	  relevance	  to	  in	  MT-­‐based	  transport	  (Strunze	  et	  al.,	  2011).	  	  To	  test	  for	  kinesin	  binding	  to	  the	  capsid	  during	  the	  cytoplasmic	  transport	  phase	  of	  Ad5,	  we	  used	  A549	  cell	  lysate	  at	  40min	  p.i.	  infected	  with	  1000pa/cell	  of	  a	  modified	  Ad5	  virus	  containing	  FLAG-­‐tagged	  protein	  IX	  (Ad5pIXflag)	  to.	  	  Immunoprecipitation	  with	  anti-­‐flag	  antibody	  reveals	  binding	  of	  cytoplasmic	  dynein	  to	  Ad5	  and	  a	  weaker,	  but	  detectable	  signal	  for	  kinesin-­‐1	  (Fig	  3-­‐1A).	  	  	  For	   further	   analysis	   of	   the	   interaction	   between	   kinesin-­‐1	   and	   the	   viral	   capsid	   or	  capisd	  components,	  we	  relied	  on	  rat	  brain	  kinesins	  obtained	  by	  MT	  binding	  and	  GTP	  release	   as	   part	   of	   the	   dynein	   purification	   protocol,	   followed	   by	   sucrose	   gradient	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centrifugation	   (Fig	   3-­‐1B).	   	   The	   kinesin	   peak	   fraction	   contained	   active	   kinesin,	   as	  tested	   for	   by	   MT	   gliding.	   	   MTs	   show	   a	   speed	   of	   ~800nm/sec,	   characteristic	   for	  kinesin-­‐1	  propelled	  MT	  (Fig	  3-­‐1C).	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Figure	  3-­‐1:	  	  Kinesin-­‐1	  Binds	  Incoming	  Ad5	  Capsid	  and	  Kinesin	  Enrichment.	  (A)	  Ad5pIXflag	  was	   immunoprecipitated	   from	   infected	  A549	   cell	   lysate	   40min	  p.i.	  with	  a	  polyclonal	  anti-­‐flag	  antibody	  and	  the	  pellets	  were	  immunoblotted	  using	  anti-­‐dynein	   IC	   and	   LIC1	   or	   anti-­‐kinesin-­‐1	   (clone	  H2)	   antibodies.	   Dynein	   and	   kinesin-­‐1	  were	   present	   in	   the	   pellets.	   	   Note	   that	   the	   hexon	   signal	   in	   the	   input	   sample	  was	  below	  the	  detection	  limit	  but	  was	  visible	  in	  the	  concentrated	  pellet.	  	  (B)	  Kinesin	  was	  enriched	   for	  by	   sedimenting	   the	  GTP	  release	   fraction	  of	  a	  dynein	  preparation	   in	  a	  linear	  sucrose	  gradient	  (5-­‐20%).	  	  Gradient	  fractions	  were	  immunoblotted	  with	  anti-­‐kinesin-­‐1,	  -­‐2,	  and	  -­‐3,	  and	  anti-­‐dynein	  IC	  and	  anti-­‐tubulin	  antibodies,	  which	  shows	  a	  clear	   separation	   of	   the	   kinesins	   (peak	   fraction	   9)	   from	   cytoplasmic	   dynein	   (peak	  fraction	   4).	   	   (C)	   Still	   images	   of	   a	   time-­‐lapse	   acquisition	   following	   an	   individual	  microtubule	   (MT)	   in	   a	   MT	   gliding	   assay	   over	   10frames	   (1frame/sec).	   	   The	   assay	  chamber	  was	  incubated	  with	  kinesin-­‐enriched	  fraction	  9	  of	  the	  sucrose	  gradient	  in	  B	  before	  rhodamine	  labeled	  MTs	  and	  ATP	  was	  added	  and	  the	  chamber	  was	  prepared	  for	  imaging	  at	  37°C.	  	  Binding	   of	   components	   of	   this	   kinesin-­‐enriched	   fraction	   to	   immunopurified	   Ad5	  capsid	   or	   hexon	   exposed	   to	   either	   neutral	   or	   acidic	   pH	   was	   tested	   in	   pull-­‐down	  experiments.	   	  We	   find	  a	   clear	   interaction	  of	  kinesin-­‐1	  with	  Ad5	  capsid	   (Fig	  3-­‐2A),	  whereas	   other	   plus-­‐end	   kinesins,	   kinesin-­‐2	   and	   -­‐3,	   showed	   no	   clear	   evidence	   of	  virus	   binding,	   possibly	   reflecting	   their	   lower	   concentrations	   in	   the	   input	   samples.	  	  Remarkably,	   in	   contrast	   to	   cytoplasmic	  dynein,	   the	  kinesin-­‐1	   interaction	  with	  Ad5	  was	  independent	  of	  hexon	  and	  unaffected	  by	  exposure	  to	  low	  pH	  levels,	  suggesting	  independent	   recruitment	   mechanisms	   for	   kinesin	   and	   dynein	   (Fig	   3-­‐2A).	  	  Reciprocally,	  we	   also	   performed	   kinesin-­‐1	   pull-­‐downs,	   and	   found	   clear	   binding	   of	  intact	  Ad5,	  but	  not	  hexon	  (Fig	  3-­‐2B	  and	  C).	  	  We	  also	  tested	  the	  behavior	  of	  the	  capsid	  protomer	   penton,	  which	   consists	   of	   penton	   base	   and	   fiber.	   	   Although	   fiber	   is	   lost	  early	   during	   entry	   (Nakano,	   JVI,	   2000),	   penton	   base	   has	   been	   observed	  cytochemically	  to	  remain	  associated	  with	  capsids	  throughout	  early	  infection	  at	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Figure	  3-­‐2:	  	  Kinesin-­‐1	  Interacts	  with	  Penton	  Complex.	  	  (A)	  Kinesin-­‐enriched	   fraction	  was	   tested	   for	  pull-­‐down	  with	  hexon	  or	  Ad5	  capsid	  exposed	   to	   either	   neutral	   or	   acidic	   buffer	   conditions	   before	   the	   incubation	   by	  immunoblotting	   of	   the	   kinesin	   input,	   supernatants,	   and	   pellets	   with	   antibodies	  against	   hexon,	   and	   kinesin-­‐1,	   -­‐2,	   and	   -­‐3.	   	   Kinesin-­‐1	   interacts	   with	   the	   adenoviral	  capsid	   clearly	   above	   background	   and	   12-­‐14fold	   better	   with	   the	   capsid	   than	   with	  hexon	  alone	  only	  (binding	  fraction	  adjusted	  to	  the	  amount	  of	  hexon	  present	   in	  the	  pellet	  samples).	  	  Kinesin-­‐2	  and	  -­‐3	  were	  only	  detectable	  in	  the	  input.	  	  Of	  note,	  capsid	  acidification	   has	   only	   a	   minor	   effect	   on	   kinesin-­‐1	   binding,	   indicating	   a	   different	  recruitment	  mechanism	  for	  kinesin-­‐1	  and	  cytoplasmic	  dynein.	  	  Numbers	  below	  each	  lane	   indicate	   relative	   signal	   intensity.	   	   (B)	   Purified	   Ad5pIXflag	  was	   tested	   for	   co-­‐immunoprecipitation	   with	   kinesin-­‐1	   using	   the	   monoclonal	   H2	   antibody.	  	  Supernatant	   (Sup)	   and	   pellets	   were	   immunoblotted	   with	   anti-­‐kinesin	   and	   anti-­‐adenovirus	   antibodies.	   	   Clear	   pull-­‐down	   of	   Ad5pIXflaf	  was	   observed.	   	   In	   addition,	  the	  ratio	  of	  hexon	  to	  penton	  base	  was	  higher	   in	   the	  supernatants	   than	   in	   the	  anti-­‐kinesin	  co-­‐immunoprecipitate	  indicating	  possible	  free	  hexon	  protomers	  in	  the	  input	  sample,	  which	  do	  not	  interact	  with	  kinesin.	  	  (C)	  Same	  as	  in	  B,	  except	  MonoQ	  purified	  hexon	   or	   purified	   Penton-­‐Dodecahedra	   (Pt-­‐Dd)	   were	   tested	   for	   kinesin-­‐1	   co-­‐immunoprecipitation.	   	   Pt-­‐Dd	   are	   present	   in	   the	   pellets,	   whereas	   hexon	   was	   not	  pulled-­‐down.	   	   (D)	   After	   incubation	   in	   either	   neutral	   or	   low	   pH	   buffer,	   Pt-­‐Dd	  was	  tested	   for	   binding	   to	   cytoplasmic	   dynein	   or	   kinesin-­‐1	   by	   immunoblotting	   of	  supernatants	   (Sup)	   and	   pellets.	   	   Pt-­‐Dd	   was	   present	   in	   anti-­‐kinesin	   pellets	  independent	   of	   pH	   at	   the	   pre-­‐incubation	   step,	   but	   was	   absent	   in	   the	   anti-­‐dynein	  pellets.	  	  	  	  relatively	   constant	   levels	   (Bremner	   et	   al.,	   2009;	   Greber	   et	   al.,	   1996;	   Martin-­‐Fernandez	   et	   al.,	   2004),	   consistent	   with	   a	   potential	   role	   in	   early	   adenovirus	  transport.	   	   As	   one	   test	   for	   kinesin-­‐1	   binding	  we	   produced	   penton	   dodecahedrons	  (Pt-­‐Dd),	   stable	   complexes	   of	   penton	   base	   with	   fiber	   subunits	   found	   in	   lysates	   of	  adenovirus-­‐infected	   cells	   (see	   chapter	   3.2.2.1.	   (Fender	   et	   al.,	   1997;	   Norrby	   and	  Skaaret,	   1967).	   	  We	  observed	  pH-­‐independent	   pull-­‐down	  of	   Pt-­‐Dd	  with	   kinesin-­‐1,	  but	  not	  cytoplasmic	  dynein	  (Fig	  3-­‐2D).	  We	  also	  expressed	   individual	  capsid	  subunits	   in	  293A	  cells	  and	   found	  that	  penton	  base	  alone	  interacted	  with	  kinesin-­‐1	  (Fig	  3-­‐3A),	  while	  no	  apparent	  interaction	  with	  protein	   IX	   was	   observed,	   the	   only	   previously	   reported	   kinesin-­‐1	   interacting	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adenovirus	  capsid	  protein,	  though	  that	  interaction	  appeared	  to	  be	  weak	  (Strunze	  et	  al.,	   2011).	   	   In	   this	   assay,	   hexon	   was	   also	   negative	   for	   kinesin-­‐1	   binding.	  	  Furthermore,	   we	   tested	   a	   polyclonal	   Kif5b-­‐specific	   antibody	   in	  immunoprecipitations	   of	   rat	   brain	   kinesin-­‐1	   and	   penton	   base	   binding	   (Fig	   3-­‐3B).	  	  Surprisingly,	  this	  antibody	  pulled-­‐down	  less	  KLC1	  than	  the	  monoclonal	  H2	  antibody,	  but	   the	   amount	   of	   bound	   penton	   base	   was	   comparable.	   	   These	   data	   suggest	   a	  potentially	   KLC1-­‐independent	   interaction	   between	   penton	   base	   and	   Kif5b.	  	  However,	   the	   contribution	   of	   other	   kinesin	   family	  members,	   especially	   Kif5a	   and	  Kif5c,	  in	  cytoplasmic	  adenovirus	  motility	  cannot	  be	  ruled	  out.	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Figure	  3-­‐3:	  	  Kinesin-­‐1	  Pulls-­‐Down	  Penton	  Base.	  (A)	  Pull-­‐down	  of	  virus	  components	  with	  kinesin-­‐1	  as	  in	  Figure	  3-­‐2,	  but	  using	  lysate	  from	  293A	  cells	  expressing	  either	  GFP,	  hexon	  and	  GFP-­‐100K,	  GFP-­‐pIX-­‐flag,	  or	  HA-­‐tagged	   penton	   base.	   	   Penton	   base	   alone	   binds	   kinesin-­‐1,	  whereas	   all	   other	   capsid	  proteins	  were	  negative	  for	  motor	  binding.	  	  (B)	  Pull-­‐down	  of	  HA-­‐tagged	  penton	  base	  expressed	   in	   293A	   cells	   with	   kinesin-­‐1	   immunopurified	   with	   monoclonal	   H2	  antibody	   (similar	   to	   panel	   A)	   or	   polyclonal	   Kif5B	   antibody.	   	   Inputs,	   supernatants	  and	  pellets	  were	  immunoblotted	  with	  anti-­‐HA,	  anti-­‐kinesin	  HC	  (H2	  and	  Kif5B)	  and	  LC	  (KLC1)	  antibodies.	   	  Similar	  amounts	  of	  penton	  base	  were	  present	   in	  the	  pellets	  independent	   of	   the	   antibody	   used	   for	   the	   immunoprecipitation	   and	   the	   co-­‐immunoprecipitated	   amount	   of	  KLC1.	   	  Numbers	   below	   each	   lane	   indicate	   relative	  signal	  intensity.	  	  3.2.2.	  Intracellular	  Penton	  Dodecahedron	  Motility	  Penton	   dodecahedra	   (Pt-­‐Dd),	   subviral	   particles	   consisting	   exclusively	   of	   penton	  base	   and	   fiber	   (Norrby	   and	   Skaaret,	   1967),	   have	   been	   proposed	   as	   possible	   gene	  delivery	  vectors,	  since	  they	  show	  nuclear	  accumulation	  in	  cultured	  cells	  (Fender	  et	  al.,	  1997).	  	  They	  can	  be	  loaded	  with	  extra-­‐genomic	  DNA	  leading	  to	  gene	  expression	  48h	   p.i.	   (Fender	   et	   al.,	   1997).	   	   Thus	   far,	   Pt-­‐Dd	   have	   only	   been	   described	   for	  recombinant	   baculovirus	   expressed	   adenovirus	   3	   pentons	   purified	   by	   sucrose	  gradient	   centrifugation	   (Fender	   et	   al.,	   2008).	   In	   addition,	   visualization	   of	  intracellular	   translocating	   Pt-­‐Dd,	   revealing	   their	   transport	   mechanism,	   is	   still	  lacking.	   	   Here,	   we	   describe	   a	   two-­‐step	   purification	   process	   for	   Pt-­‐Dd	   from	   Ad5	  infected	   cell	   lysate	   and	   the	   intracellular	   transport	   characteristics	   of	   Alexa546-­‐dye	  labeled	  Pt-­‐Dd	  incubated	  with	  cultured	  hippocampal	  neurons.	  	  3.2.2.1.	  Penton	  Dodecahedron	  Purification	  Penton	   base	   and	   fiber	   undergo	   a	   structural	   change	   during	   penton	   complex	  formation	   (Zubieta	  et	  al.,	  2005).	   	  The	  assembly	  of	   twelve	  pentons	   to	   form	  a	  Pt-­‐Dd	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requires	   proteolytic	   cleavage	   of	   the	   N-­‐terminal	   37	   residues	   of	   penton	   base,	   60	  copies	   of	  which	   cannot	   fit	   into	   the	   interior	   volume	   of	   the	   Pt-­‐Dd	   (Fuschiotti	   et	   al.,	  2006).	   	   Proteolysis	   can	   be	   achieved	   by	   incubating	   virus-­‐depleted	   cell	   lysate	   of	  infected	  cells	   for	  7days	  at	  4°C.	   	  Under	  mildly	  acidic	  conditions	  (pH	  6.8),	  which	  are	  optimal	   for	   Pt-­‐Dd	   formation	   (Fuschiotti	   et	   al.,	   2006),	   we	   subjected	   the	   lysate	   to	  anion-­‐exchange	   chromatography	   (AEC),	   following	  protocols	   for	   hexon	  purification	  adjusted	  for	  MonoQ	  columns	  (Waris	  and	  Halonen,	  1987)	  (Figure	  3-­‐4A).	  	  	  
	  
	   92	  
Figure	   3-­‐4:	   	   Anion	   Exchange	   Chromatography	   of	   Ad5pIX-­‐flag	   Infected	   A549	   Cell	  Lysate.	  (A)	   Virus-­‐depleted	   lysate	   of	   Ad5pIXflag	   infected	   293A	   cells	   2-­‐3	   days	   p.i.	   was	  incubated	  at	  4°C	  for	  7	  days	  before	  poured	  over	  a	  MonoQ	  anion	  exchange	  column	  and	  eluted	   with	   0.5M	   NaCl	   at	   pH6.5	   (Waris	   and	   Halonen,	   1987).	   	   Besides	   the	   flow-­‐through	   (peak	   I)	   and	   the	   hexon	   peak	   (III)	   an	   additional	   peak	   (II)	   elutes	   at	  approximately	   0.2M	   NaCl.	   Solid	   line	   indicates	   fractions	   used	   for	   SDS-­‐PAGE	   and	  immunoblotting	   in	  B.	   	  Protein	   levels	  are	  measured	  by	  absorbtion	  at	  280nm	  (thick	  line),	  salt	  concentration	  (thin	  line)	  is	  indicated	  on	  the	  right.	  	  (B)	  Total	  lysate,	  fraction	  of	  peak	  I,	  wash,	  and	  anion	  exchange	  fractions	  of	  peak	  II	  were	  tested	  for	  the	  presence	  of	  adenoviral	  capsid	  proteins	  by	  immunoblotting	  with	  anti-­‐adenovirus	  and	  anti-­‐Flag	  antibodies.	  	  Penton	  base,	  fiber,	  pV,	  pVI,	  pVII,	  and	  pIX	  are	  eluting	  in	  peak	  II,	  whereas	  hexon	   is	   absent	   in	   these	   fractions.	   	   Fractions	   indicated	   by	   the	   dashed	   line	   were	  pooled	  and	  subjected	  to	  size	  exclusion	  chromatography.	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  Figure3-­‐5:	  Size	  Exclusion	  Chromatography.	  (A)	   Pooled	   fractions	   of	   anion	   exchange	   chromatography	   were	   poured	   over	   size	  exclusion	  column	  and	  protein	  levels	  were	  measured	  at	  280nm.	  	  One	  individual	  peak	  (I)	  elutes	  at	  the	  void	  volume	  before	  an	  additional	  double	  peak	  (IIa	  and	  IIb).	  Solid	  line	  indicates	   fractions	   used	   for	   SDS-­‐PAGE	   and	   immunoblotting	   in	   B	   and	   C.	   	   (B)	  Immunoblotting	   with	   anti-­‐adenovirus	   and	   anti-­‐flag	   antibodies	   or	   (C)	   Coomassie-­‐staining	  of	  input	  and	  elution	  fractions	  indicate	  a	  high	  concentration	  of	  penton	  base	  and	   fiber	   in	   peak	   I,	   which	   can	   be	   separated	   from	   most	   cellular	   and	   viral	  contaminants.	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The	  first	  peak	  eluting	  at	  low	  salt	  concentrations	  was	  devoid	  of	  hexon	  but	  contained	  the	  viral	  proteins	  penton,	  fiber,	  and	  proteins	  V,	  VI,	  and	  IX	  (Figure	  3-­‐4B).	  We	  pooled	  fractions	  with	  high	  penton	  concentration	  and	  poured	  them	  over	  a	  size-­‐exclusion	  chromatography	  (SEC)	  column,	  which	  resulted	  in	  two	  major	  peaks	  (Figure	  3-­‐5A).	  	  Peak	  I	  eluted	  at	  the	  void	  volume	  and	  only	  contained	  penton,	  fiber	  and	  a	  high	  molecular	  weight	   contaminant	   (Figure	   3-­‐5B	   and	   C).	   	   Peak	   II	   contained	   the	  minor	  capsid	  components	  and	  further	  host	  cell	  contaminants	  (Figure	  3-­‐5B	  and	  C).	  	  Using	  this	  method,	  we	  enriched	  for	  Pt-­‐Dd	  by	  280%	  from	  the	  initial	  cell	  lysate	  to	  SEC	  elution	  (Figure	  3-­‐6A	  and	  B,	  Figure	  3-­‐7A	  and	  B).	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Figure	  3-­‐6:	  Pt-­‐Dd	  Purification.	  (A)	   Immunoblotting	   with	   anti-­‐adenovirus	   and	   anti-­‐Flag	   antibodies	   or	   (B)	  Coomassie-­‐staining	   of	   virus-­‐depleted	   lysate	   of	   infected	   293A	   cells	   (lysate),	   peak	  fractions	  of	  anion	  exchange	  chromatography	  (AEC),	  size	  exclusion	  chromatography	  (SEC),	  and	  sucrose	  gradient	  centrifucation	  (SGC)	  indicate	  an	  increasing	  purity	  of	  the	  Pt-­‐Dd	  and	  the	  absence	  of	  any	  other	  adenoviral	  polypeptides	  in	  the	  final	  sample.	  	  Sucrose	  density	  gradient	  centrifugation	  clearly	   reveals	   the	   identity	  of	  Pt-­‐Dd	   in	   the	  preparation,	  which	   can	   also	   be	   separated	   from	   the	   high	  molecular	  weight	   by	   this	  method	   (Figure	   3-­‐7C).	   	   The	   final	   purity	   of	   Pt-­‐Dd	   after	   sucrose	   density	   gradient	  centrifugation	  was	  99.0%	  (Figure	  3-­‐6B).	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Figure	  3-­‐7:	  Sucrose	  Gradients	  of	  Pt-­‐Dd	  Purification.	  Coomassie-­‐stained	   SDS-­‐PAGE	   gels	   after	   centrifugation	   through	   5-­‐20%	   sucrose	  gradient	   of	   (A)	   virus-­‐depleted	   lysate	   of	   infected	   293A	   cells,	   (B)	   anion	   exchange	  chromatography	  peak	  fraction,	  and	  (C)	  size	  exclusion	  chromatography	  peak	  fraction	  indicate	   increasing	   purity	   of	   the	   Pt-­‐Dd	   (bracket	   “penton”),	   which	   maintains	   its	  sedimentation	  coefficient	  throughout	  the	  purification	  process.	  	  1:	  protein	  marker,	  2:	  10%	  of	  input,	  3-­‐15:	  fractions	  with	  decreasing	  sucrose	  concentration.	  	  	  3.2.2.2.	  Motility	  in	  Cultured	  Hippocampal	  Neurons	  We	  also	  tested	  intracellular	  motility	  of	  Alexa546	  dye-­‐labeled	  Pt-­‐Dd	  in	  5DIV	  cultured	  hippocampal	   neurons.	   	   Attachment	   was	   performed	   in	   the	   cold	   to	   synchronize	  uptake,	   and	   live	   cell	   imaging	   with	   streaming	   acquisition	   was	   used	   to	   visualize	  intracellular	  movements	  (Figure	  3-­‐8).	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Figure	  3-­‐8:	  	  Intracellular	  Alexa546-­‐Pt-­‐Dd	  Motility	  in	  Hippocampal	  Neurons.	  Alexa546-­‐Pt-­‐Dd	  motility	  was	  tested	  in	  hippocampal	  neurons	  by	  live	  cell	  imaging	  of	  cells	  incubated	  with	  Alexa546-­‐Pt-­‐Dd	  at	  10frames/sec.	  (A)	  DIC	  image	  of	  neuronal	  cell	  chosen	   for	   imaging	   (upper	   panel).	   	   Box	   indicates	   area	   of	   high	   Alexa546-­‐Pt-­‐Dd	  motility.	   	   Bar	  =	  20µm.	   	   (B)	  Magnified	   view	  of	   box	   in	  panel	  A	   in	  Alexa546	   channel	  shows	   distinct	   Alexa546-­‐Pt-­‐Dd	   signals.	   	   Box	   indicates	   area	   used	   for	   montage	   in	  panel	  C.	  	  Bar	  =	  5µm.	  	  (C)	  Montage	  of	  boxed	  area	  in	  panel	  B,	  shows	  clear,	  bidirectional	  movement	  of	  two	  Alexa546-­‐Pt-­‐Dd	  particles	  in	  this	  part	  of	  the	  neuronal	  cell.	  	  Images	  every	  10	  frames.	  Hippocampal	  neurons	  were	  a	  generous	  gift	  of	  Shahrnaz	  Kemal.	  	  Almost	   all	   Alexa546-­‐Pt-­‐Dd	  were	  motile	   up	   to	   1.5h	   after	   synchronous	   uptake	  was	  initiated.	  	  The	  movements	  were	  fast	  with	  speeds	  up	  to	  1.7	  µm/sec	  and	  bidirectional,	  especially	  close	  to	  the	  cell	  body	  and	  in	  thicker	  portions	  of	  cell	  processes.	  	  Almost	  no	  movement	  was	  observed	  in	  thinner	  parts	  of	  dendrites	  or	  axons.	   	  However,	  caution	  has	   to	   be	   taken	   interpreting	   these	   results	   since	   uptake	   of	   Pt-­‐Dd	   has	   not	   been	  investigated	   to	   the	   same	  detail	   as	   for	   the	   adenovirus	   capsid.	   	  Hence,	   it	   is	   possible	  that	  the	  crucial	  step	  of	  endosomalysis	  occurs	  much	  later	  or	  even	  never	  for	  Pt-­‐Dd	  and	  the	  described	  movements	  are	  representative	  of	  Pt-­‐Dd	  inside	  vesicular	  structures.	  	  	  	  	  	  3.3.	  Discussion	  3.3.1.	  Role	  of	  Kinesin	  in	  Virus	  Entry	  Besides	   the	  work	  presented	  here,	  which	   indicates	  a	  direct	   interaction	  of	  kinesin-­‐1	  with	   the	  viral	   capsid	  protein	  penton	  base,	   roles	  of	  kinesin	   transport	   in	  adenoviral	  entry	  has	  been	  investigated	  in	  various	  contexts	  (Leopold	  et	  al.,	  2000;	  Strunze	  et	  al.,	  2011;	  Yi	  et	  al.,	  2011),	  Jie	  Zhou,	  personal	  communication).	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In	   early	   entry	   phases,	   kinesin-­‐1	   is	   presumably	   responsible	   for	   lysosome/LE	  (lyso/LE)	   dispersion	   upon	   virus-­‐induced	   PKA	   stimulation,	   which	   reduces	   dynein	  attachment	  to	  this	  class	  of	  organelles	  and	  rapidly	  increases	  their	  kinesin-­‐driven	  MT	  plus-­‐end	   motility	   (see	   chapter	   1.1.2.2.	   and	   2.3.1.).	   	   A	   clear	   host	   cell	   protection	  mechanism	   for	   lyso/LE	   dispersal	   could	   not	   be	   shown	   for	   subgroub	   C	   adenoviral	  infections	  since	  they	  leave	  the	  endosomal	  pathway	  early.	  However,	  subgroup	  B	  and	  F	   adenoviruses	   stay	   inside	   vesicles	   for	   prolonged	   periods	   of	   time,	   a	   phenotype	  correlated	   with	   lower	   infectivity	   (see	   chapter	   2.3.3).	   	   Here,	   kinesin-­‐mediated	  lyso/LE	  redistribution	  might	   represent	  a	  host	  defense	  mechanism,	  which	  employs	  degradative	  organelles	  to	  inactivate	  incoming	  adenoviral	  particles.	  In	  contrast,	  the	  kinesin-­‐1	  isoform	  Kif5c	  has	  been	  reported	  to	  improve	  infectivity	  by	  aiding	  injection	  of	  the	  viral	  genome	  into	  the	  nucleus	  (Strunze	  et	  al.,	  2011).	  	  Kinesin	   is	   also	   involved	   in	   the	   cytoplasmic	   transport	   of	   incoming	   adenovirus	  particles	   which	   can	   be	   unmasked	   by	   acute	   dynein	   inhibition	   (Yi	   et	   al.,	   2011).	  	  Reports	   that	  microinjection	  of	   function-­‐blocking	  kinesin-­‐1	  antibodies	  has	  no	  effect	  on	   nuclear	   targeting	   of	   Ad5	   (Leopold	   et	   al.,	   2000)	  might	   be	   of	   limited	   relevance,	  since	  direct	  effects	  on	  viral	  motility	  were	  not	  examined	  and	  the	  possibility	  remains	  that	   kinesin-­‐1	   is	   involved	   in	   viral	   movements	   away	   from	   the	   nucleus	   and	   its	  inhibition	   leads	   to	   an	   increased	   redistribution	   of	   capsids	   to	   the	   nucleus.	  	  Furthermore,	   various	   other	   kinesins	   might	   substitute	   for	   kinesin-­‐1.	   	   We	   did	   not	  detect	  interactions	  of	  kinesin-­‐2	  or	  kinesin-­‐3	  with	  the	  viral	  capsid	  or	  penton	  base	  by	  the	   described	   methods.	   	   However,	   abundance	   of	   these	   kinesins	   was	   low	   in	   the	  starting	  material	   for	  the	  binding	  studies	  and	  we	  might	  have	  missed	  a	  possible	   low	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affinity	  interaction,	  which	  might	  have	  further	  been	  masked	  if	  kinesins	  complete	  for	  binding	  sites	  on	  the	  capsid.	  	  Using	  recombinant	  penton	  base	  constructs	  expressed	  in	  Sf9	   cells	   (Wickham	  et	   al.,	   1993)	   and	   kinesin	   full-­‐length	   or	   truncation	   proteins	   for	  further	   binding	   analysis	   might	   reveal	   additional	   interactions	   and	   also	   elucidate	  clearly	   which	   part	   of	   kinesin-­‐1	   interacts	   with	   the	   viral	   capsid.	   	   Mapping	   of	   the	  penton	   base	   binding	   site	   on	   kinesin-­‐1	   might	   allow	   the	   generation	   of	   specific	  dominant-­‐negative	   approaches	   blocking	   exclusively	   the	   capsid	   –	   kinesin-­‐1	  interaction	   and	   affecting	   virus	   transport	   while	   physiological	   transport	   processes	  remain	   unaffected.	   	   This	   would	   also	   allow	   investigations	   regarding	   a	   possible	  protective	   role	   for	   MT	   plus-­‐end	   directed	   transport	   during	   viral	   infections	   (see	  below).	  	  	  Interestingly,	  preliminary	  data	  show	  a	  complete	  inhibition	  of	  virus	  motility	  in	  cells	  expressing	  the	  cargo-­‐	  and	  light	  chain	  interacting	  tail	  domain	  of	  Kif5b	  indicative	  of	  a	  possible	   dominant-­‐negative	   effect	   (Jie	   Zhou,	   personal	   communication).	   	   This	  construct	   also	   seems	   to	   localize	   to	   viral	   capsids	   in	   their	   cytoplasmic	   entry	   phase	  between	   15-­‐45min	   p.i.,	   in	   accordance	   with	   kinesin-­‐1	   reactive	   antibodies	   also	  staining	  cytoplasmic	  capsids	  (Jie	  Zhou,	  personal	  communication).	  	  	  	  The	  biochemical	  and	  live	  cell	  imaging	  data	  together	  with	  these	  immunocytochemical	  results	   indicate	   that	  kinesin-­‐1	   is	   a	  very	   strong	   candidate	   responsible	   for	  MT	  plus-­‐end	   directed	   capsid	   motility	   through	   a	   direct	   interaction	   with	   the	   major	   capsid	  protein	  penton	  base.	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3.3.2.	  Bidirectional	  Capsid	  Transport	  We	  are	  only	  beginning	  to	  understand	  the	  puzzling	  result	  that	  adenovirus	  is	  not	  only	  transported	  by	  a	  minus-­‐end	  directed	  motor	  but	  shows	  plus-­‐end	  directed	  transport	  as	  well.	  	  Bidirectional	  motility	  might	  represent	  an	  evolutionary	  safety	  mechanism	  by	  which	  infected	  host	  cells	  are	  trying	  to	  prevent	  the	  virus	  from	  gaining	  access	  to	  the	  nucleus.	  	  Kinesin-­‐inhibited	  cells	  still	  show	  virus	  redistribution	  to	  the	  nucleus	  (Leopold	  et	  al.,	  2000),	   implying	   kinesin-­‐function	   to	   be	   part	   of	   the	   host	   defense.	   	   In	   contrast	   to	  dynein,	  which	   is	   clearly	   needed	   for	   viral	   transport	   purposes	   towards	   the	   nucleus	  (Bremner	   et	   al.,	   2009;	   Leopold	   et	   al.,	   2000;	   Suomalainen	   et	   al.,	   1999).	   	   Rates	   of	  nuclear	   localization	   and	   high	   resolution	   imaging	   during	   cytoplasmic	   transport	   of	  Ad5	   in	   kinesin-­‐inhibited	   cells	   might	   reveal	   more	   striking	   support	   for	   a	   role	   of	  kinesin	  in	  host	  defense.	  	  	  However,	   given	   the	   evolutionary	   pressure	   on	   adenoviruses	   to	   traverse	   the	  cytoplasm	   quickly	   after	   endosomal	   escape	   avoiding	   innate	   immune	   defense	  mechanisms	  mediated	  through	  TRIM21	  leading	  to	   intracellular	  capsid	  degradation	  (Mallery	  et	  al.,	  2010),	  it	  seems	  more	  likely	  that	  bidirectional	  motility	  supports	  viral	  fitness.	   	   Based	   on	   the	   virus	   population	  motility	   inside	   the	   cytoplasm,	   an	   assisted	  diffusion	  or	  “random-­‐walk”	  model	  has	  been	  proposed.	   	  Here,	  capsids	  explore	  wide	  cell	  areas	  as	  quickly	  as	  possible	  until	  they	  encounter	  binding	  partners	  at	  the	  nuclear	  pore	  complex	  to	  which	  they	  bind	  with	  high	  affinity.	  	  According	  to	  this	  model,	  similar	  MT	  minus-­‐	  and	  plus-­‐end	  directed	  motilities	  would	  be	  beneficial	  for	  viral	  fitness.	  	  In	  enucleated	  cells,	  however,	  adenovirus	  clearly	  accumulates	  at	  the	  MTOC	  with	  highly	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similar	   kinetics	   as	   nuclear	   localization	   occurs	   in	  mock	   treated	   cells	   (Bailey	   et	   al.,	  2003)	   and	   does	   not	   stay	   dispersed	   in	   the	   cytoplasm,	   indicating	   a	   MT	   minus-­‐end	  directed	  bias	  of	  population	  motility.	  	  It	  cannot	  be	  ruled	  out,	  that	  bidirectional	  capsid	  movement	   enhances	   viral	   motility	   in	   general	   by	   increased	   flexibility	   to	  circumnavigate	  obstacles	  on	  MT	  and	  to	  reduces	  the	  possibility	  that	  the	  processivity	  of	   a	   particular	   motor	   becomes	   limiting	   (Suomalainen	   et	   al.,	   2001),	   despite	   the	  observation	  that	  most	  particles	  show	  predominantly	  bursts	  of	  motility	  in	  the	  course	  of	   a	   60min	   infection	   period	   (Bremner	   et	   al.,	   2009;	   Scherer	   and	   Vallee,	   2011).	  	  Similarly,	   the	   ability	   to	   use	   both	   types	   of	  motors	  might	   be	   beneficial	   for	  Ad	   entry	  into	   polarized	   cells	  with	   altered	  MT	   orientations	   (Suomalainen	   et	   al.,	   1999).	   	   The	  transport	  step	  from	  the	  MTOC	  to	  the	  nucleus	  might	  also	  require	  kinesins,	  but	  others	  and	   we	   have	   not	   identified	   significant	   MTOC	   accumulation	   of	   viral	   capsids	   in	  kinesin-­‐inhibited	  cells	  ((Leopold	  et	  al.,	  2000),	  Jie	  Zhou,	  personal	  communication).	  	  	  Lastly,	  bidirectional	  MT-­‐dependent	  transport	  might	  be	  an	  intrinsic	  characteristic	  of	  MT-­‐based	   transport	   since	   opposite	   polarity	   motors	   are	   intrinsically	   present	  together	   at	   their	   cargo	   through	   a	   cargo-­‐independent	   association.	   	   For	   the	   dynein-­‐dynactin	  supercomplex	  two	  possible	  modes	  of	   interaction	  with	  kinesins	  have	  been	  reported.	   	   Biochemical	   assays	   and	   immunostaining	   indicated	   that	   kinesin-­‐1	   can	  directly	   interact	  with	   dynein	   IC	   (Ligon	   et	   al.,	   2004).	   	   Intermediate	   chain	   residues	  120-­‐283	   interact	   with	   kinesin	   light	   chain	   1	   and	   2,	   an	   in	   vitro	   finding	   further	  supported	   by	   the	   presence	   of	  WD	   repeats	   in	   the	   IC	   sequence,	   a	   motif	   which	   has	  previously	  been	   associated	  with	  KLC	  binding	   (Dodding	   et	   al.,	   2011;	  Morgan	   et	   al.,	  2010).	   	   A	   functional	   relevance	   was	   shown	   by	   co-­‐localization	   of	   dynein	   IC	   and	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kinesin-­‐1	  on	  some	  but	  not	  all	  vesicles	  inside	  fixed	  cells	  and	  co-­‐fractionation	  of	  both	  motor	   proteins	   with	   membranous	   vesicles	   in	   flotation	   sucrose	   gradient	  centrifugations	   in	   an	   ATP-­‐dependent	   manner	   (Ligon	   et	   al.,	   2004).	   	   In	   addition,	  dynactin	   has	   also	   been	   shown	   to	   interact	   with	   the	   kinesin-­‐2	   light	   chain	   KAP	   in	  biochemical	  experiments	  with	  Xenopus	  proteins	  (Deacon	  et	  al.,	  2003).	  	  According	  to	  these	   data,	   residues	   530-­‐793	   of	   KAP	   interact	   with	   the	   dynactin	   p150Glued	   subunit	  residues	   600-­‐811.	   	   Interestingly,	   this	   site	   in	   p150Glued	   has	   also	   been	   implied	   in	  dynein	   IC	   binding	   and	   a	   steric	   competition	  was	   postulated	   (Deacon	   et	   al.,	   2003).	  	  However,	   in	   light	   of	   more	   recent	   data,	   this	   p150Glued	   binding	   site	   seems	   only	  secondary	  to	  a	  N-­‐terminal	  binding	  site	  (McKenney	  et	  al.,	  2011;	  Morgan	  et	  al.,	  2011),	  leaving	  the	  possibility	  of	  simultaneous	  interaction	  of	  dynein	  and	  kinesin-­‐2	  with	  the	  dynactin	  complex.	  In	   the	  case	  of	   the	  adenoviral	  capsid,	  a	  more	  detailed	  picture	  of	  motor	  recruitment	  emerges.	  	  The	  two	  capsid	  proteins	  hexon	  and	  penton	  base	  interact	  directly	  with	  the	  opposite	  polarity	  motors	  dynein	  and	  kinesin-­‐1,	   respectively.	   	  Dynactin	   is	   required	  for	  dynein	  regulation	  but	  presumably	  not	  for	  motor	  recruitment.	  	  This	  would	  allow	  for	   studies	   investigating	   the	   role	   of	   mechanical	   strain	   based	   (tug-­‐of-­‐war)	   or	  signaling	  mechanisms	   during	   bidirectional	   runs.	   	   In	   contrast	   to	  models	   proposing	  the	  role	  of	  dynactin	  as	  a	  platform	  and	  switch	  of	  bidirectional	  transport,	  bidirectional	  capsid	  motility	  seems	  to	  follow	  different	  mechanisms.	  	  If	  reversals	  in	  run	  directions	  represent	   indeed	   a	   strain-­‐	   or	   tension-­‐controlled	   mechanism,	   the	   force-­‐sensing	  element	   has	   to	   be	   an	   intrinsic	   characteristic	   of	   the	   motor	   complexes	   themselves	  (Mallik	  et	  al.,	  2004),	  independent	  of	  cargo	  adaptors	  or	  recruitment	  factors.	   	  If	  local	  
	   103	  
signaling	   events	   control	   bidirectional	   behavior	   immediately	   as	   proposed	   recently	  (Yi	  et	  al.,	  2011),	  studies	  on	  capsid	  motility	  might	  facilitate	  the	  identification	  of	  this	  mechanism	   since	   the	   biochemical	   results	   presented	   here	   reveal	   a	   decreased	  complexity	  compared	  to	  physiological	  cargoes.	  	  Further	   work	   on	   MT	   plus-­‐end	   directed	   adenovirus	   motility,	   employing	   high	  temporal	   and	   spatial	   resolution	   imaging	   techniques,	   is	   required	   to	   elucidate	   the	  underlying	   principle	   how	   incoming	   adenovirus	   simultaneously	   engages	   opposite	  polarity	  motors.	   In	   addition,	   to	  determine	   the	   identity	  of	   the	  plus-­‐end	  motor(s)	   is	  crucial	   for	   any	   kind	   of	   cell-­‐based	   assays	   to	   test	   their	   importance	   and	   function	   in	  adenovirus	  infection.	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Chapter	  4:	   Structural	   Change	   of	   Adenovirus	   Hexon	  
Dependent	  on	  pH	  
	  
4.1.	  Introduction	  4.1.1.	  Introduction	  Adenoviral	   capsids	   protect	   the	   viral	   genome	   and	   ensure	   its	   rapid	   delivery	   to	   the	  nucleus	  of	  permissible	  host	  cells.	   	  The	  highly	  symmetric	  proteinaceus	  capsids	  self-­‐assemble	  from	  hexon	  and	  penton	  protomers	  with	  the	  help	  of	  cement	  proteins	  into	  icosahedral	   structures	   (Liu	   et	   al.,	   2010;	   Reddy	   et	   al.,	   2010).	   	   The	   facets	   of	   the	  icosahedra	   mainly	   consist	   of	   the	   major	   capsid	   protein	   hexon,	   which	   represents	  extremely	  tightly	  packed	  homotrimers	  that	  require	  the	  viral	  chaperon	  protein	  100K	  for	  correct	  folding	  (Hong	  et	  al.,	  2005;	  Oosterom-­‐Dragon	  and	  Ginsberg,	  1981).	  	  Hexon	  trimers	   feature	   a	   double-­‐jelly-­‐roll	   fold	   which	   consists	   of	   two	   eight-­‐stranded	   β-­‐barrels	   joined	   by	   a	   linker	   region	   and	   can	   be	   found	   in	  multiple	   capsid	   proteins	   of	  other	  viruses	  (Krupovic	  and	  Bamford,	  2011).	  	  It	  is	  thought	  to	  give	  them	  the	  required	  resistance	  against	  environmental	  influences	  such	  as	  temperature,	  pH,	  radiation,	  and	  oxidation	   (Rexroad	   et	   al.,	   2003).	   	   The	   structural	   rigidity,	   the	   large	   abundance	   of	  soluble,	  non-­‐capsid	  associated	  hexon	  in	  the	  lysate	  of	  infected	  cells	  and	  the	  advance	  in	   single-­‐step	   ion-­‐exchange	   based	   purification	   protocols	   (Boulanger	   and	   Puvion,	  1973;	   Rux	   and	   Burnett,	   2007;	   Waris	   and	   Halonen,	   1987),	   greatly	   facilitated	  crystallographic	   work	   on	   hexon	   (Rux	   and	   Burnett,	   2000;	   Rux	   and	   Burnett,	   2007;	  Rux	  et	   al.,	   2003).	   	  The	   structure	  of	  one	  hexon	  monomer	   can	  be	  divided	   into	  eight	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domains:	   two	  eight-­‐stranded	  viral	   jellyroll	  domains,	  V1	  and	  V2,	   in	   the	  base,	  which	  also	  includes	  a	  55-­‐residue	  loop	  at	  the	  N-­‐terminus,	  NT,	  and	  a	  53-­‐residue	  “viral	  jelly-­‐roll-­‐connector”	   domain,	   VC,	   that	   holds	   the	   V1	   and	   V2	   domains	   apart.	   	   The	   loops	  forming	  the	  top	  of	  the	  molecule	  (FG1	  and	  2,	  DE1	  and	  2)	  are	  named	  for	  the	  β-­‐strands	  in	   V1	   and	   V2	   that	   they	   connect	   (Rux	   and	   Burnett,	   2000).	   	   Seven	   loops	   extending	  from	  the	  FG	  and	  DE	  domains	  are	  not	  structurally	  resolved	  indicating	  their	  flexibility	  and	  are	   termed	  hypervariable	   regions	   (HVR).	   	  HVRs	  differ	   in	   length	  and	  sequence	  between	   serotypes	   and	   presumably	   contain	   the	   majority	   of	   serotype-­‐specific	  residues	  (Rux	  and	  Burnett,	  2000).	  	  We	   reported	   earlier	   that	   brief	   capsid	   or	   hexon	   exposure	   to	   low	   pH	   conditions,	  significantly	   increased	   cytoplasmic	   dynein	   binding	   (Bremner	   et	   al.,	   2009).	   	   There	  are	  several	  lines	  of	  evidence	  that	  link	  low	  pH	  exposure	  of	  the	  adenovirus	  capsid	  in	  general	  and	  hexon	  in	  particular	  to	  biochemical	  changes	  presumably	  by	  affecting	  the	  structural	   conformation.	   	   It	   was	   found	   that	   not	   only	   the	   virus	   capsid	   but	   also	   all	  three	  major	  capsid	  proteins	  hexon,	  penton	  base,	  and	  fiber	  individually	  exhibit	  a	  pH-­‐dependent	   hydrophobicity	   indicating	   a	   structural	   rearrangement	   between	   pH6.0-­‐5.0	   (Seth	  et	  al.,	  1985).	   	  Expanding	  on	   these	   findings,	   it	  was	   shown	   that	   the	  capsid	  structure	  loosens	  after	  low	  pH	  exposure	  as	  indicated	  by	  an	  increased	  accessibility	  of	  the	   viral	   DNA	   to	   an	   intercalating	   fluorophore	   below	   pH5.5	   and	   by	   a	   facilitated	  dissociation	  of	  most	  capsid	  proteins	   from	  the	  viral	  genome	  (Wiethoff	  et	  al.,	  2005).	  	  According	   to	   this	   model,	   only	   hexons	   residing	   in	   the	   facets	   of	   the	   capsid	   remain	  bound	  to	  the	  viral	  genome	  after	  low	  pH	  exposure	  while	  the	  peripentonal	  hexon,	  the	  penton	  complex	  and	  protein	  VI	  dissociate	  from	  the	  virion	  to	  varying	  extents.	  	  These	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results	  contradict	  an	  earlier	  view	  of	  the	  interaction	  between	  hexon	  and	  protein	  VI,	  since	  hexon	  showed	  an	  increased	  affinity	  for	  protein	  VI	  in	  low	  pH	  incubation	  buffer	  during	  Blot	  Overlay	   experiments	  with	   a	  maximal	   affinity	   at	   pH5.5	   (Matthews	   and	  Russell,	   1994).	   	   Interestingly,	   below	   pH5.5	   hexon	   becomes	   susceptible	   to	   dispase	  proteolysis,	   which	   results	   in	   15kDa	   and	   85kDa	   cleavage	   products	   (Everitt	   et	   al.,	  1988).	   	   The	   15kDa	   fragment	   covers	   the	   amino-­‐terminal	   135	   to	   150	   residues	  including	  the	  NT	  domain	  and	  parts	  of	  the	  V1	  and	  DE1	  domains,	  which	  are	  involved	  in	  quartary	  structure	   formation	  of	   the	  hexon	  trimer	  (Rux	  et	  al.,	  2003).	   	  Antibodies	  raised	  against	  this	  15kDa	  fragment	  show	  strong	  adenovirus	  neutralizing	  capabilities	  (Varga	  et	  al.,	  1990).	  	  A	  predicted	  dispase	  cleavage	  site	  is	  on	  the	  amino-­‐terminal	  side	  of	  W135	  and	  therefore	  in	  the	  hinge	  sequence	  of	  HVR1	  of	  hexon	  containing	  an	  acidic	  stretch	   of	   residues	   (133–161)	  with	   16	   glutamate	   and	   4	   aspartate	   residues	   in	   the	  Ad2	  sequence	  (Rux	  and	  Burnett,	  2000).	  	  It	  has	  been	  speculated,	  that	  HVR1	  plays	  an	  important	   role	   in	   histone	   H1	   binding	   during	   passage	   of	   hexon	   and	   viral	   DNA	  through	  the	  NPC	  (Trotman	  et	  al.,	  2001).	  	  In	   addition	   to	   histone	   H1	   binding,	   hexon	   also	   interacts	   with	   Nup214	   and	  cytoplasmic	   dynein	   (Bremner	   et	   al.,	   2009;	   Trotman	   et	   al.,	   2001).	   	   	   Dynein	   can	   be	  structurally	   divided	   into	   a	   force	   generating	   head	   and	   a	   cargo	   binding	   tail	   region.	  	  The	  tail	  contains	  the	  accessory	  subunits	  intermediate	  chain	  (IC),	  light	  intermediate	  chain	  (LIC)	  and	  IC	  binding	  light	  chains	  (LC)	  (Figure	  1-­‐1).	  	  It	  has	  been	  shown,	  that	  IC	  and	  LIC1	  are	  responsible	  for	  motor	  recruitment	  to	  the	  viral	  capsid,	  presumably	  by	  forming	   a	   continuous	   binding	   surface	   for	   the	   hexon	   trimer	   (Bremner	   et	   al.,	   2009;	  Scherer	  and	  Vallee,	  2011).	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Here,	  we	  present	  data	  indicating	  a	  reversible	  subtle	  structural	  change	  within	  hexon	  at	   low	   pH,	   which	   changes	   the	   homotrimeric	   structure	   leading	   to	   SDS	   sensitive	  monomerization.	  	  Furthermore,	  we	  show	  that	  hexon-­‐IC	  binding	  can	  be	  controlled	  by	  the	  presence	  of	  LCs	  in	  vitro.	  	  	  	  4.1.2.	  Materials	  and	  Methods	  
Cells,	  Viruses,	  Plasmids,	  Molecular	  Methods,	  and	  Antibodies	  	  293A	  cells	  were	  grown	  in	  DMEM	  supplemented	  with	  10%	  FBS.	  Replication-­‐deficient	  Ad5	  engineered	  to	  express	  GFP	  (Ad5-­‐GFP,	  plaque-­‐purified;	  obtained	  from	  H.	  Young,	  Columbia	  University)	  were	  propagated	  in	  293A	  cells	  and	  purified	  by	  banding	  on	  two	  linear	   CsCl	   gradients	   (Lawrence	   and	   Ginsberg,	   1967)	   and	   dialysed	   against	   10%	  glycerol	  in	  PBS	  before	  cryo-­‐storage.	  	  Viral	  titer	  was	  obtained	  using	  fluorescent	  focus	  assays	  for	  Ad5-­‐GFP	  (Thiel	  and	  Smith,	  1967).	  	  Truncation	   constructs	   of	   GST-­‐tagged	   dynein	   intermediate	   chain	   2C	   and	   LC8	  were	  described	  earlier	  (McKenney	  et	  al.,	  2011).	  	  Bacterial	  expression	  constructs	  for	  TcTex	  and	  LC7	  from	  Sarah	  Weil	  (unpublished).	  	  	  Snapin	   was	   cloned	   form	   full-­‐length	   cDNA	   (Thermo	   Scientific)	   into	   the	   pGEX-­‐6p	  vector	   (GE	  Bioscience)	   by	   introducing	   5’	   	   BamHI	   and	  3’	   EcoRI	   restriction	   sites	   by	  PCR. 	  The	  additional	  C-­‐terminal	  FLAG-­‐tag	  was	  introduced	  during	  PCR.	  	  Mutations	  in	  the	  sequence	  and	  in-­‐frame	  cloning	  were	  tested	  for	  by	  sequencing.	  	  Antibodies	   used	   included	   mouse	   monoclonal	   anti-­‐hexon	   (Novocastra)	   and	   anti-­‐dynein	   IC	   (74.1,	   Chemicon),	   rabbit	   antibodies	   anti-­‐adenovirus5	   (Abcam),	   anti-­‐LC8	  (Santa	  Cruz),	  anti-­‐HA	  (Sigma),	  and	  anti-­‐TcTex	  (S.Weil,	  unpublished).	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Proteins	  and	  Biochemical	  Analysis	  Adenovirus	  hexon	  was	  either	  recovered	  from	  virus-­‐depleted	  supernatant	  of	  the	  first	  CsCl	   gradient	   by	   immunoprecipitation	   as	   described	   (Bremner	   et	   al.,	   2009)	   or	   by	  anion	  exchange	  chromatography	  (Waris	  and	  Halonen,	  1987).	  	  Hexon	   was	   incubated	   with	   a	   six-­‐fold	   molar	   excess	   of	   neutral	   protease	   (dispase;	  Worthington	  Biochemicals,	  Freehold,	  NJ)	  in	  dispase	  buffer	  (100mM	  Trizma-­‐maleate,	  120mM	  NaCl,	  2.5mM	  CaCl2),	  pH	  adjusted	  to	  either	  pH	  7.4	  	  (neutral)	  or	  pH4.4	  (acidic)	  for	  5min	  at	  37°C	  until	  the	  reaction	  was	  stopped	  either	  by	  addition	  of	  protein	  sample	  buffer	  or	  5mM	  EDTA.	  	  	  Sucrose	   gradient	   density	   centrifugation	   of	   hexon	   preparation	   was	   performed	   on	  linear	  5-­‐20%	  sucrose	  gradients	  with	  a	  total	  volume	  of	  1.4ml.	  	  Sucrose	  was	  dissolved	  in	  Tris-­‐maleate	  buffer	  (50	  mM	  Trizma-­‐maleate,	  10	  mM	  NaCl,	  1	  mM	  EDTA,	  and	  0.1%	  Tween	  20)	  at	  indicated	  pH	  values.	  Sample	  (100µL)	  was	  added	  on	  top	  and	  gradients,	  which	   were	   centrifuged	   for	   3h	   at	   54,000	   rpm	   in	   a	   TL-­‐	   55	   rotor	   at	   4°C	   and	  fractionated	   into	  14	  fractions	  of	  equal	  volume.	   	  Dynein	  (20S)	  and	  BSA	  (4.4S)	  were	  used	  as	  calibration	  standards.	  For	   time-­‐dependent	  SDS	  sensitivity	  assays,	  hexon	  was	  exposed	  to	  250mM	  Trizma-­‐maleate	   at	   indicated	   pH	   for	   30min	   on	   ice	   before	   protein	   sample	   buffer	   (final	  concentration:	   60mM	   TrisHCl,	   1.5%	   SDS,	   5%	   glycerol,	   0.1M	   DTT,	   20µg/ml	  bromphenol	   blue,	   pH6.8)	   was	   added	   for	   incubation	   at	   room	   temperature	   for	  indicated	  amount	  of	  time.	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Purification	  of	  dynein	  IC	  fragments	  and	  LC8	  were	  described	  earlier	  (McKenney	  et	  al.,	  2011).	   	   Briefly,	   purifications	  were	   performed	   following	   standard	   procedures	  with	  Ni+	  (Sigma-­‐Aldrich)	  in	  buffer	  A	  (30mM	  TrisHCl,	  150mM	  NaCl,	  5mM	  imidazole,	  5mM	  β-­‐Mercaptoethanol,	   pH7.4)	   supplemented	  with	   protease	   inhibitor	   cocktail	   (Sigma-­‐Aldrich),	   eluted	   with	   450mM	   NaCl	   and	   200mM	   imidazole,	   followed	   by	   buffer	  exchange	   into	   buffer	   A	   or	   glutathione	   (USB)	   beads	   in	   buffer	   B	   (10mM	   TrisHC,	  150mM	   NaCl,	   1mM	   EDTA,	   0.5mM	   DTT,	   pH7.4),	   and	   eluted	   with	   10mM	   reduced	  glutathione	  or	  digested	  with	  R3C	  protease	   to	   cleave	  off	  GST.	   	   Snapin	  was	  purified	  using	   glutathione	  beads	   and	  buffer	  B	   only.	   	   Purified	  proteins	  were	   flash	   frozen	   in	  liquid	  nitrogen	  and	  stored	  at	   -­‐80°C.	   	  Roadblock	  and	  TcTex	  protein	  was	  a	  generous	  gift	  of	  Sarah	  Weil.	  Hexon	   binding	   assays	   were	   described	   previously	   (Bremner	   et	   al.,	   2009).	   	   Briefly,	  hexon	  was	  immunoprecipitated	  and	  hexon	  beads	  were	  washed	  and	  incubated	  for	  30	  min	  in	  Tris-­‐maleate	  buffer	  (50	  mM	  Trizma-­‐maleate,	  10	  mM	  NaCl,	  1	  mM	  EDTA,	  and	  0.1%	  Tween	  20,	  pH	  4.4),	  washed	  in	  the	  same	  buffer	  at	  pH	  7.4,	  and	  then	  incubated	  with	   purified	   bacterially	   expressed	   dynein	   subunits	   at	   4°C	   for	   1.5	   hr.	   Following	  washing,	   the	   beads	   were	   analyzed	   for	   the	   presence	   of	   dynein	   polypeptides	   by	  Coomassie	  staining	  or	  immunoblotting.	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4.2.	  Results	  4.2.1.	  pH-­‐dependent	  Monomerization	  of	  Hexon	  Adenovirus	   capsids	   remain	   unaffected	   by	   extreme	   environmental	   conditions,	  maintaining	   their	   icosahedral	   structure	   even	   over	   pH4-­‐8	   from	   10°C	   to	   85°C	  (Rexroad	  et	  al.,	  2006).	  	  The	  most	  abundant	  adenovirus	  capsid	  protein	  hexon	  shows	  high	   structural	   complexity	   (Figure	   4-­‐1A)	   (Rux	   et	   al.,	   2003)	   but	   presumably	  represents	   the	  main	   factor	   ensuring	   structural	   capsid	   integrity	   and	   stays	  with	   the	  viral	  genome	  until	  its	  delivery	  into	  the	  nucleus	  (Greber	  et	  al.,	  1993;	  Wiethoff	  et	  al.,	  2005).	  	  Strikingly,	  low	  pH	  exposure	  of	  purified	  hexon,	  an	  effect	  reflecting	  endosomal	  passage	   during	   cell	   entry,	   primes	   the	   viral	   polypeptide	   for	   binding	   to	   the	  intermediate	   and	   light	   intermediate	   chains	   of	   cytoplasmic	   dynein	   (Bremner	   et	   al.,	  2009).	   	   This	   behavior	   can	   be	   explained	   by	   a	   low	   pH-­‐induced	   structural	   change	  exposing	   the	   dynein	   binding	   site.	   	   Purification	   of	   hexon	   trimers	   to	   a	   high	   degree	  (Figure	  4-­‐1B)	  allowed	  tests	  if	  low	  pH	  exposure	  affects	  hexon	  trimers	  leading	  to	  their	  monomerization,	  we	  incubated	  purified	  hexon	  (Figure	  4-­‐1C)	  over	  night	  in	  pH7.4	  or	  pH4.4	  buffer	  and	  prepared	  unboiled	  gel	  samples	  for	  SDS-­‐PAGE.	  We	  noticed,	  that	  the	  samples	   differed	   in	   their	   migration	   pattern,	   indicating	   changed	   electrophoretic	  characteristics.	   	  After	   low	  pH	   incubation	  hexon	  becomes	  monomeric	  while	  neutral	  pH	  does	  not	  affect	  the	  hexon	  trimer	  (Figure	  4-­‐1C)	  as	  previously	  reported	  (Fortsas	  et	  al.,	  1994).	  	  However,	  the	  monomerization	  could	  be	  induced	  either	  by	  acidic	  pH	  alone	  or	  by	  acidic	  pH	  treatment	  in	  combination	  with	  exposure	  to	  protein	  sample	  buffer.	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  Figure	  4-­‐1:	  Purified	  Hexon	  Reacts	  to	  Low	  pH.	  (A)	  X-­‐ray	  crystal	  structure	  of	  hexon	  trimer	  (PDB	  ID:	  1P30)	  with	  monomers	  colored	  in	  red,	  green,	  and	  blue	  and	  possible	  dispase	  hydrolysis	  site	  at	  W135	  in	  yellow.	  Side	  and	   top	   views	   are	   shown.	   	   Illustration	   was	   generated	   with	   PyMol.	   	   (B)	   MonoQ	  purified	   hexon	   from	   virus-­‐depleted	   infected	   293A	   lysate	   was	   poured	   over	   size	  exclusion	  column	  and	  protein	  levels	  were	  measured	  at	  280nm.	  	  One	  individual	  peak	  elutes	   at	   366kDa	   (theoretical	   trimer	   size:	   360kDa).	   Ferritin,	   BSA,	   and	   Ovalbumin	  were	   used	   as	   size	   standards.	   	   (C)	   Purified	   hexon	   was	   tested	   for	   monomerization	  after	  low	  pH	  treatment	  by	  incubation	  in	  protein	  sample	  buffer	  (PSB)	  over	  night	  and	  SDS-­‐PAGE	   of	   unboiled	   samples.	   	   Monomerization	   was	   detected	   on	   Coomassie-­‐stained	  gel	  for	  the	  pH4.4	  condition	  but	  not	  for	  pH7.4.	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Therefore,	  we	  tested	  if	  hexon	  monomerization	  occurs	  by	  low	  pH	  exposure	  alone	  and	  compared	   sedimentation	   coefficients	   of	   hexon	   on	   sucrose	   gradients	   poured	   with	  pH7.4	   or	   pH4.4	   buffers.	   	   Strikingly,	   independent	   of	   pH,	   hexon	   remains	   trimeric,	  sedimenting	  at	  12S	  (Figure	  4-­‐2A	  and	  B),	  as	  reported	  earlier	  (Velicer	  and	  Ginsberg,	  1970).	   	  Strikingly,	  unboiled	  hexon	  samples	  of	   the	   low	  pH	  gradient	  migrated	  at	   the	  monomeric	   size	   on	   the	   SDS-­‐PAGE	   gel,	   while	   neutral	   pH	   hexon	   samples	   remained	  trimeric.	  	  	  
	  Figure	  4-­‐2:	  Hexon	  Monomerization	  by	  Low	  pH	  and	  SDS.	  Purified	   hexon	   was	   tested	   for	   monomerization	   after	   low	   pH	   treatment	   by	  sedimentation	  on	   linear	  sucrose	  gradients	  (5-­‐20%)	  at	   (A)	  pH7.4,	   (B)	  pH4.4,	  or	   (C)	  pH7.4	   but	   hexon	  was	   boiled	   in	   1%	   SDS	   before	   loading	   on	   gradient.	   	   SDS-­‐PAGE	   of	  unboiled	   fraction	   samples	   and	   Coomassie-­‐stained	   gels	   show	   pH-­‐independent	  sedimentation	   coefficient	   for	   pH7.4	   and	   pH4.4	   conditions	   but	   monomerization	  induced	   by	   SDS	   at	   pH4.4.	   	   Boiling	   in	   SDS	   prior	   to	   sucrose	   gradient	   centrifugation	  leads	  to	  sedimentation	  profile	  of	  hexon	  monomers.	  	  T:	  trimer;	  M:	  monomer.	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These	  results	  indicate	  that	  acidification	  of	  hexon	  leads	  to	  subtle	  structural	  changes,	  which	   do	   not	   affect	   the	   trimeric	   hexon	   structure	   but	   manifests	   itself	   by	   strongly	  increased	  SDS-­‐sensitivity	  to	  monomerization.	  Since	   boiling	   of	   hexon	   in	   1%	   SDS	   at	   100°C	   prior	   to	   loading	   onto	   the	   gradient	   at	  neutral	   pH	   results	   in	   the	   sedimentation	   profile	   of	   the	   monomeric	   polypeptide	  (Figure	  4-­‐2C),	  it	  is	  plausible	  that	  the	  SDS-­‐containing	  protein	  sample	  buffer	  crucially	  contributes	  to	  acid-­‐induced	  hexon	  monomerization.	  To	   test	   the	   kinetics	   of	   SDS	   induced	   monomerization	   of	   acidified	   hexon,	   we	  investigated	   the	   time-­‐dependency	   of	   hexon	   monomerization	   after	   acidification.	  	  Hexon	   was	   incubated	   a	   low	   pH	   for	   30min	   and	   than	   treated	   with	   protein	   sample	  buffer	  for	  0-­‐25min	  before	  all	  samples	  were	  simultaneously	  loaded	  onto	  a	  SDS-­‐PAGE	  gel	  without	  prior	  boiling.	  Under	  these	  conditions,	  SDS	  sensitivity	  of	  acidified	  hexon	  is	  time-­‐dependent	  and	  full	  hexon	  monomerization	  occurs	  not	  before	  20	  min	  (Figure	  4-­‐3A).	  We	  also	   tested	   the	   reported	  effects	  of	  hexon	  acidification	  on	  dispase	  cleavage	  and	  furthermore	   on	   dispase	   cleavage	   inducing	   monomerization.	   	   Dispase	   proteolyses	  hexon	   into	   85kDa	   and	   15kDa	   digestion	   products	   only	   at	   pH4.4	   but	   not	   pH7.4	  confirming	  earlier	  results	  (Figure	  4-­‐3B;	  (Everitt	  et	  al.,	  1988)).	   	  Interestingly,	  hexon	  remains	   trimeric	   after	   low	   pH	   digest	   (Figure	   4-­‐3B),	   indicating	   that	   dispase	  proteolysis	   strongly	   inhibits	   SDS-­‐sensitivity	   of	   hexon	   after	   low	   pH	   treatment.	   In	  addition,	   these	   data	   indicate	   that	   the	   N-­‐terminal	   fragment	   removed	   by	   dispase	  treatment	  is	  an	  integral	  part	  of	  the	  core	  of	  the	  hexon	  trimer	  and	  cannot	  be	  clipped	  off	  to	  rest	  of	  the	  structure.	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  Figure	  4-­‐3:	  	  Hexon	  SDS-­‐Sensitivity	  Kinetics	  and	  Inhibition	  by	  Dispase	  Hydrolysis.	  (A)	   Kinetics	   of	   low	   pH-­‐induced	   hexon	   SDS-­‐sensitivity	   were	   tested	   after	   purified	  hexon	  was	  pH4.4	  treated	   for	  30min	  by	  protein	  sample	  buffer	  (PSB)	   incubation	   for	  indicated	  times	  durations	  and	  SDS-­‐PAGE	  of	  unboiled	  samples.	  	  Monomerization	  was	  detected	  as	  early	  as	  5min	  after	  the	  addition	  of	  PSB,	  a	  complete	  effect	  was	  seen	  after	  20min,	   indicating	   a	   gradual	   SDS	   effect.	   	   (B)	   Purified	   hexon	   was	   tested	   for	  monomerization	   after	   dispase	   treatment.	   	   Dispase	   hydrolyses	   hexon	   in	   low	   pH	  conditions	  resulting	  in	  two	  major	  digestion	  products	  (85kDa	  and	  15kDa)	  visible	  by	  Coomassie	   staining	   of	   SDS-­‐PAGE	   boiled	   samples.	   	   Unboiled	   samples	   show	   hexon	  trimers	   in	   the	   digested	   and	   undigested	   condition	   and	   no	   digestion	   products,	  indicating	  that	  the	  hexon	  trimer	  remains	  inact	  even	  after	  dispase	  hydrolysis	  and	  low	  pH	  treatment.	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Together,	   these	   results	   indicate	   that	   low	   pH	   treatment	   of	   hexon	   alone	   does	   not	  disrupt	  the	  trimeric	  structure	  but	  monomerization	  of	   the	  polypeptide	  requires	  the	  additional	   exposure	   to	   SDS	   and,	   for	   a	   full	   effect,	   SDS	   treatment	   needs	   to	   exceed	  20min.	  	  In	  addition,	  a	  likely	  site	  of	  subtle	  pH-­‐induced	  structural	  change	  in	  the	  hexon	  trimer	   surrounds	   a	   dispase	   proteolysis	   site	   N-­‐terminal	   of	   HVR1	   since	   dispase	  treatment	  inhibits	  SDS	  sensitivity.	  	  	  	  4.2.2.	  Reversible	  Monomerization	  We	  further	  asked	  if	  the	  effect	  of	  low	  pH	  and	  SDS-­‐induced	  monomerization	  could	  be	  reversed	  by	  raising	  the	  pH	  before	  addition	  of	  SDS.	  	  Therefore,	  we	  incubated	  purified	  hexon	   at	   pH4.4	   for	   30min	   on	   ice	   before	   subjecting	   it	   to	   sucrose	   density	   gradient	  centrifugation	  on	  a	  linear	  5-­‐20%	  gradient	  poured	  at	  pH7.4.	  	  As	  expected,	  hexon	  still	  sedimented	  at	  12S	  (Figure	  4-­‐4).	  	  Strikingly,	  unboiled	  gel	  samples	  run	  exclusively	  at	  hexon	   trimer	   size	   on	   SDS-­‐PAGE	   (Figure	  4-­‐4),	   revealing	   a	   complete	   reversal	   of	   the	  low	  pH	  induced	  effect.	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  Figure	  4-­‐4:	  Low	  pH-­‐induced	  Hexon	  SDS	  Sensitivity	  Is	  Reversible.	  Purified	  hexon	  was	  tested	  for	  reversibility	  of	  SDS-­‐sensitivity	  for	  monomerization	  by	  pH4.4	   treatment	   before	   sedimentation	   on	   linear	   sucrose	   gradients	   (5-­‐20%)	   at	  pH7.4.	  	  SDS-­‐PAGE	  of	  unboiled	  fraction	  samples	  and	  Coomassie-­‐stained	  gels	  show	  the	  sedimentation	   coefficient	   and	   SDS-­‐PAGE	   sedimentation	   of	   the	   trimeric	   hexon	  molecule	   indicating	   full	   reversibility	  of	   the	   low	  pH	  effect	   leading	   to	   increased	  SDS	  sensitivity.	  	  T:	  trimer;	  M:	  monomer.	  	  	  4.2.3.	  Hexon	  Binding	  to	  Dynein	  IC	  	  We	   also	   continued	   hexon	   binding	   screens	   with	   IC2C	   truncation	   constructs	  expressed	   in	   bacteria	   (McKenney	   et	   al.,	   2011)	   to	   elucidate	   the	   minimal	   binding	  region	   for	  hexon	  and	  possible	  overlap	  with	   the	  dynein	  regulatory	   factors	  dynactin	  and	   NudE/EL	   which	   both	   seem	   to	   interact	   with	   the	   N-­‐terminal	   70	   residues	  (McKenney	   et	   al.,	   2011).	   	   Interestingly,	   only	   the	   1-­‐250	   construct	   interacted	   with	  hexon	   whereas	   the	   1-­‐150	   and	   shorter	   fragments	   did	   not	   pull-­‐down	   significant	  amounts	  (Figure	  4-­‐5A	  and	  B).	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  Figure	  4-­‐5:	  Hexon	  Binding	  to	  Dynein	  Intermediate	  Chain.	  (A)	  MonoQ	  purified	  and	  acidified	  hexon	  was	  tested	  in	  pull-­‐down	  experiments	  with	  bacterially	   expressed	   GST-­‐tagged	   truncation	   constructs	   covering	   the	   N-­‐terminal	  part	  of	  the	  dynein	  IC2C.	  	  The	  hexon	  binding	  site	  could	  be	  mapped	  to	  IC	  residues	  150-­‐250.	   	   (B)	  Diagram	  of	   the	  dynein	   IC	  with	  binding	  sites	   for	   light	  chains	   (TcTex,	  LC8,	  LC7),	  dynactin,	  snapin,	  and,	  dynein	  heavy	  chain	  and	  the	  IC-­‐IC	  dimerization	  domain.	  	  The	   hexon	   binding	   region	   overlaps	  with	   the	   reported	   snapin	   binding	   site	   but	   not	  dynactin	  or	  NudE.	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Furthermore,	   the	   IC-­‐hexon	   interaction	   could	   be	   modulated	   by	   the	   addition	   of	  different	   classes	   of	   light	   chains.	   Roadblock/LC7	   reduced	   the	   amount	   of	   IC	   in	   the	  hexon	   pellet	   (Figure	   4-­‐6A	   and	   C),	   whereas	   LC8	   and	   TcTex-­‐1	   increased	   it	   in	   an	  additive	   fashion	   (Figure	   4-­‐6B	   and	   C).	   	   Importantly,	   none	   of	   the	   light	   chains	   by	  themselves	  bind	  to	  hexon	  ((Bremner	  et	  al.,	  2009),	  and	  Figure	  2-­‐1C).	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Figure	  4-­‐6:	  Light	  Chains	  Affect	  Hexon	  -­‐	  IC	  Binding.	  Bacterially	  expressed	  dynein	  light	  chains	  were	  tested	  for	  affecting	  the	  affinity	  of	  the	  IC2C	  fragment	  1-­‐250	  to	  hexon	  by	  addition	  of	  IC	  fragment	  with	  (A)	  roadblock/LC7	  or	  (B)	  HA-­‐TcTex	   and	   Flag-­‐LC8	   separately	   or	   combined	   to	   the	   hexon	   pull-­‐downs	   and	  immunoblotting	  of	   inputs	   (panel	  A)	   and	  pellets	   (panels	  A	   and	  B)	  with	   anti-­‐hexon,	  anti-­‐IC,	   anti-­‐LC7,	   and	   anti-­‐tag	   antibodies.	   	   (C)	   Quantification	   of	   hexon-­‐bound	   IC	  fragment	  shows	  that	  LC7	  has	  an	  inhibitory	  effect	  on	  the	  hexon	  affinity,	  reducing	  the	  amount	  of	   interacting	   IC	   fragment	  by	  ~30%,	  whereas	  TcTex	  and	  LC8	   increase	   the	  affinity	  by	  up	  to	  45%.	  	  Since	  hexon	  does	  not	  interact	  within	  the	  N-­‐terminal	  70	  residues	  of	  the	  IC,	  it	  remains	  possible	   that	   dynein	   regulators	   and	   the	   viral	   capsid	   bind	   to	   the	   motor	   complex	  simultaneously.	  	  Interestingly,	  antibodies,	  which	  interfere	  with	  dynein-­‐dynactin	  and	  dynein-­‐NudE	   binding	   (McKenney	   et	   al.,	   2011)	   do	   not	   affect	   the	   dynein-­‐hexon	  interaction	   (Bremner	   et	   al.,	   2009).	   	   However,	   recently,	   a	   small	   protein	   of	   the	  lysosomal	  pathway,	   snapin,	  was	   shown	   to	   interact	  with	   the	   IC	  108-­‐268	   (Cai	   et	   al.,	  2010),	   similar	   to	   the	   hexon	   binding.	   	   We	   conducted	   competition	   experiments	  between	  snapin	  and	  hexon	  and	  saw	  a	  reduction	  of	  dynein	  signal	   in	   the	  anti-­‐hexon	  coimmunoprecipitates	   if	   snapin	  was	  added	  compared	   to	   the	   snapin	   free	   condition	  indicative	  of	  overlapping	  binding	  sites	  of	  hexon	  and	  snapin	  in	  the	  IC	  (Figure	  4-­‐7).	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  Figure	  4-­‐7:	  Lysosomal	  Dynein	  Recruitment	  Factor	  Snapin	  Competes	  With	  Hexon	  for	  Dynein.	  (B)	  Purified	  rat	  brain	  cytoplasmic	  dynein	  was	  tested	  for	  pull-­‐down	  with	  hexon	  in	  the	  presence	   of	   bacterially	   expressed	   snapin	   by	   immunoblotting	   of	   the	   supernatants	  and	  pellets	  with	  antibodies	  against	  hexon,	  snapin,	  and	  dynein	  IC	  and	  LIC1	  subunits.	  	  Snapin	  strongly	  reduced	  sedimentable	  dynein,	  as	  indicated	  by	  a	  loss	  of	  IC	  and	  LIC1	  signal.	   	   (B)	   Snapin	   was	   tested	   for	   pull-­‐down	   with	   IC2C	   1-­‐250	   fragment	   in	   the	  presence	   of	   dynein	   IC	   binding	  proteins	   p150Glued-­‐CC1,	  NudE,	   and	  74.1	  monoclonal	  antibody	   (IC	   mAb)	   by	   Coomassie	   staining	   of	   SDS-­‐PAGE	   gel.	   	   None	   of	   the	   tested	  binding	  partners	  reduced	  the	  amount	  of	  pull-­‐down	  snapin,	   indicating	   independent	  IC	  binding	  sites.	  	  All	  proteins	  expressed	  in	  bacteria.	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These	   results	   demonstrate	   a	   further	   interaction	   between	   the	   dynein	   complex	   and	  the	   major	   adenoviral	   capsid	   protein	   hexon	   in	   additional	   to	   LIC1	   (chapter	   2.2.1.).	  	  The	   described	   hexon-­‐IC	   interaction	   can	   be	   modulated	   by	   the	   presence	   of	   dynein	  light	   chains	   and	   is	   sensitive	   to	   competition	   with	   the	   small	   lyso/LE	   associated	  protein	  snapin.	  	  	  	  
4.3.	  Discussion	  4.3.1.	  pH	  Effects	  on	  Hexon	  Tertiary	  Structure	  	  The	  results	  presented	  here	  indicate	  a	  reversible,	  subtle	  but	  reproducible	  structural	  effect	   of	   low	  pH	   exposure	   on	   the	   hexon	   trimer.	   	  We	   can	   only	   speculate,	   if	   the	   pH	  effects	   obtained	   with	   purified	   hexon	   are	   representative	   of	   structural	  rearrangements	  of	  capsid-­‐associated	  hexon	  (Figure	  4-­‐8).	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Figure	  4-­‐8:	  	  Model	  of	  pH-­‐Sensitive	  Hexon	  Monomerization	  upon	  SDS	  Treatment.	  Diagram	  illustrating	  different	  structural	  states	  of	  the	  hexon	  trimer	  dependent	  on	  pH	  leading	   to	  SDS	  sensitivity.	   	  The	  hexon	   trimer	  at	  neutral	  pH	  (purple)	   is	   resistant	   to	  SDS	   and	   remains	   monomeric	   after	   addition	   of	   1%	   SDS.	   	   Acidified	   hexon	   (green)	  maintains	   the	   trimeric	   state.	   	  However,	   low	  pH	   treatment	   induces	   subtle	   changes,	  which	   lead	   to	   strongly	   increased	   dynein	   affinity	   (Bremner	   et	   al.,	   2009)	   and	   SDS	  sensitivity	  resulting	   in	  monomerization	  but	  which	  can	  be	   fully	  reversed	  by	  raising	  the	  pH.	  	  	  However,	   interestingly,	   the	  reported	  pH-­‐dependent	  structural	  change	   in	  the	  hexon	  trimer,	  which	  appears	   to	  unmask	  a	  dispase	  hydrolysis	   site	   at	   low	  pH,	  presumably	  affects	  the	  external	  loop	  sequence	  HVR1	  (Everitt	  et	  al.,	  1988).	  	  This	  rearrangement	  is	   possible	   in	   the	   individual	   hexon	   trimer	   and	   also	   in	   capsid-­‐associated	   hexons	  (Everitt	   et	   al.,	   1988).	   Hence,	   it	   is	   very	   likely	   that	   the	   low	   pH	   effect	   leading	   to	  increased	  SDS	  sensitivity	  represents	  a	  structural	  change	  possible	  in	  free	  and	  capsid-­‐incorporated	  hexon	   trimers,	   as	  well.	   	   Furthermore,	   low	  pH	  exposure	  also	   leads	   to	  increased	  hydrophobicity	  of	  the	  viral	  capsid	  and	  capsid	  proteins	  (Seth	  et	  al.,	  1985).	  	  The	  effect	  is	  maximal	  at	  pH<5.5	  and	  reversible	  by	  addition	  of	  pH7	  buffer	  (Seth	  et	  al.,	  1985).	   	   Of	   note,	   hydrophobicity	   effects	   on	   hexon	   are	   pronounced	   after	   low	   pH	  dispase	   cleavage	   (Everitt	   et	   al.,	   1988).	   	   At	   this	   point,	   however,	   it	   remains	   to	   be	  shown	   if	   effects	   of	   low	   pH	   exposure	   leading	   to	   increases	   in	   dynein	   binding,	  hydrophobicity,	   and	   dispase-­‐	   and	   SDS-­‐sensitivity	   have	   separate	   or	   distinct	  molecular	   causes	   in	   the	   hexon	   structure.	   	   Nevertheless,	   hexon	   HVR1	   and	  surrounding	   sequences	   emerge	   as	   a	   likely	   candidate	   region	   of	   the	   polypeptide	  mediating	   the	   reported	   low	   pH	   effects	   since	   dispase	   treatment	   strongly	   reduced	  low-­‐pH	   induced	   SDS	   sensitivity.	   	  HVR1	   represents	   the	  N-­‐terminal	   part	   of	   the	  DE1	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domain,	  which	  connects	   the	  two	  halves	  of	   the	  viral	   jellyroll	  domain	  V1	  and	  covers	  large	   portions	   of	   the	   external	   hexon	   surface.	   	   It	  would	   be	   interesting	   to	   test	   cells	  expressing	  DE1	  for	  binding	  between	  this	  hexon	  fragment	  and	  dynein	  or	  for	  possible	  effects	  on	  virus	  motility.	  	  	  	  4.3.2.	  Role	  in	  Virus	  Transport	  During	   regular	   adenovirus	   infection,	   capsid	   acidification	   occurs	   while	   the	   capsid	  passages	   through	   the	   endosome.	   	   The	   effects	   on	   infectivity	   remain	   under	   debate	  (Smith	  et	  al.,	  2010b),	  but	  several	  lines	  of	  evidence	  indicate	  that	  fitness	  is	  increased	  for	   subgroup	   C	   adenoviruses	   by	   low	   pH	   priming	   inside	   the	   endocytic	   vesicle.	  	  Endosomalysis,	  dynein	  binding,	  and	  efficient	  microtubule-­‐based	   transport	  seem	  to	  require	  low	  pH	  exposure	  of	  the	  capsid	  (Bremner	  et	  al.,	  2009;	  Wiethoff	  et	  al.,	  2005).	  	  Interestingly,	   two	   dynein	   subunits,	   which	   have	   both	   been	   implicated	   in	   cargo	  binding,	  also	  mediate	  the	  interaction	  with	  adenovirus	  hexon	  (Bremner	  et	  al.,	  2009).	  	  Dynein	   light	   intermediate	   chain	   1	   (LIC1)	   appears	   to	   be	   the	   dominant	   binding	  partner	  but	  intermediate	  chain	  (IC)	  also	  contributes	  to	  the	  interaction	  (see	  chapter	  2.2.1	  and	  4.2.3.).	   	   IC	  alone	  can	  bind	   to	  acidified	  hexon	  but	   the	  affinity	  seems	  to	  be	  increased	   in	   the	   presence	   of	   the	   dynein	   light	   chains	   LC8	   and	  TcTex-­‐1.	   	   Both	   light	  chains	   have	   been	   implied	   in	   cargo	   recruitment	   (Table	   1-­‐1),	   but	   they	   show	   no	  interaction	   with	   hexon	   (Bremner	   et	   al.,	   2009)	   and	   Figure	   2-­‐1C).	   	   This	   implies	  indirect	  effects	  of	   the	  LCs	  on	  hexon	  binding	  by	  structurally	  modulating	  IC.	   	   In	   fact,	  LC8	   and	   TcTex-­‐1	   have	   been	   found	   to	   function	   in	   structural	   stabilization	   and	  dimerization	  of	   the	   IC	   (Barbar,	  2008;	  Makokha	  et	   al.,	   2002;	  Williams	  et	   al.,	   2007).	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Trapping	   experiments	   to	   sequester	   LCs	   from	   the	   dynein	   complex	   have	   effects	   on	  cargo	  transport	  and	  mitosis	  (Varma	  et	  al.,	  2010).	  	  Hence,	  it	  is	  conceivable	  that	  upon	  LC8	  and	  TcTex-­‐1	  binding,	  the	  conformation	  of	  IC	  is	  altered	  to	  a	  state	  more	  favorable	  for	  hexon	  binding,	  inducing	  IC-­‐IC	  dimerization	  and	  increasing	  stability.	  	  The	  role	  of	  the	  third	  class	  of	  dynein	   light	  chains,	  Roadblock/LC7,	   is	   less	  understood	  (Bowman	  et	  al.,	  1999).	  	  They	  are	  also	  implied	  in	  cargo	  recruitment	  but	  seem	  to	  be	  less	  crucial	  for	  IC-­‐IC	  dimerization.	   	  Their	  mode	  of	  interaction	  with	  the	  IC	  also	  differs	  from	  LC8	  and	   TcTex,	  which	   act	   like	   a	  molecular	   clamp,	   bringing	   two	   IC	  monomers	   in	   close	  contact.	  	  Roadblock/LC7,	  however,	  is	  binding	  between	  two	  IC	  monomers,	  increasing	  their	  distance	   (Hall	   et	   al.,	   2010;	   Song	  et	   al.,	   2005).	   	  Therefore,	   the	  here	  presented	  reduction	   in	   IC	  affinity	   for	  hexon	  by	  addition	  of	  Roadblock/LC7	  might	  be	  due	   to	  a	  disruption	   of	   the	   hexon	   binding	   site	   or	   similarly	   is	   due	   to	   competition	   between	  hexon	  and	  Roadblock/LC7	  for	  IC	  binding.	  	  We	  detected	   competition	   for	   the	   dynein	   IC	   between	  hexon	   and	   snapin.	   	   Snapin	   is	  reported	   to	   associate	   with	   lysosomes	   and	   late	   endosomes	   (Cai	   et	   al.,	   2010)	   and	  functions	  by	  dynein	   recruitment	   to	   these	  organelles	   via	   a	  direct	   IC	   interaction.	   	   It	  remains	   to	   be	   tested,	   if	   snapin	  might	   also	  have	   additional	   regulatory	   control	   over	  the	  dynein	  complex.	  	  Hence,	  hexon	  might	  not	  only	  replace	  snapin	  on	  the	  IC	  sterically,	  recruiting	  more	  dynein	  from	  a	  lysosome/late	  endosome	  associated	  motor	  pool,	  but	  also	  bind	  to	  a	  critical	  functional	  element	  in	  the	  dynein	  motor	  complex.	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CONCLUSIONS	  
	  The	  here	  presented	  work	  combines	  research	  in	  two	  fields,	  motor	  proteins	  and	  host-­‐pathogen	  interactions.	  	  It	  reveals	  how	  MT-­‐dependent	  motor	  processes	  play	  a	  pivotal	  role	  in	  virus	  attack	  and	  cellular	  host	  defense.	  Our	  data	  connects	   the	  effects	  of	  adenovirus	  stimulated	  PKA	  activity	  on	  MT	  minus-­‐end	  directed	  transport	  with	  a	  specific	  role	  of	  dynein	  LIC1-­‐T213	  in	  recruitment	  of	  the	  motor	   complex	   to	   the	   viral	   capsid.	   	   This	   has	   implications	   on	   the	   future	   design	   of	  adenovirus	  based	  gene	  vectors,	  which	  should	  keep	  their	  ability	  to	  induce	  a	  cellular	  PKA	  response	   to	  ensure	  efficient	  capsid	   transport	   to	   the	  nucleus	   to	  maintain	   their	  infectivity.	  	  Furthermore,	  we	  have	  determined	  the	  independent	  hexon	  binding	  sites	  within	   the	   dynein	   IC	   and	   LIC1	   polypeptides.	   	   In	   contrast,	   the	   parts	   of	   hexon	  interacting	  with	  the	  dynein	  subunits	  are	  still	  unknown.	  	  Testing	  recombinant	  hexon	  fragments	   for	   IC	   or	   LIC1	   bindig	   might	   give	   additional	   insight	   in	   the	   molecular	  mechanism	   of	   capsid	   –	   motor	   binding.	   	   We	   suspect	   flexible	   surface	   loops	   of	   the	  trimeric	   hexon	   structure	   to	  mediate	   the	   interaction.	   	   Unfortunately,	   none	   of	   them	  could	   be	   resolved	   in	   x-­‐ray	   crystallographic	   studies	   and	   structural	   information	   on	  possible	  pH-­‐dependent	  reorientations	  is	  lacking	  at	  this	  time	  as	  well.	  	  Another	  caviat	  of	   the	   use	   of	   hexon	   fragments	   is	   the	   closely	   packed	   structure	   of	   the	   full-­‐length	  polypeptide.	   	   Presumably,	   hexon	   fragments	   will	   most	   likely	   fail	   to	   fold	   properly	  leaving	   them	   of	   limited	   use.	   	   Another	   possibility	   is	   proteolytic	   digest	   of	   purified	  hexon	   at	   specific	   hydrolysis	   sites.	   	   It	   should	   be	   possible	   to	   extract	   parts	   from	   the	  hexon	   structure,	   isolate	   and	  purify	   them,	   and	   test	   them	   in	  dynein	   IC	  or	  LIC1	  pull-­‐
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downs.	  	  Good	  protease	  candidates	  recognize	  a	  limited	  number	  of	  hydrolysis	  sites	  in	  hexon	   such	   as	   trypsin	   or	   dispase.	   	   It	   would	   be	   interesting	   to	   test	   additional	  proteases	  in	  hexon	  digests	  and	  to	  identify	  their	  affinity	  to	  dynein	  subunits.	  	  	  An	  additional	  method	  to	  determine	  IC	  and	  LIC1	  binding	  regions	  in	  hexon	  is	  cryoEM	  using	   purified	  Ad	   capsid	   either	   alone	   or	   pre-­‐incubated	  with	   fragements	   of	   dynein	  subunits.	   	   Additional	   protein	   mass	   might	   indicate	   the	   localization	   of	   capsid-­‐interacting	  proteins	  as	  has	  been	  done	  with	  defensins	  (Smith	  et	  al.,	  2010a).	  In	  addition	   to	   facilitating	  smarter	  Ad	  vector	  design	  by	  keeping	   the	  dynein	  binding	  parts	   of	   hexon	   intact,	   this	   information	   can	   also	   be	   used	   to	   develop	   hexon-­‐based	  peptides	  that	  block	  the	  capsid	  –	  motor	  interaction	  specifically	  and	  might	  prevent	  Ad	  infection	   in	   a	   post-­‐entry	   step.	   	   Similarly,	   using	   fragements	   of	   IC	   or	   LIC1,	   which	  contain	   the	   hexon	   binding	   site,	  might	   also	   lead	   to	   a	   post-­‐entry	   block	   of	   infection.	  	  However,	   this	   approach	   presumably	   results	   in	   less	   specific	   effects,	   since	  physiological	  dynein	  interacting	  proteins	  are	  known	  to	  compete	  with	  hexon	  for	  the	  same	  dynein	  binding	  sites	  and	  might	  also	  be	  affected.	  	  	  	  Intracellular	   adenovirus	   transport	   might	   serve	   as	   a	   model	   system	   for	   various	  reported	  characteristics	  of	  MT-­‐based	  motility	  of	  physiological	  cargos.	  Intruigingly,	  Ad	  also	  moves	  in	  a	  bidirectional	  fashion	  and	  the	  work	  presented	  here	  indicate	   independent	   recruitment	   of	   the	   opposite	   polarity	   motors	   cytoplasmic	  dynein	  and	  kinesin.	   	  Hence,	   the	  Ad	  capsid	  might	  emerge	  as	  an	   ideal	  pseudo-­‐cargo	  studying	   transport	   processes	   at	   the	   single	  molecule	   level	  with	   high	   temporal	   and	  special	  resulution	  inside	  living	  cells.	  	  At	  this	  point,	  more	  and	  more	  evidence	  emerges	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that	   opposite	   polarity	   motors	   coordinate	   their	   activity	   not	   only	   through	   a	  mechanical	  tug-­‐of-­‐war.	   	  Possible	  regulatory	  mechanisms	  such	  as	  signaling,	  binding	  of	  regulatory	  factors,	  or	  MT	  track	  based	  phenomena	  might	  be	  easier	  to	  study	  using	  Ad	   which	   gives	   a	   distinct	   bright	   fluorescent	   signal	   without	   any	   concerning	  background	  than	  using	  endogenous	  cargo.	  The	  role	  of	  MT	  in	  bidirectional	  transport	  has	  been	  addressed	  only	  inadequately.	  	  We	  can	   see	   several	   Ad	   tracking	   along	   the	   same	   linear	   part	   during	   entry	   in	   short	  temporal	  succession,	  which	  might	  indicate	  the	  preferred	  use	  of	  particular	  MT	  inside	  the	  cell.	  	  It	  would	  be	  interesting	  to	  elucidate	  the	  specific	  characteristics	  of	  these	  MT,	  if	  they	  are	  more	  dynamic	  or	  more	  stable,	  their	  role	  in	  Ad	  transport	  and	  possibly	  the	  general	  role	  of	  MT	  stability	  in	  intracellular	  transport	  procceses.	  	  	  Furthermore,	   the	   binding	   of	   regulatory	   factors	   might	   determine	   the	   bidirectional	  behavior	  of	  cargo	  transport.	  	  We	  and	  others	  have	  shown	  that	  Ad	  relies	  on	  the	  dynein	  regulatory	  complex	  dynactin	  for	  cytoplasmic	  motility	  but	  not	  NudE,	  Lis1,	  or	  ZW10.	  	  This	  makes	  Ad	  transport	  a	  reasonable	  model	   for	  dynactin-­‐regulated	  transport	  and	  therefore	  dynactin	  function	  in	  vivo.	  	  For	  instance,	  it	  is	  still	  under	  debate,	  what	  roles	  the	   different	   parts	   of	   dynactin-­‐p150Glued	   play	   in	   dynein	   mediated	   motility.	   	   It	   is	  unknown	  if	  the	  p150Glued	  MT	  binding	  site	  is	  active	  during	  runs	  and	  if	  it	  contributes	  to	  increased	  dynein	  processivity.	  	  Another	  unanswered	  question	  represents	  the	  dynein	  recruitment	   mechanism	   to	   cargo	   before	   runs	   and	   if	   dynactin	   might	   also	   act	   as	   a	  loading	   station.	   	   Furthermore,	   is	   the	   minimal	   p150Glued	   binding	   region	   with	   the	  dynein	  IC,	  p150Glued-­‐CC1,	  able	  to	  regulate	  dynein	  by	  itself	  or	  are	  additional	  parts	  of	  the	  dynactin	  complex	  reguired	  for	  its	  complete	  function.	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In	  addition,	  it	  would	  be	  interesting	  the	  visualize	  co-­‐localization	  and	  co-­‐transport	  of	  fluorescently	   tagged	  dynein	  regulators	  with	   the	   incoming	  capsid.	   	  Stable	  cell	   lines,	  constitutively	   expressing	   GFP-­‐tagged	   kinesin,	   dynein,	   or	   dynactin	   subunits	   and	  additional	   dynein	   regulators	   at	   low	   levels,	   might	   indicate	   a	   dynamic	   presence	   of	  motors	  or	  regulators	  at	  the	  viral	  capsid	  during	  or	  in	  between	  runs.	  	  	  Importantly,	   results	   presented	   above	   indicate	   that	   dynein-­‐based	   Ad	   motility	   is	  dependent	   on	   stimulated	  PKA	  activity,	  which	   facilitates	  dynein	   recruitment	   to	   the	  capsid	   and	   hence	   links	   Ad	   transport	   to	   established	   models	   of	   PKA-­‐regulated	  transport	   systems	   such	   as	   melanosome	   movements	   in	   pigment	   cells.	   	   Here,	  increased	   PKA	   activity	   leads	   to	  melanosome	   dispersal	   and	   it	   has	   been	   postulated	  that	  an	  increase	  in	  kinesin	  run-­‐length	  is	  responsible	  for	  this	  effect.	  However,	  dynein	  effects	   regarding	  possible	   cargo	   recruitment	  mechanisms,	   as	   seems	   to	  be	   the	   case	  with	   the	   Ad	   capsid,	   cannot	   be	   ruled	   out.	   	   To	   our	   surprise,	   we	   also	   found	  lysosomes/late	  endosomes	  (lyso/LE)	  to	  be	  affected	  be	  Ad	  entry	  in	  a	  PKA	  dependent	  fashion.	   	   Lyso/LE	   disperse	   through	   the	   cytoplasm	   upon	   Ad5	   infection	   or	   PKA	  stimulation,	   leading	   to	   strong	   peripheralization	   within	   30-­‐60	   minutes.	   	   For	   both	  transport	   systems,	   Ad	   capsid	   and	   lyso/LE,	   we	   were	   able	   to	   identify	   the	   same	  conserved	  PKA	  site,	  LIC1-­‐T213,	  to	  mediate	  these	  effects.	  	  Hence,	  LIC1-­‐T213	  becomes	  an	  intruiging	  candidate	  to	  be	  tested	  in	  established	  PKA	  regulated	  transport	  systems	  and	   might	   reveal	   a	   role	   of	   dynein	   recruitment	   to	   other	   classes	   of	   organelles	  dependent	  on	  LIC1	  phosphorylation	  by	  PKA.	  	  	  If	  PKA	  activity	  represents	  a	  general	  mechanism	  for	  bidirectional	  transport	  remains	  to	  be	  elucidated.	  	  However,	  given	  the	  rather	  slow	  response	  time	  to	  external	  cues	  like	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Ad5	   binding	   or	   forskolin	   treatment	   and	   a	   rather	   gradual	   effect	   on	   lysosome	  redistribution	   in	   the	   course	   of	   several	   minutes,	   might	   indicate	   that	   bidirectional	  transport	   is	  regulated	  by	  different	  means,	  since	  reversals	  occur	  on	  the	  millisecond	  time	  scale.	  	  	  Questions	   more	   specific	   to	   Ad	   motility,	   but	   maybe	   also	   general	   cytoplasmic	  pathogen	   movements	   evolve	   around	   the	   function	   of	   kinesin	   during	   entry.	  	  Continuing	  our	  studies	  to	  elucidate	  the	  identity	  of	  the	  MT	  plus	  end-­‐directed	  motor	  should	  give	  inside	  into	  whether	  it	  functions	  as	  part	  of	  the	  host	  defense	  machinery	  or	  is	   part	   of	   the	   viral	   attack	   and	   required	   for	   rapid	   nuclear	   targeting	   of	   adenoviral	  capsids.	   	   To	   this	   end,	   we	   will	   employ	   dominant-­‐negative	   constructs	   disrupting	  known	   kinesin	   –	   cargo	   interactions	   and	   kinesin	   targeting	   RNAi.	   	   However,	   the	  complex	   nature	   of	   the	   kinesin	   family	   and	   the	   possibility	   of	   additional	   familiy	  members	  substituting	  for	  the	  preferred	  capsid-­‐trasnporting	  kinesin,	  might	  hamper	  a	  rapid	   identification	   process.	   	   However,	   the	   here	   presented	   biochemical	   evidence	  indicates	   that	   kinesin-­‐1	   is	   a	   very	   likely	   candidate	   in	   Ad	   motility	   and	   that	   cell	  biological	  efforts	  should	  focus	  on	  this	  motor	  protein.	  	  We	  here	  show	  that	  a	  sub-­‐viral	  particle	   consisting	   of	   penton	   base	   and	   fiber,	   penton	   dodecahedron	   (Pt-­‐Dd),	   can	  enter	  cells	  and	  exhibits	   fast	   linear	  movements.	   	   It	   is	  unclear,	  however,	   if	   the	  Pt-­‐Dd	  can	  escape	  the	  endo-­‐lysosomal	  pathway,	  but	  given	  their	  affinity	  for	  kinesin-­‐1	  even	  microinjected	  particles	  should	  move	   inside	  cells.	   	  MT	  plus	  end	  directed	  motility	  of	  Pt-­‐Dd	   or	   dedocahedra	   consisting	   of	   penton	   base	   exclusively	   would	   be	   a	   strong	  indication	  that	  penton	  base	  represents	  a	  functional	  link	  between	  the	  Ad	  capsid	  and	  the	  MT	  plus	  end	  motor.	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We	   also	   further	   investigated	   the	   low	   pH-­‐effect	   on	   the	   capsid	   protein	   hexon.	   	  We	  identified	  a	  subtle	  structural	  change	  upon	  low	  pH	  treatment	  which	  con	  be	  visualized	  by	  increased	  SDS	  sensitivity	  leading	  to	  hexon	  monomerization.	  	  The	  SDS	  sensitivity	  increase	  is	  relatively	  slow,	  occuring	  over	  several	  minutes	  at	  room	  temperature,	  and	  reversible,	  since	  pH	  neutralization	  reverses	  hexon	  into	  its	  SDS	  insensitive	  state.	   	   It	  would	  be	  interesting	  to	  see,	  if	  the	  here	  described	  effects	  are	  also	  possible	  for	  capsid	  associated	  hexon	   trimers	  or	   if	   the	   tightly	  packed	  arrangement	   in	   the	  capsid	   facets	  restricts	  possible	  structural	  changes.	  	  We	  assume,	  that	  a	  surface	  loop	  is	  responsible	  for	   the	   effect,	   which	   should	   also	   be	   exposed	   in	   capsid	   associated	   hexons.	  	  Furthermore,	   of	   the	   known	   low	   pH	   effects	   on	   hexon	   -­‐	   increased	   hydrophobicity	  (Seth	   et	   al.,	   1985),	   increased	   dispase	   sensitivity	   (Varga	   et	   al.,	   1990),	   increased	  dynein	  binding	  (Bremner	  et	  al.,	  2009),	  increased	  SDS	  sensitivity	  to	  monomerization	  (this	   work)	   -­‐	   we	   can	   now	   link	   two.	   	   Low	   pH	   dispase	   proteolysis	   inhibits	   SDS	  sensitivity	  to	  monomerization.	  	  It	  is	  possible	  that	  additional	  low	  pH	  effects	  are	  also	  linked	  to	  the	  same	  structural	  feature	  of	  the	  hexon	  trimer,	  the	  hypervariable	  region	  1	  (HVR1).	  Besides	  determining	  the	  kinetics	  of	  hexon	  monomerization	  after	  shorter	  and	  shorter	  low	  pH	  treaments	  it	  would	  also	  be	  interesting	  to	  investigate	  low	  pH	  effects	  on	  hexon	  of	   additional	   Ad	   serotypes.	   	   Ad3,	   for	   instance,	   remains	   in	   the	   endo-­‐lysosomal	  pathway	  for	  multilple	  hours,	  which	  might	  be	  explained	  by	  a	  decreased	  pH	  sensitivity	  of	  Ad3	  hexon	  and	  therefore	  a	  more	  rigid	  capsid	  structure,	  preventing	  the	  exposure	  of	  protein	  VI	   into	   the	  endo-­‐lysosomal	   lumen	  and	  ultimately	  endosomalysis.	   	  Other	  Ad40	  and	  Ad41	  enter	  their	  host	  organism	  through	  the	  gastrointestinal	   tract,	  being	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exposed	  to	  a	  low	  pH	  environment	  before	  cell	  attachement.	   	  It	  would	  be	  interesting	  to	  see	  if	  Ad40	  or	  Ad41	  hexon	  exhibits	  a	  different	  pH	  sensitivity	  than	  Ad5	  hexon.	  Furthermore,	  more	  and	  more	  viruses	  and	  additional	  pathogens	  have	  been	  reported	  to	   require	   a	   post-­‐attachment	   low	   pH	   step	   for	   optimal	   infectivity.	   	   The	  work	   here	  implies	   that	   the	   rather	   vague	   requirement	   for	   low	   pH	   can	   be	   specified	  mechanistically	   to	   a	   small	   number	   of	   proteins	   or	   even	   an	   individual	   polypeptide.	  Identification	  of	  the	  crucial	  pH	  sensors	  in	  further	  pathogens	  and	  establishing	  ways	  to	  inhibit	  them	  might	  result	  in	  interesting	  therapeutic	  advances.	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